JP5651291B2 - Polyethylene glycol derivative and process for producing the intermediate - Google Patents
Polyethylene glycol derivative and process for producing the intermediate Download PDFInfo
- Publication number
- JP5651291B2 JP5651291B2 JP2008104089A JP2008104089A JP5651291B2 JP 5651291 B2 JP5651291 B2 JP 5651291B2 JP 2008104089 A JP2008104089 A JP 2008104089A JP 2008104089 A JP2008104089 A JP 2008104089A JP 5651291 B2 JP5651291 B2 JP 5651291B2
- Authority
- JP
- Japan
- Prior art keywords
- mmol
- added
- room temperature
- silica gel
- thf
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000002202 Polyethylene glycol Substances 0.000 title claims description 9
- 229920001223 polyethylene glycol Polymers 0.000 title claims description 9
- 150000002334 glycols Chemical class 0.000 title description 5
- 238000000034 method Methods 0.000 title description 5
- 150000001875 compounds Chemical class 0.000 claims description 31
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 2
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 claims 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 297
- 239000000243 solution Substances 0.000 description 211
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 133
- 238000006243 chemical reaction Methods 0.000 description 126
- 238000005160 1H NMR spectroscopy Methods 0.000 description 119
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 112
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 112
- 238000001035 drying Methods 0.000 description 110
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 108
- UREBWPXBXRYXRJ-UHFFFAOYSA-N ethyl acetate;methanol Chemical compound OC.CCOC(C)=O UREBWPXBXRYXRJ-UHFFFAOYSA-N 0.000 description 108
- 239000012046 mixed solvent Substances 0.000 description 108
- 239000000741 silica gel Substances 0.000 description 108
- 229910002027 silica gel Inorganic materials 0.000 description 108
- 238000010898 silica gel chromatography Methods 0.000 description 108
- 239000002904 solvent Substances 0.000 description 108
- 238000003756 stirring Methods 0.000 description 108
- 239000000725 suspension Substances 0.000 description 104
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 103
- 239000002480 mineral oil Substances 0.000 description 103
- 235000010446 mineral oil Nutrition 0.000 description 103
- 239000012312 sodium hydride Substances 0.000 description 103
- 229910000104 sodium hydride Inorganic materials 0.000 description 103
- WGKYSFRFMQHMOF-UHFFFAOYSA-N 3-bromo-5-methylpyridine-2-carbonitrile Chemical compound CC1=CN=C(C#N)C(Br)=C1 WGKYSFRFMQHMOF-UHFFFAOYSA-N 0.000 description 85
- 229920000847 nonoxynol Polymers 0.000 description 85
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 56
- 239000000203 mixture Substances 0.000 description 47
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 40
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 33
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 30
- WRZXKWFJEFFURH-UHFFFAOYSA-N dodecaethylene glycol Chemical compound OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO WRZXKWFJEFFURH-UHFFFAOYSA-N 0.000 description 27
- HTZCNXWZYVXIMZ-UHFFFAOYSA-M benzyl(triethyl)azanium;chloride Chemical compound [Cl-].CC[N+](CC)(CC)CC1=CC=CC=C1 HTZCNXWZYVXIMZ-UHFFFAOYSA-M 0.000 description 22
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 21
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 13
- 0 CC(*)OCCC(C)(C)Oc1cccc(C(F)(F)F)c1 Chemical compound CC(*)OCCC(C)(C)Oc1cccc(C(F)(F)F)c1 0.000 description 9
- 230000010354 integration Effects 0.000 description 9
- 239000000543 intermediate Substances 0.000 description 8
- 238000000746 purification Methods 0.000 description 7
- ARNKHYQYAZLEEP-UHFFFAOYSA-N 1-naphthalen-1-yloxynaphthalene Chemical compound C1=CC=C2C(OC=3C4=CC=CC=C4C=CC=3)=CC=CC2=C1 ARNKHYQYAZLEEP-UHFFFAOYSA-N 0.000 description 6
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- YWYHGNUFMPSTTR-UHFFFAOYSA-N 1-methyl-4-(4-methylphenoxy)benzene Chemical compound C1=CC(C)=CC=C1OC1=CC=C(C)C=C1 YWYHGNUFMPSTTR-UHFFFAOYSA-N 0.000 description 5
- YYROPELSRYBVMQ-UHFFFAOYSA-N 4-toluenesulfonyl chloride Chemical compound CC1=CC=C(S(Cl)(=O)=O)C=C1 YYROPELSRYBVMQ-UHFFFAOYSA-N 0.000 description 5
- CGARGJZZBOHMIZ-UHFFFAOYSA-N methyl 4-(4-methoxycarbonylphenoxy)benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1OC1=CC=C(C(=O)OC)C=C1 CGARGJZZBOHMIZ-UHFFFAOYSA-N 0.000 description 5
- -1 polyoxyethylene (2,4-diisooctylphenyl) ether Polymers 0.000 description 5
- 238000000926 separation method Methods 0.000 description 5
- 125000001424 substituent group Chemical group 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- AJDONJVWDSZZQF-UHFFFAOYSA-N 1-(2,4,4-trimethylpentan-2-yl)-4-[4-(2,4,4-trimethylpentan-2-yl)phenoxy]benzene Chemical compound C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OC1=CC=C(C(C)(C)CC(C)(C)C)C=C1 AJDONJVWDSZZQF-UHFFFAOYSA-N 0.000 description 4
- KBDBBNZIVQWKGV-UHFFFAOYSA-N 1-(trifluoromethyl)-2-[2-(trifluoromethyl)phenoxy]benzene Chemical compound FC(F)(F)C1=CC=CC=C1OC1=CC=CC=C1C(F)(F)F KBDBBNZIVQWKGV-UHFFFAOYSA-N 0.000 description 4
- CBWUXOLLRSLJNU-UHFFFAOYSA-N 1-(trifluoromethyl)-3-[3-(trifluoromethyl)phenoxy]benzene Chemical compound FC(F)(F)C1=CC=CC(OC=2C=C(C=CC=2)C(F)(F)F)=C1 CBWUXOLLRSLJNU-UHFFFAOYSA-N 0.000 description 4
- WLZFDTRREUSCGR-UHFFFAOYSA-N 1-(trifluoromethyl)-4-[4-(trifluoromethyl)phenoxy]benzene Chemical compound C1=CC(C(F)(F)F)=CC=C1OC1=CC=C(C(F)(F)F)C=C1 WLZFDTRREUSCGR-UHFFFAOYSA-N 0.000 description 4
- ZGJHWJHXKZLZFC-UHFFFAOYSA-N 1-[2,4-bis(2-methylbutan-2-yl)phenoxy]-2,4-bis(2-methylbutan-2-yl)benzene Chemical compound CC(CC)(C)C1=C(C=CC(=C1)C(CC)(C)C)OC1=C(C=C(C=C1)C(CC)(C)C)C(CC)(C)C ZGJHWJHXKZLZFC-UHFFFAOYSA-N 0.000 description 4
- PLHWNVGKMDMLGU-UHFFFAOYSA-N 1-[3,5-bis(trifluoromethyl)phenoxy]-3,5-bis(trifluoromethyl)benzene Chemical compound FC(C=1C=C(C=C(C1)C(F)(F)F)OC1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)(F)F PLHWNVGKMDMLGU-UHFFFAOYSA-N 0.000 description 4
- ALSVFJIXSNRBLE-UHFFFAOYSA-N 1-bromo-3-(3-bromophenoxy)benzene Chemical compound BrC1=CC=CC(OC=2C=C(Br)C=CC=2)=C1 ALSVFJIXSNRBLE-UHFFFAOYSA-N 0.000 description 4
- YAWIAFUBXXPJMQ-UHFFFAOYSA-N 1-bromo-4-(4-bromophenoxy)benzene Chemical compound C1=CC(Br)=CC=C1OC1=CC=C(Br)C=C1 YAWIAFUBXXPJMQ-UHFFFAOYSA-N 0.000 description 4
- VHEGXFQQYZIMMF-UHFFFAOYSA-N 1-iodo-4-(4-iodophenoxy)benzene Chemical compound C1=CC(I)=CC=C1OC1=CC=C(I)C=C1 VHEGXFQQYZIMMF-UHFFFAOYSA-N 0.000 description 4
- VIOJQBMMOKZZMO-UHFFFAOYSA-N 2-(2,6-dimethylphenoxy)-1,3-dimethylbenzene Chemical compound CC1=CC=CC(C)=C1OC1=C(C)C=CC=C1C VIOJQBMMOKZZMO-UHFFFAOYSA-N 0.000 description 4
- RSAUOQFEFINEDM-UHFFFAOYSA-N 4-(4-cyanophenoxy)benzonitrile Chemical compound C1=CC(C#N)=CC=C1OC1=CC=C(C#N)C=C1 RSAUOQFEFINEDM-UHFFFAOYSA-N 0.000 description 4
- GXZZHLULZRMUQC-UHFFFAOYSA-N 4-(4-formylphenoxy)benzaldehyde Chemical compound C1=CC(C=O)=CC=C1OC1=CC=C(C=O)C=C1 GXZZHLULZRMUQC-UHFFFAOYSA-N 0.000 description 4
- YCUFSWSSTPKFHC-UHFFFAOYSA-N 4-methyl-2-(5-methyl-2-propan-2-ylphenoxy)-1-propan-2-ylbenzene Chemical compound CC(C)C1=CC=C(C)C=C1OC1=CC(C)=CC=C1C(C)C YCUFSWSSTPKFHC-UHFFFAOYSA-N 0.000 description 4
- DAVCBXCICIGLET-UHFFFAOYSA-N 6-(5,6,7,8-tetrahydronaphthalen-2-yloxy)-1,2,3,4-tetrahydronaphthalene Chemical compound C1CCCC2=CC(OC=3C=C4CCCCC4=CC=3)=CC=C21 DAVCBXCICIGLET-UHFFFAOYSA-N 0.000 description 4
- ILNMRZOJXLDNNY-UHFFFAOYSA-N 6-quinolin-6-yloxyquinoline Chemical compound N1=CC=CC2=CC(OC=3C=C4C=CC=NC4=CC=3)=CC=C21 ILNMRZOJXLDNNY-UHFFFAOYSA-N 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 230000003833 cell viability Effects 0.000 description 4
- 150000002148 esters Chemical class 0.000 description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 239000002246 antineoplastic agent Substances 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 230000030833 cell death Effects 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 150000002430 hydrocarbons Chemical group 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 229920006395 saturated elastomer Polymers 0.000 description 3
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 3
- 235000017557 sodium bicarbonate Nutrition 0.000 description 3
- ZBGCFGDFVQCFOT-UHFFFAOYSA-N 1,5-ditert-butyl-2-(2,4-ditert-butyl-5-methylphenoxy)-4-methylbenzene Chemical compound C(C)(C)(C)C1=C(C=C(C(=C1)C(C)(C)C)OC1=CC(=C(C=C1C(C)(C)C)C(C)(C)C)C)C ZBGCFGDFVQCFOT-UHFFFAOYSA-N 0.000 description 2
- WTJNUOZMYRVHKU-UHFFFAOYSA-N 1-(2-phenylpropan-2-yl)-4-[4-(2-phenylpropan-2-yl)phenoxy]benzene Chemical compound C=1C=C(OC=2C=CC(=CC=2)C(C)(C)C=2C=CC=CC=2)C=CC=1C(C)(C)C1=CC=CC=C1 WTJNUOZMYRVHKU-UHFFFAOYSA-N 0.000 description 2
- GUTHFMAFQRJHLG-UHFFFAOYSA-N 1-(trifluoromethoxy)-4-[4-(trifluoromethoxy)phenoxy]benzene Chemical compound C1=CC(OC(F)(F)F)=CC=C1OC1=CC=C(OC(F)(F)F)C=C1 GUTHFMAFQRJHLG-UHFFFAOYSA-N 0.000 description 2
- OHTSCIJMYOSITC-UHFFFAOYSA-N 1-[2,4-di(propan-2-yl)phenoxy]-2,4-di(propan-2-yl)benzene Chemical compound CC(C)C1=CC(C(C)C)=CC=C1OC1=CC=C(C(C)C)C=C1C(C)C OHTSCIJMYOSITC-UHFFFAOYSA-N 0.000 description 2
- VNASEHKLANBWAG-UHFFFAOYSA-N 1-[2-[2-(1-adamantyl)-4-methylphenoxy]-5-methylphenyl]adamantane Chemical compound C12(CC3CC(CC(C1)C3)C2)C1=C(C=CC(=C1)C)OC1=C(C=C(C=C1)C)C12CC3CC(CC(C1)C3)C2 VNASEHKLANBWAG-UHFFFAOYSA-N 0.000 description 2
- RUPNWDBWENLZPP-UHFFFAOYSA-N 1-[4-[4-(1-adamantyl)phenoxy]phenyl]adamantane Chemical compound C12(CC3CC(CC(C1)C3)C2)C1=CC=C(C=C1)OC1=CC=C(C=C1)C12CC3CC(CC(C1)C3)C2 RUPNWDBWENLZPP-UHFFFAOYSA-N 0.000 description 2
- YSJKKWSWPSQIDP-UHFFFAOYSA-N 1-benzyl-4-(4-benzylphenoxy)benzene Chemical compound C=1C=C(OC=2C=CC(CC=3C=CC=CC=3)=CC=2)C=CC=1CC1=CC=CC=C1 YSJKKWSWPSQIDP-UHFFFAOYSA-N 0.000 description 2
- UUOHDCMKZCBADU-UHFFFAOYSA-N 1-bromo-2-(2-bromo-4,6-difluorophenoxy)-3,5-difluorobenzene Chemical compound BrC1=C(C(=CC(=C1)F)F)OC1=C(C=C(C=C1F)F)Br UUOHDCMKZCBADU-UHFFFAOYSA-N 0.000 description 2
- URUJZHZLCCIILC-UHFFFAOYSA-N 1-chloro-4-(4-chlorophenoxy)benzene Chemical compound C1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1 URUJZHZLCCIILC-UHFFFAOYSA-N 0.000 description 2
- UMAHIEDJGKQIIJ-UHFFFAOYSA-N 1-cyclohexyl-4-(4-cyclohexylphenoxy)benzene Chemical compound C1CCCCC1C(C=C1)=CC=C1OC1=CC=C(C2CCCCC2)C=C1 UMAHIEDJGKQIIJ-UHFFFAOYSA-N 0.000 description 2
- RNKYSBXAAQYWKF-UHFFFAOYSA-N 1-dodecyl-4-(4-dodecylphenoxy)benzene Chemical compound C1=CC(CCCCCCCCCCCC)=CC=C1OC1=CC=C(CCCCCCCCCCCC)C=C1 RNKYSBXAAQYWKF-UHFFFAOYSA-N 0.000 description 2
- VRSYBSHYSIABHO-UHFFFAOYSA-N 1-ethyl-4-(4-ethylphenoxy)benzene Chemical compound C1=CC(CC)=CC=C1OC1=CC=C(CC)C=C1 VRSYBSHYSIABHO-UHFFFAOYSA-N 0.000 description 2
- SXOMQCWKYXDRAM-UHFFFAOYSA-N 1-fluoro-3-(3-fluorophenoxy)benzene Chemical compound FC1=CC=CC(OC=2C=C(F)C=CC=2)=C1 SXOMQCWKYXDRAM-UHFFFAOYSA-N 0.000 description 2
- UUKHFGSOCZLVJO-UHFFFAOYSA-N 1-fluoro-4-(4-fluorophenoxy)benzene Chemical compound C1=CC(F)=CC=C1OC1=CC=C(F)C=C1 UUKHFGSOCZLVJO-UHFFFAOYSA-N 0.000 description 2
- OQDTVHIDNIUURR-UHFFFAOYSA-N 1-methoxy-3-(3-methoxyphenoxy)benzene Chemical compound COC1=CC=CC(OC=2C=C(OC)C=CC=2)=C1 OQDTVHIDNIUURR-UHFFFAOYSA-N 0.000 description 2
- CBDLNOVOFXJEOB-UHFFFAOYSA-N 1-methoxy-4-(4-methoxyphenoxy)benzene Chemical compound C1=CC(OC)=CC=C1OC1=CC=C(OC)C=C1 CBDLNOVOFXJEOB-UHFFFAOYSA-N 0.000 description 2
- GQGTXJRZSBTHOB-UHFFFAOYSA-N 1-phenoxy-4-(4-phenoxyphenoxy)benzene Chemical compound C=1C=C(OC=2C=CC(OC=3C=CC=CC=3)=CC=2)C=CC=1OC1=CC=CC=C1 GQGTXJRZSBTHOB-UHFFFAOYSA-N 0.000 description 2
- ZQKIYXRPCVRJTG-UHFFFAOYSA-N 1-trityl-4-(4-tritylphenoxy)benzene Chemical compound C=1C=C(C(C=2C=CC=CC=2)(C=2C=CC=CC=2)C=2C=CC=CC=2)C=CC=1OC(C=C1)=CC=C1C(C=1C=CC=CC=1)(C=1C=CC=CC=1)C1=CC=CC=C1 ZQKIYXRPCVRJTG-UHFFFAOYSA-N 0.000 description 2
- QOCLRPMIJGICFT-UHFFFAOYSA-N 2,4-ditert-butyl-1-(2,4-ditert-butylphenoxy)benzene Chemical compound CC(C)(C)C1=CC(C(C)(C)C)=CC=C1OC1=CC=C(C(C)(C)C)C=C1C(C)(C)C QOCLRPMIJGICFT-UHFFFAOYSA-N 0.000 description 2
- CMBWXJSVIYPVHX-UHFFFAOYSA-N 2-methoxy-1-(2-methoxy-4-prop-2-enylphenoxy)-4-prop-2-enylbenzene Chemical compound COC1=CC(CC=C)=CC=C1OC1=CC=C(CC=C)C=C1OC CMBWXJSVIYPVHX-UHFFFAOYSA-N 0.000 description 2
- DZRLNYVDCIYXPG-UHFFFAOYSA-N 2-naphthalen-2-yloxynaphthalene Chemical compound C1=CC=CC2=CC(OC=3C=C4C=CC=CC4=CC=3)=CC=C21 DZRLNYVDCIYXPG-UHFFFAOYSA-N 0.000 description 2
- HLIQXNLGRSPOGR-UHFFFAOYSA-N 2-tert-butyl-1-(2-tert-butyl-4-methoxyphenoxy)-4-methoxybenzene Chemical compound C(C)(C)(C)C1=C(C=CC(=C1)OC)OC1=C(C=C(C=C1)OC)C(C)(C)C HLIQXNLGRSPOGR-UHFFFAOYSA-N 0.000 description 2
- VZUJTDYSGISPLP-UHFFFAOYSA-N 3-pyridin-3-yloxypyridine Chemical compound C=1C=CN=CC=1OC1=CC=CN=C1 VZUJTDYSGISPLP-UHFFFAOYSA-N 0.000 description 2
- COVLJFPCJHIAGW-UHFFFAOYSA-N 4-(1h-indol-4-yloxy)-1h-indole Chemical compound C=1C=CC=2NC=CC=2C=1OC1=CC=CC2=C1C=CN2 COVLJFPCJHIAGW-UHFFFAOYSA-N 0.000 description 2
- NBSVQJVZYVYKMG-UHFFFAOYSA-N 5-(1,3-benzodioxol-5-yloxy)-1,3-benzodioxole Chemical compound C1=C2OCOC2=CC(OC2=CC=C3OCOC3=C2)=C1 NBSVQJVZYVYKMG-UHFFFAOYSA-N 0.000 description 2
- YWNCNIGGQYTRAR-UHFFFAOYSA-N 5-(1h-indol-5-yloxy)-1h-indole Chemical compound C1=C2NC=CC2=CC(OC=2C=C3C=CNC3=CC=2)=C1 YWNCNIGGQYTRAR-UHFFFAOYSA-N 0.000 description 2
- LTNGKRLVNSXLJK-UHFFFAOYSA-N 5-isoquinolin-5-yloxyisoquinoline Chemical compound C1=NC=CC=2C(=CC=CC1=2)OC1=C2C=CN=CC2=CC=C1 LTNGKRLVNSXLJK-UHFFFAOYSA-N 0.000 description 2
- BUOOILDXMZLGBP-UHFFFAOYSA-N 5-quinolin-5-yloxyquinoline Chemical compound C1=CC=C2C(OC=3C4=CC=CN=C4C=CC=3)=CC=CC2=N1 BUOOILDXMZLGBP-UHFFFAOYSA-N 0.000 description 2
- MIMNIOYYFCCNCI-UHFFFAOYSA-N 7-[(2-oxo-3,4-dihydro-1H-quinolin-7-yl)oxy]-3,4-dihydro-1H-quinolin-2-one Chemical compound N1C(CCC2=CC=C(C=C12)OC1=CC=C2CCC(NC2=C1)=O)=O MIMNIOYYFCCNCI-UHFFFAOYSA-N 0.000 description 2
- FVMVDAUPKOXTJX-UHFFFAOYSA-N 8-quinolin-8-yloxyquinoline Chemical compound C1=CN=C2C(OC=3C4=NC=CC=C4C=CC=3)=CC=CC2=C1 FVMVDAUPKOXTJX-UHFFFAOYSA-N 0.000 description 2
- GUJDGMNFWKEEMZ-UHFFFAOYSA-N C(C)(C)(C)C1=C(C=CC(=C1)CC)OC1=C(C=C(C=C1)CC)C(C)(C)C Chemical compound C(C)(C)(C)C1=C(C=CC(=C1)CC)OC1=C(C=C(C=C1)CC)C(C)(C)C GUJDGMNFWKEEMZ-UHFFFAOYSA-N 0.000 description 2
- ZJOQCELMMDEVFU-UHFFFAOYSA-N C(C)(C)OC(=O)C1=CC=C(C=C1)OC1=CC=C(C=C1)C(=O)OC(C)C Chemical compound C(C)(C)OC(=O)C1=CC=C(C=C1)OC1=CC=C(C=C1)C(=O)OC(C)C ZJOQCELMMDEVFU-UHFFFAOYSA-N 0.000 description 2
- YEWYEKWVQOAHOX-UHFFFAOYSA-N C(CCCCCCCCCCC)C1=C(C=CC(=C1)C)OC1=C(C=C(C=C1)C)CCCCCCCCCCCC Chemical compound C(CCCCCCCCCCC)C1=C(C=CC(=C1)C)OC1=C(C=C(C=C1)C)CCCCCCCCCCCC YEWYEKWVQOAHOX-UHFFFAOYSA-N 0.000 description 2
- RVRBWBOPKCHGLM-UHFFFAOYSA-N C(CCCCCCCCCCC)C1=CC(=C(C=C1)OC1=C(C=C(C=C1)CCCCCCCCCCCC)C)C Chemical compound C(CCCCCCCCCCC)C1=CC(=C(C=C1)OC1=C(C=C(C=C1)CCCCCCCCCCCC)C)C RVRBWBOPKCHGLM-UHFFFAOYSA-N 0.000 description 2
- WSRGOAGHEYPDRI-UHFFFAOYSA-N C1CCC2=CC(=CC=C12)OC=1C=C2CCCC2=CC1 Chemical compound C1CCC2=CC(=CC=C12)OC=1C=C2CCCC2=CC1 WSRGOAGHEYPDRI-UHFFFAOYSA-N 0.000 description 2
- SEBPXHSZHLFWRL-UHFFFAOYSA-N CC(C)(CCc1c2C)Oc1c(C)c(C)c2O Chemical compound CC(C)(CCc1c2C)Oc1c(C)c(C)c2O SEBPXHSZHLFWRL-UHFFFAOYSA-N 0.000 description 2
- DLJDVXBIFAIOFV-UHFFFAOYSA-N CC1(OC2=C(C(=C(C(=C2CC1)C)OC=1C(=C2CCC(OC2=C(C=1C)C)(C)C)C)C)C)C Chemical compound CC1(OC2=C(C(=C(C(=C2CC1)C)OC=1C(=C2CCC(OC2=C(C=1C)C)(C)C)C)C)C)C DLJDVXBIFAIOFV-UHFFFAOYSA-N 0.000 description 2
- CMMGEVGTZSDNFN-UHFFFAOYSA-N CC1(OC2=C(C1)C=CC=C2OC1=CC=CC=2CC(OC=21)(C)C)C Chemical compound CC1(OC2=C(C1)C=CC=C2OC1=CC=CC=2CC(OC=21)(C)C)C CMMGEVGTZSDNFN-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- RQZMBFMQSSMQKJ-UHFFFAOYSA-N N1C(CCC2=CC(=CC=C12)OC=1C=C2CCC(NC2=CC=1)=O)=O Chemical compound N1C(CCC2=CC(=CC=C12)OC=1C=C2CCC(NC2=CC=1)=O)=O RQZMBFMQSSMQKJ-UHFFFAOYSA-N 0.000 description 2
- XTQYNKFHRKIHFA-UHFFFAOYSA-N N=1N(N=C2C=1C=CC=C2)C1=C(C=CC(=C1)CC(CC(C)C)(C)C)OC1=C(C=C(C=C1)CC(CC(C)C)(C)C)N1N=C2C(=N1)C=CC=C2 Chemical compound N=1N(N=C2C=1C=CC=C2)C1=C(C=CC(=C1)CC(CC(C)C)(C)C)OC1=C(C=C(C=C1)CC(CC(C)C)(C)C)N1N=C2C(=N1)C=CC=C2 XTQYNKFHRKIHFA-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- RFESNAMUUSDBQQ-UHFFFAOYSA-N [4-(4-benzoylphenoxy)phenyl]-phenylmethanone Chemical compound C=1C=C(OC=2C=CC(=CC=2)C(=O)C=2C=CC=CC=2)C=CC=1C(=O)C1=CC=CC=C1 RFESNAMUUSDBQQ-UHFFFAOYSA-N 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 229910052728 basic metal Inorganic materials 0.000 description 2
- 238000004166 bioassay Methods 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- BOTLEXFFFSMRLQ-UHFFFAOYSA-N cyclopentyloxycyclopentane Chemical compound C1CCCC1OC1CCCC1 BOTLEXFFFSMRLQ-UHFFFAOYSA-N 0.000 description 2
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical group C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 2
- 239000003480 eluent Substances 0.000 description 2
- RJSQMNBJPSWPTF-UHFFFAOYSA-N ethyl 4-(4-ethoxycarbonylphenoxy)benzoate Chemical compound C1=CC(C(=O)OCC)=CC=C1OC1=CC=C(C(=O)OCC)C=C1 RJSQMNBJPSWPTF-UHFFFAOYSA-N 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- SRFOAYBAHXFDEW-UHFFFAOYSA-N methyl 2-[4-[4-(2-methoxy-2-oxoethyl)phenoxy]phenyl]acetate Chemical compound C1=CC(CC(=O)OC)=CC=C1OC1=CC=C(CC(=O)OC)C=C1 SRFOAYBAHXFDEW-UHFFFAOYSA-N 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- BUGCHAIWUSBYIZ-UHFFFAOYSA-N n-[4-(4-acetamidophenoxy)phenyl]acetamide Chemical compound C1=CC(NC(=O)C)=CC=C1OC1=CC=C(NC(C)=O)C=C1 BUGCHAIWUSBYIZ-UHFFFAOYSA-N 0.000 description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- RNOJOOFUHCJCSQ-UHFFFAOYSA-N 1-(2,4-dimethylphenoxy)-2,4-dimethylbenzene Chemical compound CC1=CC(C)=CC=C1OC1=CC=C(C)C=C1C RNOJOOFUHCJCSQ-UHFFFAOYSA-N 0.000 description 1
- GZRGHDIUPMPHCB-UHFFFAOYSA-N 1-[4-(4-acetylphenoxy)phenyl]ethanone Chemical compound C1=CC(C(=O)C)=CC=C1OC1=CC=C(C(C)=O)C=C1 GZRGHDIUPMPHCB-UHFFFAOYSA-N 0.000 description 1
- LPVUODKKDACXRD-UHFFFAOYSA-N 2-[4-[4-(2-aminoethyl)phenoxy]phenyl]ethanamine Chemical compound C1=CC(CCN)=CC=C1OC1=CC=C(CCN)C=C1 LPVUODKKDACXRD-UHFFFAOYSA-N 0.000 description 1
- WVDRSXGPQWNUBN-UHFFFAOYSA-N 4-(4-carboxyphenoxy)benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1OC1=CC=C(C(O)=O)C=C1 WVDRSXGPQWNUBN-UHFFFAOYSA-N 0.000 description 1
- HLBLWEWZXPIGSM-UHFFFAOYSA-N 4-Aminophenyl ether Chemical compound C1=CC(N)=CC=C1OC1=CC=C(N)C=C1 HLBLWEWZXPIGSM-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- MJYOOIUOSPIWCK-UHFFFAOYSA-P CC(C)OCC(C)(C)OS(c1ccc(C)cc1)([OH2+])[OH2+] Chemical compound CC(C)OCC(C)(C)OS(c1ccc(C)cc1)([OH2+])[OH2+] MJYOOIUOSPIWCK-UHFFFAOYSA-P 0.000 description 1
- SIFSNFNVXCYDFZ-UHFFFAOYSA-N CC(C)OCCC(C)(C)Oc(cc1)cc2c1nccc2 Chemical compound CC(C)OCCC(C)(C)Oc(cc1)cc2c1nccc2 SIFSNFNVXCYDFZ-UHFFFAOYSA-N 0.000 description 1
- IWKCXIBFVZSMGZ-UHFFFAOYSA-N CCOCCC(C)(C)Oc1c(C)c(C)c2OC(C)(C)CCc2c1C Chemical compound CCOCCC(C)(C)Oc1c(C)c(C)c2OC(C)(C)CCc2c1C IWKCXIBFVZSMGZ-UHFFFAOYSA-N 0.000 description 1
- KXDHJXZQYSOELW-UHFFFAOYSA-N Carbamic acid Chemical group NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 description 1
- SHXUNFVMTROYPY-UHFFFAOYSA-N Cc(cc1)ccc1SOCCO Chemical compound Cc(cc1)ccc1SOCCO SHXUNFVMTROYPY-UHFFFAOYSA-N 0.000 description 1
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- NIPKXTKKYSKEON-UHFFFAOYSA-N Oc1ccc(C(c2ccccc2)(c2ccccc2)c2ccccc2)cc1 Chemical compound Oc1ccc(C(c2ccccc2)(c2ccccc2)c2ccccc2)cc1 NIPKXTKKYSKEON-UHFFFAOYSA-N 0.000 description 1
- OVYWMEWYEJLIER-UHFFFAOYSA-N Oc1ccc2ncccc2c1 Chemical compound Oc1ccc2ncccc2c1 OVYWMEWYEJLIER-UHFFFAOYSA-N 0.000 description 1
- UGEJOEBBMPOJMT-UHFFFAOYSA-N Oc1cccc(C(F)(F)F)c1 Chemical compound Oc1cccc(C(F)(F)F)c1 UGEJOEBBMPOJMT-UHFFFAOYSA-N 0.000 description 1
- 208000002495 Uterine Neoplasms Diseases 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000011481 absorbance measurement Methods 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 125000002723 alicyclic group Chemical group 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 125000003342 alkenyl group Chemical group 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 125000005018 aryl alkenyl group Chemical group 0.000 description 1
- 125000003710 aryl alkyl group Chemical group 0.000 description 1
- KCXMKQUNVWSEMD-UHFFFAOYSA-N benzyl chloride Chemical compound ClCC1=CC=CC=C1 KCXMKQUNVWSEMD-UHFFFAOYSA-N 0.000 description 1
- 229940073608 benzyl chloride Drugs 0.000 description 1
- 125000006269 biphenyl-2-yl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C1=C(*)C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 229940125782 compound 2 Drugs 0.000 description 1
- 125000004093 cyano group Chemical group *C#N 0.000 description 1
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 description 1
- 125000000753 cycloalkyl group Chemical group 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 239000000411 inducer Substances 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- SIAPCJWMELPYOE-UHFFFAOYSA-N lithium hydride Chemical compound [LiH] SIAPCJWMELPYOE-UHFFFAOYSA-N 0.000 description 1
- 229910000103 lithium hydride Inorganic materials 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 230000002438 mitochondrial effect Effects 0.000 description 1
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 1
- YZUUTMGDONTGTN-UHFFFAOYSA-N nonaethylene glycol Chemical compound OCCOCCOCCOCCOCCOCCOCCOCCOCCO YZUUTMGDONTGTN-UHFFFAOYSA-N 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000003444 phase transfer catalyst Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 1
- 229930195734 saturated hydrocarbon Natural products 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- JRMUNVKIHCOMHV-UHFFFAOYSA-M tetrabutylammonium bromide Chemical compound [Br-].CCCC[N+](CCCC)(CCCC)CCCC JRMUNVKIHCOMHV-UHFFFAOYSA-M 0.000 description 1
- DPKBAXPHAYBPRL-UHFFFAOYSA-M tetrabutylazanium;iodide Chemical compound [I-].CCCC[N+](CCCC)(CCCC)CCCC DPKBAXPHAYBPRL-UHFFFAOYSA-M 0.000 description 1
- ZMANZCXQSJIPKH-UHFFFAOYSA-O triethylammonium ion Chemical compound CC[NH+](CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-O 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 229930195735 unsaturated hydrocarbon Natural products 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N urea group Chemical group NC(=O)N XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 206010046766 uterine cancer Diseases 0.000 description 1
Landscapes
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Quinoline Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Furan Compounds (AREA)
- Pyridine Compounds (AREA)
- Pyrane Compounds (AREA)
- Steroid Compounds (AREA)
- Indole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Polyethers (AREA)
Description
本発明は、ポリエチレングリコールの誘導体およびその中間体の製造方法に関する。 The present invention relates to a method for producing a polyethylene glycol derivative and an intermediate thereof.
細胞死を誘導する化合物あるいは細胞死を誘導する化合物の作用を増強する化合物としては種々の化合物が知られており、種々の疾患の予防あるいは治療用の医薬における有効成分としての利用についての検討は盛んに行なわれている。 Various compounds are known as compounds that induce cell death or compounds that enhance the action of compounds that induce cell death, and studies on their use as active ingredients in drugs for the prevention or treatment of various diseases It is actively performed.
細胞死誘導剤及び抗癌剤の活性成分として利用可能なポリエチレングリコール誘導体(例えば、ポリオキシエチレン(2,4−ジイソオクチルフェニル)エーテル)およびその製造方法については、WO2006/043338号(A1)パンフレット、WO2006/043353号(A1)パンフレット及びWO2006/134648号(A1)パンフレットに記載されている。 For a polyethylene glycol derivative (for example, polyoxyethylene (2,4-diisooctylphenyl) ether) that can be used as an active ingredient of a cell death inducer and an anticancer agent, and a method for producing the same, WO 2006/043338 (A1) pamphlet, It is described in WO2006 / 043353 (A1) pamphlet and WO2006 / 134648 (A1) pamphlet.
更に、かかるポリエチレングリコール誘導体の合成についてはOrg. Lett., 2002, 4, 2329-2332に記載されている。
上記のポリエチレングリコール誘導体の製造中間体の製造工程では、高価な金属試薬と厳密な無水条件下を必要とするとう課題があった。本発明は、かかる課題を解決して抗腫瘍剤の有効成分として有用な多くの化合物を提供し、そしてこれらの化合物の合成中間体の、より簡便な製造方法を提供することを目的としている。 In the production process of the intermediate for producing the polyethylene glycol derivative, there is a problem that an expensive metal reagent and strict anhydrous conditions are required. An object of the present invention is to solve such problems and provide many compounds useful as an active ingredient of an antitumor agent, and to provide a simpler method for producing synthetic intermediates of these compounds.
本発明のポリエチレングリコールモノエーテル化合物は、下記式(1)で表される化合物である。 The polyethylene glycol monoether compound of the present invention is a compound represented by the following formula (1).
(上記式(1)中のRは置換基を有していてもよい炭化水素基を示し、nは正の整数を示す。)
上記(1)の化合物の製造は、以下の式(2)の化合物を中間体として効率良く製造することができる。
(R in the above formula (1) represents a hydrocarbon group which may have a substituent, and n represents a positive integer.)
The compound of the above (1) can be efficiently produced using a compound of the following formula (2) as an intermediate.
(上記式(2)の中のnは正の整数を示す。)
この中間体化合物は、下記式(3):
(N in the above formula (2) represents a positive integer.)
This intermediate compound has the following formula (3):
(上記式(3)の中のnは正の整数を示す。)
で表されるポリエチレングリコール化合物の、一方の水酸基のみをパラトルエンスルホニルエステル化することにより得ることができる。
(N in the above formula (3) represents a positive integer.)
It can obtain by carrying out the paratoluenesulfonyl esterification of only one hydroxyl group of the polyethyleneglycol compound represented by these.
本発明によれば、抗腫瘍剤などの有効成分として有用な化合物を提供することができる。また、上記の効率良い中間体化合物の製造方法により、かかる有用な化合物の効率良い製造が可能となる。 According to the present invention, a compound useful as an active ingredient such as an antitumor agent can be provided. In addition, the above efficient production method of an intermediate compound enables efficient production of such a useful compound.
上記式(1)におけるRとしては、脂肪族、脂環族、芳香族、芳香脂肪族等の各種の飽和または不飽和の炭化水素基を挙げることができる。具体例としては、アルキル基、シクロアルキル基、シクロアルキルアルキル基、アリール基、アリールアルキル基、アルケニル基、アリールアルケニル基などが例示される。Rが置換基により置換されている場合における置換基としては、上記の炭化水素基を、更には、アルコキシ基、アシル基、シアノ基、カーバメート基、ウレア基等の含窒素置換基、水素原子、フッ素原子、塩素原子、臭素原子、ヨウ素原子などのハロゲン原子などを挙げることができる。このましい置換基としては後述する実施例に記載される置換基を挙げることができる。nとして好適な数は、後述する実施例に記載される数を挙げることができる。 Examples of R in the above formula (1) include various saturated or unsaturated hydrocarbon groups such as aliphatic, alicyclic, aromatic and araliphatic. Specific examples include an alkyl group, a cycloalkyl group, a cycloalkylalkyl group, an aryl group, an arylalkyl group, an alkenyl group, and an arylalkenyl group. As the substituent in the case where R is substituted with a substituent, the above-described hydrocarbon group, and further, a nitrogen-containing substituent such as an alkoxy group, an acyl group, a cyano group, a carbamate group, a urea group, a hydrogen atom, Examples thereof include halogen atoms such as fluorine atom, chlorine atom, bromine atom and iodine atom. Examples of the preferable substituent include the substituents described in Examples described later. Suitable numbers for n include the numbers described in the examples described later.
上記式(1)の化合物およびその塩(例えば薬理学的に許容される塩)には抗腫瘍活性を有するものがあり、その代表例について実施例に示すが、本発明は実施例に限定されるものではない。 Some compounds of the above formula (1) and salts thereof (for example, pharmacologically acceptable salts) have antitumor activity, and typical examples thereof are shown in the Examples, but the present invention is limited to the Examples. It is not something.
上記式(1)の化合物は、その中間体化合物(式(2)で示される化合物)のパラトルエンスルホニル基をRに置換することで合成可能である。 The compound of the above formula (1) can be synthesized by substituting R for the paratoluenesulfonyl group of the intermediate compound (the compound represented by the formula (2)).
反応は、水、水と任意の割合で混和しない溶媒及び水溶性である塩基性の金属塩の存在下、空気雰囲気下で行うことができる。溶媒としては実施例で用いているものの他に、ジクロロメタンを挙げることができる。塩基性の金属塩としては、実施例において使用しているものに加えて、炭酸ナトリウム、炭酸水素ナトリウム、水素化リチウム、水酸化カリウムなどを挙げることができる。触媒としては、、実施例において使用しているものに加えて、臭化テトラブチルアンモニウム、ヨウ化テトラブチルアンモニウム、臭化セチルトリメチルアンモニウムなどの4級アンモニウム塩を挙げることができる。反応温度は、室温を含む範囲から適宜設定できる。反応終了後、反応液から目的とする式(1)で示され化合物を回収する。この回収には、ろ過、各種のクロマトグラフィーを利用した分離方法などの常法を用いることができる。 The reaction can be carried out in an air atmosphere in the presence of water, a solvent immiscible with water in any proportion, and a basic metal salt that is water-soluble. In addition to those used in the examples, dichloromethane can be used as the solvent. Examples of the basic metal salt include sodium carbonate, sodium hydrogen carbonate, lithium hydride, potassium hydroxide and the like in addition to those used in the examples. Examples of the catalyst include quaternary ammonium salts such as tetrabutylammonium bromide, tetrabutylammonium iodide, cetyltrimethylammonium bromide in addition to those used in the examples. The reaction temperature can be appropriately set from a range including room temperature. After completion of the reaction, the desired compound represented by the formula (1) is recovered from the reaction solution. For this recovery, conventional methods such as filtration and separation methods using various chromatographies can be used.
また、この中間体化合物(式(2)で示される化合物)は、上記式(3)のポリエチレングリコールと塩化パラトルエンスルホニルをトルエン等の不活性溶媒中で水酸化ナトリウム等のアルカリ水溶液および塩化ベンジルトリエチルアンモニウム等の相間移動触媒の存在下で反応させることにより得ることができる。反応温度は、室温を含む範囲から適宜設定できる。反応終了後、反応液から目的とする式(2)で示され化合物を回収する。この回収には、ろ過、各種のクロマトグラフィーを利用した分離方法などの常法を用いることができる。 Further, this intermediate compound (compound represented by formula (2)) is prepared by mixing polyethylene glycol of formula (3) and paratoluenesulfonyl chloride with an alkaline aqueous solution such as sodium hydroxide and benzyl chloride in an inert solvent such as toluene. It can be obtained by reacting in the presence of a phase transfer catalyst such as triethylammonium. The reaction temperature can be appropriately set from a range including room temperature. After completion of the reaction, the desired compound represented by the formula (2) is recovered from the reaction solution. For this recovery, conventional methods such as filtration and separation methods using various chromatographies can be used.
上記の合成における経路を以下の反応スキームとして示す。 The route in the above synthesis is shown as the following reaction scheme.
以下実施例により本発明を詳細に説明する。 Hereinafter, the present invention will be described in detail by way of examples.
(実施例1)
Nonaethylene glycol mono(p-toluenesulfonyl) ester (5)
Example 1
Nonaethylene glycol mono (p-toluenesulfonyl) ester (5)
ノナエチレングリコール 2 (1.00 g, 2.41 mmol) をトルエン (10 mL) に溶解させた。これに塩化ベンジルトリエチルアンモニウム (0.05 g, 0.24 mmol) および20% 水酸化ナトリウム水溶液 (10 mL) を加え撹拌した。このものに塩化p-トルエンスルホニル (0.53 g, 2.75 mmol) のトルエン (5.0 mL) 溶液を添加し、室温で18時間撹拌を続けた。その後10% 塩酸 (25 mL) を加えトルエン層と水層を分離した。水層は酢酸エチル (25 mL×3) で抽出した。トルエン層と 酢酸エチル層を合し、水 (20 mL)、飽和重曹水 (20 mL)、飽和食塩水 (20 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 20 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 200 対 1 → 16 対 1) で分離精製し、無色液体5 (0.88 g, 1.55 mmol, 収率 64%) を得た。IR(ATR)v max cm-1: 3433。1H-NMR(CDCl3)δ: 2.27 (3H, s), 2.93 (1H, br), 3.56-3.64 (34H, br), 4,14 (2H, t, J=5.0 Hz), 7.34 (2H, d, J=8.4 Hz), 7.79 (2H, d, J=8.4 Hz)。 Nonaethylene glycol 2 (1.00 g, 2.41 mmol) was dissolved in toluene (10 mL). To this, benzyltriethylammonium chloride (0.05 g, 0.24 mmol) and 20% aqueous sodium hydroxide solution (10 mL) were added and stirred. To this was added a solution of p-toluenesulfonyl chloride (0.53 g, 2.75 mmol) in toluene (5.0 mL), and stirring was continued at room temperature for 18 hours. Thereafter, 10% hydrochloric acid (25 mL) was added, and the toluene layer and the aqueous layer were separated. The aqueous layer was extracted with ethyl acetate (25 mL × 3). The toluene layer and the ethyl acetate layer were combined and washed successively with water (20 mL), saturated aqueous sodium hydrogen carbonate (20 mL), and saturated brine (20 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The resulting residue was separated and purified by silica gel column chromatography (silica gel: 20 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 200 to 1 → 16 to 1), and colorless liquid 5 (0.88 g, 1.55 mmol) Yield 64%). IR (ATR) v max cm -1 : 3433. 1 H-NMR (CDCl 3 ) δ: 2.27 (3H, s), 2.93 (1H, br), 3.56-3.64 (34H, br), 4,14 (2H, t, J = 5.0 Hz), 7.34 (2H , d, J = 8.4 Hz), 7.79 (2H, d, J = 8.4 Hz).
Nonaethylene glycol monophenyl ether (9b) Nonaethylene glycol monophenyl ether (9b)
7b (100 mg, 1.07 mmol) を THF (1.0 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 50 mg, 1.25 mmol) を加え室温にて1時間撹拌した。このものに 5 (206 mg, 0.36 mmol) の THF (1.0 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を酢酸エチル (10 mL) で希釈し、水 (10 mL)、飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 6 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 15 対 1) で分離精製し、9b (99 mg, 0.20 mmol, 収率 56%) を得た。1H-NMR(CDCl3)δ: 1.78 (1H, br), 3.58-3.74 (32H, br), 3.85 (2H, t, J=5.2 Hz), 4,12 (2H, t, J=5.2 Hz), 6.89-6.95 (2H, m), 7.23-7.29 (3H, m)。 7b (100 mg, 1.07 mmol) was dissolved in THF (1.0 mL). To this, sodium hydride (mineral oil suspension, purity 60%, 50 mg, 1.25 mmol) was added and stirred at room temperature for 1 hour. To this was added a solution of 5 (206 mg, 0.36 mmol) in THF (1.0 mL) and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with ethyl acetate (10 mL), and washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The obtained residue was separated and purified by silica gel column chromatography (silica gel: 6 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 15 to 1), 9b (99 mg, 0.20 mmol, yield 56%) Got. 1 H-NMR (CDCl 3 ) δ: 1.78 (1H, br), 3.58-3.74 (32H, br), 3.85 (2H, t, J = 5.2 Hz), 4,12 (2H, t, J = 5.2 Hz ), 6.89-6.95 (2H, m), 7.23-7.29 (3H, m).
Nonaethylene glycol mono(2,6-dimethylphenyl) ether (9c) Nonaethylene glycol mono (2,6-dimethylphenyl) ether (9c)
7c (130 mg, 1.07 mmol) を THF (1.5 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 52 mg, 1.30 mmol) を加え室温にて1時間撹拌した。このものに 5 (192 mg, 0.34 mmol) の THF (1.5 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を酢酸エチル (10 mL) で希釈し、水 (10 mL)、飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 6 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 15 対 1) で分離精製し、9c (146 mg, 0.28 mmol, 収率 83%) を得た。1H-NMR(CDCl3)δ: 2.16 (1H, br), 2.27 (6H, s), 3.58-3.75 (32H, br), 3.81 (2H, t, J=5.0 Hz), 3.93 (2H, t, J=5.0 Hz) 6.87-7.00 (3H, m)。 7c (130 mg, 1.07 mmol) was dissolved in THF (1.5 mL). To this, sodium hydride (mineral oil suspension, purity 60%, 52 mg, 1.30 mmol) was added and stirred at room temperature for 1 hour. To this was added a solution of 5 (192 mg, 0.34 mmol) in THF (1.5 mL) and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with ethyl acetate (10 mL), and washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The resulting residue was separated and purified by silica gel column chromatography (silica gel: 6 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 15 to 1), and 9c (146 mg, 0.28 mmol, 83% yield) Got. 1 H-NMR (CDCl 3 ) δ: 2.16 (1H, br), 2.27 (6H, s), 3.58-3.75 (32H, br), 3.81 (2H, t, J = 5.0 Hz), 3.93 (2H, t , J = 5.0 Hz) 6.87-7.00 (3H, m).
Nonaethylene glycol mono(3-bromophenyl) ether (9f) Nonaethylene glycol mono (3-bromophenyl) ether (9f)
7f (76 mg, 0.44 mmol) を THF (1.0 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 22 mg, 0.55 mmol) を加え室温にて1時間撹拌した。このものに 5 (95 mg, 0.17 mmol) の THF (1.0 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を酢酸エチル (10 mL) で希釈し、水 (10 mL)、飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 4 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 10 対 1) で分離精製し、9f (87 mg, 0.15 mmol, 収率 91%) を得た。1H-NMR(CDCl3)δ: 1.87 (1H, br), 3.58-3.72 (32H, br), 3.84 (2H, t, J=4.8 Hz), 4,10 (2H, t, J=4.8 Hz), 6.84 (1H, m), 7.05-7.14 (3H, m)。 7f (76 mg, 0.44 mmol) was dissolved in THF (1.0 mL). Sodium hydride (mineral oil suspension, purity 60%, 22 mg, 0.55 mmol) was added thereto, and the mixture was stirred at room temperature for 1 hour. To this was added a solution of 5 (95 mg, 0.17 mmol) in THF (1.0 mL) and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with ethyl acetate (10 mL), and washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The obtained residue was separated and purified by silica gel column chromatography (silica gel: 4 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 10 to 1), and 9f (87 mg, 0.15 mmol, yield 91%) Got. 1 H-NMR (CDCl 3 ) δ: 1.87 (1H, br), 3.58-3.72 (32H, br), 3.84 (2H, t, J = 4.8 Hz), 4,10 (2H, t, J = 4.8 Hz ), 6.84 (1H, m), 7.05-7.14 (3H, m).
Nonaethylene glycol mono(2,4-bis(1,1-dimethylethyl)phenyl) ether (9g) Nonaethylene glycol mono (2,4-bis (1,1-dimethylethyl) phenyl) ether (9g)
7g (130 mg, 0.63 mmol) を THF (1.5 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 30 mg, 0.75 mmol) を加え室温にて1時間撹拌した。このものに 5 (123 mg, 0.22 mmol) の THF (1.5 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を酢酸エチル (10 mL) で希釈し、水 (10 mL)、飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 4 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 15 対 1) で分離精製し、9g (120 mg, 0.20 mmol, 収率 92%) を得た。1H-NMR(CDCl3)δ: 1.29 (9H, s), 1.38 (9H, s), 2.22 (1H, br), 3.58-3.72 (32H, br), 3.88 (2H, t, J=5.1 Hz), 4.11 (2H, t, J=5.1 Hz), 6.76 (1H, d, J=8.3 Hz), 7.14 (1H, dd, J=8.3 Hz, 2.7 Hz), 7.30 (1H, d, J=2.7 Hz)。 7 g (130 mg, 0.63 mmol) was dissolved in THF (1.5 mL). To this, sodium hydride (mineral oil suspension, purity 60%, 30 mg, 0.75 mmol) was added and stirred at room temperature for 1 hour. To this was added a solution of 5 (123 mg, 0.22 mmol) in THF (1.5 mL) and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with ethyl acetate (10 mL), and washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The obtained residue was separated and purified by silica gel column chromatography (silica gel: 4 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 15 to 1), and 9 g (120 mg, 0.20 mmol, yield 92%) Got. 1 H-NMR (CDCl 3 ) δ: 1.29 (9H, s), 1.38 (9H, s), 2.22 (1H, br), 3.58-3.72 (32H, br), 3.88 (2H, t, J = 5.1 Hz ), 4.11 (2H, t, J = 5.1 Hz), 6.76 (1H, d, J = 8.3 Hz), 7.14 (1H, dd, J = 8.3 Hz, 2.7 Hz), 7.30 (1H, d, J = 2.7 Hz).
Nonaethylene glycol mono(4-methoxyphenyl) ether (9h) Nonaethylene glycol mono (4-methoxyphenyl) ether (9h)
7h (85 mg, 0.68 mmol) を THF (1.5 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 35 mg, 0.87 mmol) を加え室温にて1時間撹拌した。このものに 5 (197 mg, 0.35 mmol) の THF (1.5 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を酢酸エチル (10 mL) で希釈し、水 (10 mL)、飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 4 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 10 対 1) で分離精製し、9h (106 mg, 0.20 mmol, 収率 59%) を得た。1H-NMR(CDCl3)δ: 2.91 (1H, br), 3.56-3.72 (32H, br), 3.75 (3H, s), 3.81 (2H, t, J=4.8 Hz), 4.06 (2H, t, J=4.8 Hz), 6.80 (2H, d, J=9.4 Hz), 6.84 (2H, d, J=9.2 Hz)。 7h (85 mg, 0.68 mmol) was dissolved in THF (1.5 mL). To this was added sodium hydride (mineral oil suspension, purity 60%, 35 mg, 0.87 mmol), and the mixture was stirred at room temperature for 1 hour. To this was added a solution of 5 (197 mg, 0.35 mmol) in THF (1.5 mL) and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with ethyl acetate (10 mL), and washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The obtained residue was separated and purified by silica gel column chromatography (silica gel: 4 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 10 to 1), 9h (106 mg, 0.20 mmol, yield 59%) Got. 1 H-NMR (CDCl 3 ) δ: 2.91 (1H, br), 3.56-3.72 (32H, br), 3.75 (3H, s), 3.81 (2H, t, J = 4.8 Hz), 4.06 (2H, t , J = 4.8 Hz), 6.80 (2H, d, J = 9.4 Hz), 6.84 (2H, d, J = 9.2 Hz).
Nonaethylene glycol mono(4-bromophenyl) ether (9j) Nonaethylene glycol mono (4-bromophenyl) ether (9j)
7j (126 mg, 0.73 mmol) を THF (1.0 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 36 mg, 0.90 mmol) を加え室温にて1時間撹拌した。このものに 5 (192 mg, 0.34 mmol) の THF (2.0 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を酢酸エチル (10 mL) で希釈し、水 (10 mL)、飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 4 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 10 対 1) で分離精製し、9j (130 mg, 0.23 mmol, 収率 68%) を得た。1H-NMR(CDCl3)δ: 2.78 (1H, br), 3.59-3.74 (32H, br), 3.83 (2H, t, J=4.8 Hz), 4.09 (2H, t, J=4.6 Hz), 6.79 (2H, d, J=9.2 Hz), 7.35 (2H, d, J=9.2 Hz)。 7j (126 mg, 0.73 mmol) was dissolved in THF (1.0 mL). To this was added sodium hydride (mineral oil suspension, purity 60%, 36 mg, 0.90 mmol), and the mixture was stirred at room temperature for 1 hour. To this was added a solution of 5 (192 mg, 0.34 mmol) in THF (2.0 mL) and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with ethyl acetate (10 mL), and washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The obtained residue was separated and purified by silica gel column chromatography (silica gel: 4 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 10 to 1), 9j (130 mg, 0.23 mmol, yield 68%) Got. 1 H-NMR (CDCl 3 ) δ: 2.78 (1H, br), 3.59-3.74 (32H, br), 3.83 (2H, t, J = 4.8 Hz), 4.09 (2H, t, J = 4.6 Hz), 6.79 (2H, d, J = 9.2 Hz), 7.35 (2H, d, J = 9.2 Hz).
Nonaethylene glycol mono(4-methoxycarbonylphenyl) ether (9k) Nonaethylene glycol mono (4-methoxycarbonylphenyl) ether (9k)
7k (93 mg, 0.61 mmol) を THF (1.0 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 31 mg, 0.78 mmol) を加え室温にて1時間撹拌した。このものに 5 (162 mg, 0.28 mmol) の THF (1.5 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を酢酸エチル (10 mL) で希釈し、水 (10 mL) および飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 4 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 9 対 1) で分離精製し、9k (36 mg, 0.07 mmol, 収率 20%) を得た。1H-NMR(CDCl3)δ: 2.84 (1H, br), 3.59-3.73 (32H, br), 3.86 (2H, t, J=4.6 Hz), 3.87 (3H, s), 4.17 (2H, t, J=4.6 Hz), 6.92 (2H, d, J=8.9 Hz), 7.97 (2H, d, J=8.9 Hz)。 7k (93 mg, 0.61 mmol) was dissolved in THF (1.0 mL). To this, sodium hydride (mineral oil suspension, purity 60%, 31 mg, 0.78 mmol) was added and stirred at room temperature for 1 hour. To this was added a solution of 5 (162 mg, 0.28 mmol) in THF (1.5 mL) and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with ethyl acetate (10 mL), and washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The resulting residue was separated and purified by silica gel column chromatography (silica gel: 4 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 9 to 1), and 9k (36 mg, 0.07 mmol, yield 20%) Got. 1 H-NMR (CDCl 3 ) δ: 2.84 (1H, br), 3.59-3.73 (32H, br), 3.86 (2H, t, J = 4.6 Hz), 3.87 (3H, s), 4.17 (2H, t , J = 4.6 Hz), 6.92 (2H, d, J = 8.9 Hz), 7.97 (2H, d, J = 8.9 Hz).
Nonaethylene glycol mono(4-carboxyphenyl) ether (9k') Nonaethylene glycol mono (4-carboxyphenyl) ether (9k ')
9k (285 mg, 0.52 mmol) を メタノール (2.0 mL) に溶解させた。これに20% 水酸化ナトリウム水溶液 (1.0 mL) を添加し、室温で24時間撹拌した。反応溶液を水 (10 mL) で希釈し、酢酸エチル (5 mL×3) で抽出した。水層に10% 塩酸 (5.0 mL) を加えジクロロメタン (5 mL×3) で抽出した。ジクロロメタン層は、水 (10 mL)、飽和食塩水 (10 mL) で順次洗浄し、無水硫酸ナトリウムで乾燥後これを濾過した。濾液をエバポレーターで濃縮し、9k' (110 mg, 0.21 mmol, 収率 38%) を得た。1H-NMR(CDCl3)δ: 3.52-3.74 (34H, br), 3.86 (2H, t, J=4.8 Hz), 4.20 (2H, t, J=4.8 Hz), 6.94 (2H, d, J=8.7 Hz), 8.01 (2H, d, J=8.7 Hz)。 9k (285 mg, 0.52 mmol) was dissolved in methanol (2.0 mL). To this was added 20% aqueous sodium hydroxide (1.0 mL), and the mixture was stirred at room temperature for 24 hours. The reaction solution was diluted with water (10 mL) and extracted with ethyl acetate (5 mL × 3). To the aqueous layer was added 10% hydrochloric acid (5.0 mL), and the mixture was extracted with dichloromethane (5 mL × 3). The dichloromethane layer was washed successively with water (10 mL) and saturated brine (10 mL), dried over anhydrous sodium sulfate and filtered. The filtrate was concentrated by an evaporator to obtain 9k ′ (110 mg, 0.21 mmol, yield 38%). 1 H-NMR (CDCl 3 ) δ: 3.52-3.74 (34H, br), 3.86 (2H, t, J = 4.8 Hz), 4.20 (2H, t, J = 4.8 Hz), 6.94 (2H, d, J = 8.7 Hz), 8.01 (2H, d, J = 8.7 Hz).
Nonaethylene glycol mono(4-acetylphenyl) ether (9l) Nonaethylene glycol mono (4-acetylphenyl) ether (9l)
7l (102 mg, 0.75 mmol) を THF (1.0 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 34 mg, 0.85 mmol) を加え室温にて1時間撹拌した。このものに 5 (195 mg, 0.34 mmol) の THF (2.0 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を酢酸エチル (10 mL) で希釈し、水 (10 mL) および飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 4 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 10 対 1) で分離し、1H-NMR 積分比より 9l と 5 の 10 対 1 混合物 (74 mg) を得た。(9l の換算収量 62 mg, 0.12 mmol, 換算収率 34%)1H-NMR(CDCl3)δ: 2.54 (3H, s), 2.84 (1H, br), 3.56-3.73 (32H, br), 3.87 (2H, t, J=4.7 Hz), 4.18 (2H, t, J=4.7 Hz), 6.93 (2H, d, J=8.7 Hz), 7.91 (2H, d, J=8.7 Hz)。 7l (102 mg, 0.75 mmol) was dissolved in THF (1.0 mL). To this was added sodium hydride (mineral oil suspension, purity 60%, 34 mg, 0.85 mmol), and the mixture was stirred at room temperature for 1 hour. To this was added a solution of 5 (195 mg, 0.34 mmol) in THF (2.0 mL) and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with ethyl acetate (10 mL), and washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The obtained residue was separated by silica gel column chromatography (silica gel: 4 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 10 to 1), and 10 to 1 of 9 l and 5 from 1 H-NMR integration ratio. A mixture (74 mg) was obtained. (Equivalent yield of 9l 62 mg, 0.12 mmol, Equivalent yield 34%) 1 H-NMR (CDCl 3 ) δ: 2.54 (3H, s), 2.84 (1H, br), 3.56-3.73 (32H, br), 3.87 (2H, t, J = 4.7 Hz), 4.18 (2H, t, J = 4.7 Hz), 6.93 (2H, d, J = 8.7 Hz), 7.91 (2H, d, J = 8.7 Hz).
Nonaethylene glycol mono(4-tert-butoxycarboxamidophenyl) ether (9m) Nonaethylene glycol mono (4-tert-butoxycarboxamidophenyl) ether (9m)
7m (380 mg, 1.82 mmol) を THF (3.0 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 75 mg, 1.86 mmol) を加え室温にて1時間撹拌した。このものに 5 (400 mg, 0.70 mmol) の THF (4.0 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を酢酸エチル (15 mL) で希釈し、水 (15 mL) および飽和食塩水 (15 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 8 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 50 対 1→ 10 対 1) で分離精製し、9m (370 mg, 0.61 mmol, 収率 86%) を得た。1H-NMR(CDCl3)δ: 1.49 (9H, s), 2.74 (1H, br), 3.58-3.72 (32H, br), 3.82 (3H, t, J=4.8 Hz), 4.08 (2H, t, J=4.8 Hz), 6.45 (1H, br), 6.83 (2H, d, J=9.2 Hz), 7.24 (2H, d, J=9.2 Hz)。 7m (380 mg, 1.82 mmol) was dissolved in THF (3.0 mL). To this, sodium hydride (mineral oil suspension, purity 60%, 75 mg, 1.86 mmol) was added and stirred at room temperature for 1 hour. To this was added a solution of 5 (400 mg, 0.70 mmol) in THF (4.0 mL) and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with ethyl acetate (15 mL), and washed successively with water (15 mL) and saturated brine (15 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The obtained residue was separated and purified by silica gel column chromatography (silica gel: 8 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 50 to 1 → 10 to 1), and 9 m (370 mg, 0.61 mmol, yield) Rate 86%). 1 H-NMR (CDCl 3 ) δ: 1.49 (9H, s), 2.74 (1H, br), 3.58-3.72 (32H, br), 3.82 (3H, t, J = 4.8 Hz), 4.08 (2H, t , J = 4.8 Hz), 6.45 (1H, br), 6.83 (2H, d, J = 9.2 Hz), 7.24 (2H, d, J = 9.2 Hz).
Nonaethylene glycol mono(4-aminophenyl) ether (9m') Nonaethylene glycol mono (4-aminophenyl) ether (9m ')
9m (250 mg, 0.41 mmol) を メタノール (1.5 mL) に溶解させた。これに10% 塩酸 (1.0 mL) を添加し、室温で24時間撹拌した。反応溶液を水 (10 mL) で希釈し、トルエン (5 mL×4) で抽出した。水層に 20% 水酸化ナトリウム水溶液 (5.0 mL) を加えジクロロメタン (5 mL×4) で抽出した。ジクロロメタン層は、水 (10 mL)、飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 5 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 4 対 1) で分離精製し、9m' (169 mg, 0.33 mmol, 収率 80%) を得た。1H-NMR(CDCl3)δ: 2.70 (2H, br), 2.95 (1H, br), 3.58-3.73 (32H, br), 3.85 (2H, t, J=4.8 Hz), 4.11 (2H, t, J=4.8 Hz), 6.86 (2H, d, J=8.3 Hz), 7.11 (2H, d, J=8.3 Hz)。 9m (250 mg, 0.41 mmol) was dissolved in methanol (1.5 mL). To this was added 10% hydrochloric acid (1.0 mL), and the mixture was stirred at room temperature for 24 hours. The reaction solution was diluted with water (10 mL) and extracted with toluene (5 mL × 4). To the aqueous layer was added 20% aqueous sodium hydroxide solution (5.0 mL), and the mixture was extracted with dichloromethane (5 mL × 4). The dichloromethane layer was washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The resulting residue was separated and purified by silica gel column chromatography (silica gel: 5 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 4 to 1), 9m '(169 mg, 0.33 mmol, yield 80% ) 1 H-NMR (CDCl 3 ) δ: 2.70 (2H, br), 2.95 (1H, br), 3.58-3.73 (32H, br), 3.85 (2H, t, J = 4.8 Hz), 4.11 (2H, t , J = 4.8 Hz), 6.86 (2H, d, J = 8.3 Hz), 7.11 (2H, d, J = 8.3 Hz).
Nonaethylene glycol mono(4-fluorophenyl) ether (9n) Nonaethylene glycol mono (4-fluorophenyl) ether (9n)
7n (95 mg, 0.85 mmol) を THF (1.5 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 42 mg, 1.05 mmol) を加え室温にて1時間撹拌した。このものに 5 (197 mg, 0.35 mmol) の THF (2.0 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を酢酸エチル (10 mL) で希釈し、水 (10 mL)、飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 4 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 8 対 1) で分離精製し、9n (117 mg, 0.23 mmol, 収率 66%) を得た。1H-NMR(CDCl3)δ: 2.73 (1H, br), 3.58-3.72 (32H, br), 3.83 (2H, t, J=4.8 Hz), 4.07 (2H, t, J=4.8 Hz), 6.85 (2H, d, J=8.2 Hz), 6.94 (2H, d, J=8.2 Hz)。 7n (95 mg, 0.85 mmol) was dissolved in THF (1.5 mL). Sodium hydride (mineral oil suspension, purity 60%, 42 mg, 1.05 mmol) was added thereto, and the mixture was stirred at room temperature for 1 hour. To this was added 5 (197 mg, 0.35 mmol) in THF (2.0 mL) and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with ethyl acetate (10 mL), and washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The resulting residue was separated and purified by silica gel column chromatography (silica gel: 4 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 8 to 1), and 9n (117 mg, 0.23 mmol, yield 66%) Got. 1 H-NMR (CDCl 3 ) δ: 2.73 (1H, br), 3.58-3.72 (32H, br), 3.83 (2H, t, J = 4.8 Hz), 4.07 (2H, t, J = 4.8 Hz), 6.85 (2H, d, J = 8.2 Hz), 6.94 (2H, d, J = 8.2 Hz).
Nonaethylene glycol mono(4-trifluoromethylphenyl) ether (9o) Nonaethylene glycol mono (4-trifluoromethylphenyl) ether (9o)
7o (170 mg, 1.05 mmol) を THF (1.5 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 50 mg, 1.25 mmol) を加え室温にて1時間撹拌した。このものに 5 (200 mg, 0.35 mmol) の THF (2.0 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を酢酸エチル (10 mL) で希釈し、水 (10 mL)、飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 4 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 8 対 1) で分離精製し、9o (99 mg, 0.18 mmol, 収率 49%) を得た。1H-NMR(CDCl3)δ: 2.73 (1H, br), 3.57-3.73 (32H, br), 3.86 (2H, t, J=4.8 Hz), 4.16 (2H, t, J=4.8 Hz), 6.97 (2H, d, J=8.7 Hz), 7.52 (2H, d, J=8.7 Hz)。 7o (170 mg, 1.05 mmol) was dissolved in THF (1.5 mL). To this, sodium hydride (mineral oil suspension, purity 60%, 50 mg, 1.25 mmol) was added and stirred at room temperature for 1 hour. To this was added a solution of 5 (200 mg, 0.35 mmol) in THF (2.0 mL) and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with ethyl acetate (10 mL), and washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The obtained residue was separated and purified by silica gel column chromatography (silica gel: 4 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 8 to 1), 9o (99 mg, 0.18 mmol, yield 49%) Got. 1 H-NMR (CDCl 3 ) δ: 2.73 (1H, br), 3.57-3.73 (32H, br), 3.86 (2H, t, J = 4.8 Hz), 4.16 (2H, t, J = 4.8 Hz), 6.97 (2H, d, J = 8.7 Hz), 7.52 (2H, d, J = 8.7 Hz).
Nonaethylene glycol mono(3-pyridyl) ether (9q) Nonaethylene glycol mono (3-pyridyl) ether (9q)
7q (195 mg, 2.05 mmol) を THF (2.5 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 100 mg, 2.50 mmol) を加え室温にて1時間撹拌した。このものに 5 (270 mg, 0.47 mmol) の THF (2.5 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を酢酸エチル (10 mL) で希釈し、水 (10 mL)、飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 5 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 16 対 1 → 4 対 1) で分離精製し、9q (15 mg, 0.03 mmol, 収率 7%) を得た。1H-NMR(CDCl3)δ: 2.31 (1H, s), 3.57-3.72 (32H, br), 3.87 (2H, t, J=4.7 Hz), 4.15 (2H, t, J=4.7 Hz), 7.11 (1H, d, J=7.7 Hz), 7.21 (1H, d, J=2.3 Hz), 8.21 (1H, br), 8.32 (1H, br)。 7q (195 mg, 2.05 mmol) was dissolved in THF (2.5 mL). To this was added sodium hydride (mineral oil suspension, purity 60%, 100 mg, 2.50 mmol), and the mixture was stirred at room temperature for 1 hour. To this was added a solution of 5 (270 mg, 0.47 mmol) in THF (2.5 mL) and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with ethyl acetate (10 mL), and washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The obtained residue was separated and purified by silica gel column chromatography (silica gel: 5 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 16 to 1 → 4 to 1), and 9q (15 mg, 0.03 mmol, yield) Rate 7%). 1 H-NMR (CDCl 3 ) δ: 2.31 (1H, s), 3.57-3.72 (32H, br), 3.87 (2H, t, J = 4.7 Hz), 4.15 (2H, t, J = 4.7 Hz), 7.11 (1H, d, J = 7.7 Hz), 7.21 (1H, d, J = 2.3 Hz), 8.21 (1H, br), 8.32 (1H, br).
Nonaethylene glycol mono(4-cyanophenyl) ether (9r) Nonaethylene glycol mono (4-cyanophenyl) ether (9r)
7r (200 mg, 1.68 mmol) を THF (3.0 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 82 mg, 2.05 mmol) を加え室温にて1時間撹拌した。このものに 5 (240 mg, 0.42 mmol) の THF (2.0 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を酢酸エチル (10 mL) で希釈し、水 (10 mL)、飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 5 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 100 対 1 → 8 対 1) で分離精製し、9r (82 mg, 0.16 mmol, 収率 38%) を得た。1H-NMR(CDCl3)δ: 2.64 (1H, br), 3.59-3.74 (32H, br), 3.86 (2H, t, J=4.8 Hz), 4.16 (2H, t, J=4.8 Hz), 6.96 (2H, t, J=8.9 Hz), 7.57 (2H, d, J=8.9 Hz)。 7r (200 mg, 1.68 mmol) was dissolved in THF (3.0 mL). Sodium hydride (mineral oil suspension, purity 60%, 82 mg, 2.05 mmol) was added thereto, and the mixture was stirred at room temperature for 1 hour. To this was added a solution of 5 (240 mg, 0.42 mmol) in THF (2.0 mL) and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with ethyl acetate (10 mL), and washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The obtained residue was separated and purified by silica gel column chromatography (silica gel: 5 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 100 to 1 → 8 to 1), and 9r (82 mg, 0.16 mmol, collected) Rate 38%). 1 H-NMR (CDCl 3 ) δ: 2.64 (1H, br), 3.59-3.74 (32H, br), 3.86 (2H, t, J = 4.8 Hz), 4.16 (2H, t, J = 4.8 Hz), 6.96 (2H, t, J = 8.9 Hz), 7.57 (2H, d, J = 8.9 Hz).
Nonaethylene glycol mono(6-quinolyl) ether (9s) Nonaethylene glycol mono (6-quinolyl) ether (9s)
7s (200 mg, 1.38 mmol) 及び塩化ベンジルトリエチルアンモニウム (30 mg, 0.13 mmol) を THF (2.0 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 60 mg, 1.50 mmol) を加え室温にて1時間撹拌した。このものに 5 (180 mg, 0.32 mmol) の THF (2.0 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を水 (10 mL) で希釈し、クロロホルム (10 mL×4) で抽出した。クロロホルム層は、水 (10 mL)、飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 4 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 16 対 1 → 8 対 1 → 7 対 2) で分離精製し、9s (103 mg, 0.19 mmol, 収率 60%) を得た。1H-NMR(CDCl3)δ: 2.89 (1H, br), 3.58-3.79 (32H, br), 3.94 (2H, t, J=4.9 Hz), 4.26 (2H, t, J=4.9 Hz), 7.09 (1H, d, J=2.7 Hz), 7.36 (1H, dd, J=8.2 Hz, 4.1 Hz), 7.41 (1H, dd, J=9.4 Hz, 2.7 Hz), 8.00 (1H, d, J=9.4 Hz), 8.04 (1H, dd, J=8.2 Hz, 1.7 Hz), 8.77 (1H, dd, J=4.1 Hz, 1.7 Hz)。 7s (200 mg, 1.38 mmol) and benzyltriethylammonium chloride (30 mg, 0.13 mmol) were dissolved in THF (2.0 mL). To this, sodium hydride (mineral oil suspension, purity 60%, 60 mg, 1.50 mmol) was added and stirred at room temperature for 1 hour. To this was added a solution of 5 (180 mg, 0.32 mmol) in THF (2.0 mL) and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with water (10 mL) and extracted with chloroform (10 mL × 4). The chloroform layer was washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The resulting residue was separated and purified by silica gel column chromatography (silica gel: 4 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 16 to 1 → 8 to 1 → 7 to 2), and 9s (103 mg, 0.19 mmol, 60% yield). 1 H-NMR (CDCl 3 ) δ: 2.89 (1H, br), 3.58-3.79 (32H, br), 3.94 (2H, t, J = 4.9 Hz), 4.26 (2H, t, J = 4.9 Hz), 7.09 (1H, d, J = 2.7 Hz), 7.36 (1H, dd, J = 8.2 Hz, 4.1 Hz), 7.41 (1H, dd, J = 9.4 Hz, 2.7 Hz), 8.00 (1H, d, J = 9.4 Hz), 8.04 (1H, dd, J = 8.2 Hz, 1.7 Hz), 8.77 (1H, dd, J = 4.1 Hz, 1.7 Hz).
Nonaethylene glycol mono(2-naphthyl) ether (9t) Nonaethylene glycol mono (2-naphthyl) ether (9t)
7t (125 mg, 0.87 mmol) を THF (1.5 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 50 mg, 1.25 mmol) を加え室温にて1時間撹拌した。このものに 5 (212 mg, 0.37 mmol) の THF (2.0 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を酢酸エチル (10 mL) で希釈し、水 (10 mL)、飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 4 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 8 対 1) で分離精製し、9t (26 mg, 0.05 mmol, 収率 13%) を得た。1H-NMR(CDCl3)δ: 2.74 (1H, br), 3.58-3.76 (32H, br), 3.92 (2H, t, J=4.9 Hz), 4.25 (2H, t, J=4.9 Hz), 7.13-7.18 (2H, m), 7.30-7.44 (2H, m), 7.71-7.80 (3H, m)。 7t (125 mg, 0.87 mmol) was dissolved in THF (1.5 mL). To this, sodium hydride (mineral oil suspension, purity 60%, 50 mg, 1.25 mmol) was added and stirred at room temperature for 1 hour. A solution of 5 (212 mg, 0.37 mmol) in THF (2.0 mL) was added to this, and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with ethyl acetate (10 mL), and washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The resulting residue was separated and purified by silica gel column chromatography (silica gel: 4 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 8 to 1), and 9t (26 mg, 0.05 mmol, 13% yield) Got. 1 H-NMR (CDCl 3 ) δ: 2.74 (1H, br), 3.58-3.76 (32H, br), 3.92 (2H, t, J = 4.9 Hz), 4.25 (2H, t, J = 4.9 Hz), 7.13-7.18 (2H, m), 7.30-7.44 (2H, m), 7.71-7.80 (3H, m).
Nonaethylene glycol mono(1-naphthyl) ether (9u) Nonaethylene glycol mono (1-naphthyl) ether (9u)
7u (130 mg, 0.90 mmol) を THF (1.5 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 48 mg, 1.20 mmol) を加え室温にて1時間撹拌した。このものに 5 (197 mg, 0.35 mmol) の THF (2.0 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を酢酸エチル (10 mL) で希釈し、水 (10 mL)、飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 4 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 100 対 1 → 6 対 1) で分離精製し、9u (101 mg, 0.19 mmol, 収率 54%) を得た。1H-NMR(CDCl3)δ: 2.68 (1H, br), 3.64-3.79 (30H, br), 3.81 (2H, t, J=4.7 Hz), 4.01 (2H, t, J=4.9 Hz), 4.32 (2H, t, J=4.9 Hz), 6.82 (1H, d, J=7.6 Hz), 7.33-7.50 (4H, m), 7.79 (1H, dd, J=7.1 Hz, 2.3 Hz), 8.28 (1H, d, J=7.6 Hz)。 7u (130 mg, 0.90 mmol) was dissolved in THF (1.5 mL). To this, sodium hydride (mineral oil suspension, purity 60%, 48 mg, 1.20 mmol) was added and stirred at room temperature for 1 hour. To this was added 5 (197 mg, 0.35 mmol) in THF (2.0 mL) and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with ethyl acetate (10 mL), and washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The obtained residue was separated and purified by silica gel column chromatography (silica gel: 4 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 100 to 1 → 6 to 1), and 9u (101 mg, 0.19 mmol, collected) The rate was 54%). 1 H-NMR (CDCl 3 ) δ: 2.68 (1H, br), 3.64-3.79 (30H, br), 3.81 (2H, t, J = 4.7 Hz), 4.01 (2H, t, J = 4.9 Hz), 4.32 (2H, t, J = 4.9 Hz), 6.82 (1H, d, J = 7.6 Hz), 7.33-7.50 (4H, m), 7.79 (1H, dd, J = 7.1 Hz, 2.3 Hz), 8.28 ( 1H, d, J = 7.6 Hz).
Nonaethylene glycol mono(4-formylphenyl) ether (9v) Nonaethylene glycol mono (4-formylphenyl) ether (9v)
7v (120 mg, 0.98 mmol) を DMF (1.0 mL) に溶解させた。これに炭酸カリウム (140 mg, 1.01 mmol) を加え室温にて1時間撹拌した。このものに 5 (160 mg, 0.28 mmol) の DMF (2.5 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を水 (10 mL) で希釈し、酢酸エチル (10 mL×4) で抽出した。酢酸エチル層は、水 (10 mL×3)、飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 4 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 45 対 1 → 8 対 1 ) で分離し、1H-NMR 積分比より 9v と 5 の 6 対 1 混合物 (28 mg) を得た。(9v の換算収量 24 mg, 0.05 mmol, 換算収率 16%)1H-NMR(CDCl3)δ: 2.79 (1H, br), 3.58-3.74 (32H, br), 3.89 (2H, t, J=4.7 Hz), 4.22 (2H, t, J=4.7 Hz), 7.02 (1H, d, J=8.9 Hz), 7.83 (1H, d, J=8.9 Hz), 9.89 (1H, s)。 7v (120 mg, 0.98 mmol) was dissolved in DMF (1.0 mL). To this was added potassium carbonate (140 mg, 1.01 mmol), and the mixture was stirred at room temperature for 1 hour. To this was added a solution of 5 (160 mg, 0.28 mmol) in DMF (2.5 mL) and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with water (10 mL) and extracted with ethyl acetate (10 mL × 4). The ethyl acetate layer was washed successively with water (10 mL × 3) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The obtained residue was purified by silica gel column chromatography (silica gel: 4 g, developing solvent: ethyl acetate - methanol mixed solvent pair 0 → 45: 1 → 8: 1) was separated by, 1 H-NMR integral ratio than 9v and 5 A 6: 1 mixture of (28 mg) was obtained. (9v conversion yield 24 mg, 0.05 mmol, conversion yield 16%) 1 H-NMR (CDCl 3 ) δ: 2.79 (1H, br), 3.58-3.74 (32H, br), 3.89 (2H, t, J = 4.7 Hz), 4.22 (2H, t, J = 4.7 Hz), 7.02 (1H, d, J = 8.9 Hz), 7.83 (1H, d, J = 8.9 Hz), 9.89 (1H, s).
Nonaethylene glycol mono(4-(2-tert-butoxycarboxamidoethyl)phenyl) ether (9w) Nonaethylene glycol mono (4- (2-tert-butoxycarboxamidoethyl) phenyl) ether (9w)
7w (250 mg, 1.05 mmol) を THF (2.0 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 50 mg, 1.25 mmol) を加え室温にて1時間撹拌した。このものに 5 (250 mg, 0.44 mmol) の THF (2.0 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を酢酸エチル (10 mL) で希釈し、水 (10 mL)、飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 6 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 60 対 1 → 8 対 1 → 4 対 1) で分離精製し、9w (230 mg, 0.36 mmol, 収率 82%) を得た。1H-NMR(CDCl3)δ: 1.43 (9H, s), 2.73 (2H, t, J=7.1 Hz), 3.33 (3H, br), 3.57-3.74 (32H, br), 3.85 (2H, t, J=4.8 Hz), 4.11 (2H, t, J=4.8 Hz), 4.21 (1H, br), 4.54 (1H, br), 6.85 (1H, d, J=8.5 Hz), 7.09 (1H, d, J=8.5 Hz)。 7w (250 mg, 1.05 mmol) was dissolved in THF (2.0 mL). To this, sodium hydride (mineral oil suspension, purity 60%, 50 mg, 1.25 mmol) was added and stirred at room temperature for 1 hour. To this was added 5 (250 mg, 0.44 mmol) in THF (2.0 mL) and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with ethyl acetate (10 mL), and washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The resulting residue was separated and purified by silica gel column chromatography (silica gel: 6 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 60 to 1 → 8 to 1 → 4 to 1), and 9w (230 mg, 0.36 mmol, yield 82%) was obtained. 1 H-NMR (CDCl 3 ) δ: 1.43 (9H, s), 2.73 (2H, t, J = 7.1 Hz), 3.33 (3H, br), 3.57-3.74 (32H, br), 3.85 (2H, t , J = 4.8 Hz), 4.11 (2H, t, J = 4.8 Hz), 4.21 (1H, br), 4.54 (1H, br), 6.85 (1H, d, J = 8.5 Hz), 7.09 (1H, d , J = 8.5 Hz).
Nonaethylene glycol mono(4-(2-aminoethyl)phenyl) ether (9w') Nonaethylene glycol mono (4- (2-aminoethyl) phenyl) ether (9w ')
9w (185 mg, 0.29 mmol) を メタノール (1.0 mL) に溶解させた。これに10% 塩酸 (1.0 mL) を添加し、室温で24時間撹拌した。反応溶液を水 (10 mL) で希釈し、酢酸エチル (5 mL×4) で抽出した。水層に 20% 水酸化ナトリウム水溶液 (5.0 mL) を加えジクロロメタン (5 mL×4) で抽出した。ジクロロメタン層は、水 (10 mL)、飽和食塩水 (10 mL) で順次洗浄し、無水硫酸ナトリウムで乾燥後これを濾過した。濾液をエバポレーターで濃縮し、 9w' (152 mg, 0.28 mmol, 収率 97%) を得た。1H-NMR(CDCl3)δ: 2.64-3.13 (4H, br), 3.58-3.74 (32H, br), 3.84 (2H, t, J=4.7 Hz), 4.11 (2H, t, J=4.7 Hz), 6.87 (1H, d, J=8.8 Hz), 7.12 (1H, d, J=8.8 Hz)。 9w (185 mg, 0.29 mmol) was dissolved in methanol (1.0 mL). To this was added 10% hydrochloric acid (1.0 mL), and the mixture was stirred at room temperature for 24 hours. The reaction solution was diluted with water (10 mL) and extracted with ethyl acetate (5 mL × 4). To the aqueous layer was added 20% aqueous sodium hydroxide solution (5.0 mL), and the mixture was extracted with dichloromethane (5 mL × 4). The dichloromethane layer was washed successively with water (10 mL) and saturated brine (10 mL), dried over anhydrous sodium sulfate and filtered. The filtrate was concentrated by an evaporator to obtain 9w ′ (152 mg, 0.28 mmol, yield 97%). 1 H-NMR (CDCl 3 ) δ: 2.64-3.13 (4H, br), 3.58-3.74 (32H, br), 3.84 (2H, t, J = 4.7 Hz), 4.11 (2H, t, J = 4.7 Hz ), 6.87 (1H, d, J = 8.8 Hz), 7.12 (1H, d, J = 8.8 Hz).
Nonaethylene glycol mono(2,4-dimethylphenyl) ether (9x) Nonaethylene glycol mono (2,4-dimethylphenyl) ether (9x)
7x (121 mg, 0.99 mmol) を THF (1.5 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 51 mg, 1.28 mmol) を加え室温にて1時間撹拌した。このものに 5 (214 mg, 0.38 mmol) の THF (2.0 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を酢酸エチル (10 mL) で希釈し、水 (10 mL)、飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 4 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 50 対 1 → 8 対 1 → 4 対 1) で分離精製し、9x (71 mg, 0.14 mmol, 収率 36%) を得た。1H-NMR(CDCl3)δ: 2.19 (3H, s), 2.25 (3H, s), 2.86 (1H, br), 3.60-3.75 (32H, br), 3.85 (2H, t, J=5.0 Hz), 4.09 (2H, t, J=5.0 Hz), 6.71 (1H, d, J=7.8 Hz), 6.92 (2H, m)。 7x (121 mg, 0.99 mmol) was dissolved in THF (1.5 mL). Sodium hydride (mineral oil suspension, purity 60%, 51 mg, 1.28 mmol) was added thereto, and the mixture was stirred at room temperature for 1 hour. To this was added a solution of 5 (214 mg, 0.38 mmol) in THF (2.0 mL) and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with ethyl acetate (10 mL), and washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The obtained residue was separated and purified by silica gel column chromatography (silica gel: 4 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 50 to 1 → 8 to 1 → 4 to 1), and 9x (71 mg, 0.14 mmol, yield 36%). 1 H-NMR (CDCl 3 ) δ: 2.19 (3H, s), 2.25 (3H, s), 2.86 (1H, br), 3.60-3.75 (32H, br), 3.85 (2H, t, J = 5.0 Hz ), 4.09 (2H, t, J = 5.0 Hz), 6.71 (1H, d, J = 7.8 Hz), 6.92 (2H, m).
Nonaethylene glycol mono(2-isopropyl-5-methylphenyl) ether (9y) Nonaethylene glycol mono (2-isopropyl-5-methylphenyl) ether (9y)
7y (180 mg, 1.20 mmol) を THF (2.0 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 55 mg, 1.38 mmol) を加え室温にて1時間撹拌した。このものに 5 (215 mg, 0.38 mmol) の THF (1.5 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を酢酸エチル (10 mL) で希釈し、水 (10 mL)、飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 4 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 50 対 1 → 8 対 1 → 4 対 1) で分離精製し、9y (153 mg, 0.28 mmol, 収率 74%) を得た。1H-NMR(CDCl3)δ: 1.19 (6H, d, J=7.0 Hz), 2.31 (3H, s), 2.73 (1H, br), 3.28 (1H, septet, J=7.0 Hz), 3.59-3.75 (32H, br), 3.86 (2H, t, J=5.0 Hz), 4.11 (2H, t, J=5.0 Hz), 6.66 (1H, s), 6.74 (1H, d, J=7.8 Hz), 7.08 (1H, d, J=7.8 Hz)。 7y (180 mg, 1.20 mmol) was dissolved in THF (2.0 mL). To this, sodium hydride (mineral oil suspension, purity 60%, 55 mg, 1.38 mmol) was added and stirred at room temperature for 1 hour. To this was added a solution of 5 (215 mg, 0.38 mmol) in THF (1.5 mL) and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with ethyl acetate (10 mL), and washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The obtained residue was separated and purified by silica gel column chromatography (silica gel: 4 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 50 to 1 → 8 to 1 → 4 to 1), and 9y (153 mg, 0.28 mmol, yield 74%) was obtained. 1 H-NMR (CDCl 3 ) δ: 1.19 (6H, d, J = 7.0 Hz), 2.31 (3H, s), 2.73 (1H, br), 3.28 (1H, septet, J = 7.0 Hz), 3.59- 3.75 (32H, br), 3.86 (2H, t, J = 5.0 Hz), 4.11 (2H, t, J = 5.0 Hz), 6.66 (1H, s), 6.74 (1H, d, J = 7.8 Hz), 7.08 (1H, d, J = 7.8 Hz).
Nonaethylene glycol mono(2,4-bis(1,1-dimethylpropyl)phenyl) ether (9z) Nonaethylene glycol mono (2,4-bis (1,1-dimethylpropyl) phenyl) ether (9z)
7z (222 mg, 0.95 mmol) を THF (2.0 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 50 mg, 1.25 mmol) を加え室温にて1時間撹拌した。このものに 5 (220 mg, 0.39 mmol) の THF (2.0 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を酢酸エチル (10 mL) で希釈し、水 (10 mL)、飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 4 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 50 対 1 → 8 対 1 → 4 対 1) で分離精製し、9z (134 mg, 0.21 mmol, 収率 55%) を得た。1H-NMR(CDCl3)δ: 0.60 (3H, t, J=7.3 Hz), 0.66 (3H, t, J=7.3 Hz), 1.25 (6H, s), 1.34 (6H, s), 1.59 (2H, q, J=7.3 Hz), 1.83 (2H, q, J=7.3 Hz), 2.843 (1H, br), 3.58-3.74 (32H, br), 3.87 (2H, t, J=5.2 Hz), 4.10 (2H, t, J=4.8 Hz), 6.75 (1H, d, J=8.2 Hz), 7.07 (1H, dd, J=8.2 Hz, 2.3 Hz), 7.16 (1H, d, J=2.3 Hz)。 7z (222 mg, 0.95 mmol) was dissolved in THF (2.0 mL). To this, sodium hydride (mineral oil suspension, purity 60%, 50 mg, 1.25 mmol) was added and stirred at room temperature for 1 hour. To this was added a solution of 5 (220 mg, 0.39 mmol) in THF (2.0 mL) and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with ethyl acetate (10 mL), and washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The resulting residue was separated and purified by silica gel column chromatography (silica gel: 4 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 50 to 1 → 8 to 1 → 4 to 1), and 9z (134 mg, 0.21 mmol, yield 55%). 1 H-NMR (CDCl 3 ) δ: 0.60 (3H, t, J = 7.3 Hz), 0.66 (3H, t, J = 7.3 Hz), 1.25 (6H, s), 1.34 (6H, s), 1.59 ( 2H, q, J = 7.3 Hz), 1.83 (2H, q, J = 7.3 Hz), 2.843 (1H, br), 3.58-3.74 (32H, br), 3.87 (2H, t, J = 5.2 Hz), 4.10 (2H, t, J = 4.8 Hz), 6.75 (1H, d, J = 8.2 Hz), 7.07 (1H, dd, J = 8.2 Hz, 2.3 Hz), 7.16 (1H, d, J = 2.3 Hz) .
Nonaethylene glycol mono(4-methylphenyl) ether (9aa) Nonaethylene glycol mono (4-methylphenyl) ether (9aa)
7aa (150 mg, 1.02 mmol) を THF (1.5 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 70 mg, 1.75 mmol) を加え室温にて1時間撹拌した。このものに 5 (235 mg, 0.41 mmol) の THF (1.5 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を酢酸エチル (10 mL) で希釈し、水 (10 mL)、飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 5 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 50 対 1 → 8 対 1 → 4 対 1) で分離精製し、9aa (80 mg, 0.16 mmol, 収率 39%) を得た。1H-NMR(CDCl3)δ: 2.28 (3H, s), 2.86 (1H, br), 3.60-3.73 (32H, br), 3.84 (2H, t, J=4.9 Hz), 4.10 (2H, t, J=4.9 z), 6.81 (2H, d, J=8.2 Hz), 7.07 (2H, d, J=8.2 Hz)。 7aa (150 mg, 1.02 mmol) was dissolved in THF (1.5 mL). To this, sodium hydride (mineral oil suspension, purity 60%, 70 mg, 1.75 mmol) was added and stirred at room temperature for 1 hour. To this was added a solution of 5 (235 mg, 0.41 mmol) in THF (1.5 mL) and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with ethyl acetate (10 mL), and washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The obtained residue was separated and purified by silica gel column chromatography (silica gel: 5 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 50 to 1 → 8 to 1 → 4 to 1), and 9aa (80 mg, 0.16 mmol, 39% yield). 1 H-NMR (CDCl 3 ) δ: 2.28 (3H, s), 2.86 (1H, br), 3.60-3.73 (32H, br), 3.84 (2H, t, J = 4.9 Hz), 4.10 (2H, t , J = 4.9 z), 6.81 (2H, d, J = 8.2 Hz), 7.07 (2H, d, J = 8.2 Hz).
Nonaethylene glycol mono(3-trifluoromethylphenyl) ether (9ab) Nonaethylene glycol mono (3-trifluoromethylphenyl) ether (9ab)
7ab (160 mg, 0.99 mmol) を THF (1.5 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 50 mg, 1.25 mmol) を加え室温にて1時間撹拌した。このものに 5 (230 mg, 0.40 mmol) の THF (1.5 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を酢酸エチル (10 mL) で希釈し、水 (10 mL)、飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 5 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 60 対 1 → 8 対 1 → 4 対 1) で分離精製し、9ab (145 mg, 0.26 mmol, 収率 64%) を得た。1H-NMR(CDCl3)δ: 2.92 (1H, br), 3.59-3.74 (32H, br), 3.88 (2H, t, J=4.9 Hz), 4.17 (2H, t, J=4.9 Hz), 7.09 (1H, dd, J=8.3 Hz, 2.3 Hz), 7.15 (1H, br), 7.20 (1H, d, J=7.8 Hz), 7.38 (1H, dd, J=8.3 Hz, J=7.8 Hz)。 7ab (160 mg, 0.99 mmol) was dissolved in THF (1.5 mL). To this, sodium hydride (mineral oil suspension, purity 60%, 50 mg, 1.25 mmol) was added and stirred at room temperature for 1 hour. To this was added a solution of 5 (230 mg, 0.40 mmol) in THF (1.5 mL) and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with ethyl acetate (10 mL), and washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The obtained residue was separated and purified by silica gel column chromatography (silica gel: 5 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 60 to 1 → 8 to 1 → 4 to 1), and 9ab (145 mg, 0.26 mmol, yield 64%). 1 H-NMR (CDCl 3 ) δ: 2.92 (1H, br), 3.59-3.74 (32H, br), 3.88 (2H, t, J = 4.9 Hz), 4.17 (2H, t, J = 4.9 Hz), 7.09 (1H, dd, J = 8.3 Hz, 2.3 Hz), 7.15 (1H, br), 7.20 (1H, d, J = 7.8 Hz), 7.38 (1H, dd, J = 8.3 Hz, J = 7.8 Hz) .
Nonaethylene glycol mono(2-trifluoromethylphenyl) ether (9ac) Nonaethylene glycol mono (2-trifluoromethylphenyl) ether (9ac)
7ac (159 mg, 0.98 mmol) を THF (1.5 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 59 mg, 1.48 mmol) を加え室温にて1時間撹拌した。このものに 5 (250 mg, 0.44 mmol) の THF (2.0 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を酢酸エチル (10 mL) で希釈し、水 (10 mL) および飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 4 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 100 対 1 → 8 対 1 → 4 対 1 ) で分離し、1H-NMR 積分比より 9ac と 5 の 9 対 1 混合物 (151 mg) を得た。(9ac の換算収量 136 mg, 0.24 mmol, 換算収率 55%)1H-NMR(CDCl3)δ: 2.58 (1H, br), 3.58-3.76 (32H, br), 3.89 (2H, t, J=4.6 Hz), 4.21 (2H, t, J=4.6 Hz), 7.01 (2H, d, J=7.8 Hz), 7.47 (1H, t, J=7.8 Hz), 7.56 (1H, d, J=7.8 Hz)。 7ac (159 mg, 0.98 mmol) was dissolved in THF (1.5 mL). To this, sodium hydride (mineral oil suspension, purity 60%, 59 mg, 1.48 mmol) was added and stirred at room temperature for 1 hour. To this was added 5 (250 mg, 0.44 mmol) in THF (2.0 mL) and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with ethyl acetate (10 mL), and washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The obtained residues were separated by silica gel column chromatography (silica gel: 4 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 100 to 1 → 8 to 1 → 4 to 1), and 1 H-NMR integration ratio As a result, a 9 to 1 mixture of 9ac and 5 (151 mg) was obtained. (Converted yield of 9ac 136 mg, 0.24 mmol, converted yield 55%) 1 H-NMR (CDCl 3 ) δ: 2.58 (1H, br), 3.58-3.76 (32H, br), 3.89 (2H, t, J = 4.6 Hz), 4.21 (2H, t, J = 4.6 Hz), 7.01 (2H, d, J = 7.8 Hz), 7.47 (1H, t, J = 7.8 Hz), 7.56 (1H, d, J = 7.8 Hz).
Nonaethylene glycol mono(3,5-bis(trifluoromethyl)phenyl) ether (9ad) Nonaethylene glycol mono (3,5-bis (trifluoromethyl) phenyl) ether (9ad)
7ad (230 mg, 0.99 mmol) を THF (1.5 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 52 mg, 1.30 mmol) を加え室温にて1時間撹拌した。このものに 5 (245 mg, 0.43 mmol) の THF (2.0 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を酢酸エチル (10 mL) で希釈し、水 (10 mL)、飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 4 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 30 対 1 → 8 対 1) で分離精製し、9ad (128 mg, 0.20 mmol, 収率 47%) を得た。1H-NMR(CDCl3)δ: 2.73 (1H,br), 3.57-3.73 (32H, br), 3.89 (2H, t, J=4.8 Hz), 4.21 (2H, t, J=4.8 Hz), 7.34 (2H, s), 7.45 (1H, s)。 7ad (230 mg, 0.99 mmol) was dissolved in THF (1.5 mL). To this, sodium hydride (mineral oil suspension, purity 60%, 52 mg, 1.30 mmol) was added and stirred at room temperature for 1 hour. To this was added a solution of 5 (245 mg, 0.43 mmol) in THF (2.0 mL) and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with ethyl acetate (10 mL), and washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The obtained residue was separated and purified by silica gel column chromatography (silica gel: 4 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 30 to 1 → 8 to 1), and 9ad (128 mg, 0.20 mmol, yield) Rate 47%). 1 H-NMR (CDCl 3 ) δ: 2.73 (1H, br), 3.57-3.73 (32H, br), 3.89 (2H, t, J = 4.8 Hz), 4.21 (2H, t, J = 4.8 Hz), 7.34 (2H, s), 7.45 (1H, s).
Nonaethylene glycol mono(8-quinolyl) ether (9ae) Nonaethylene glycol mono (8-quinolyl) ether (9ae)
7ae (270 mg, 1.86 mmol) 及び塩化ベンジルトリエチルアンモニウム (45 mg, 0.20 mmol) を THF (3.0 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 88 mg, 2.20 mmol) を加え室温にて1時間撹拌した。このものに 5 (255 mg, 0.45 mmol) の THF (2.0 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を水 (10 mL) で希釈し、クロロホルム (10 mL×4) で抽出した。クロロホルム層は、水 (10 mL)、飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 4 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 16 対 1 → 8 対 1 → 7 対 2) で分離精製し、9ae (185 mg, 0.34 mmol, 収率 76%) を得た。1H-NMR(CDCl3)δ: 2.60 (1H, br), 3.60-3.78 (32H, br), 4.06 (2H, t, J=5.5 Hz), 4.44 (2H, t, J=5.5 Hz), 7.14 (1H, dd, J=7.6 Hz, 1.2 Hz), 7.41 (3H, m), 8.12 (1H, dd, J=8.2 Hz, 1.7 Hz), 8.94 (1H, dd, J=4.4 Hz, 1.7 Hz)。 7ae (270 mg, 1.86 mmol) and benzyltriethylammonium chloride (45 mg, 0.20 mmol) were dissolved in THF (3.0 mL). To this, sodium hydride (mineral oil suspension, purity 60%, 88 mg, 2.20 mmol) was added and stirred at room temperature for 1 hour. To this was added 5 (255 mg, 0.45 mmol) in THF (2.0 mL) and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with water (10 mL) and extracted with chloroform (10 mL × 4). The chloroform layer was washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The obtained residue was separated and purified by silica gel column chromatography (silica gel: 4 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 16 to 1 → 8 to 1 → 7 to 2), and 9ae (185 mg, 0.34 mmol, yield 76%) was obtained. 1 H-NMR (CDCl 3 ) δ: 2.60 (1H, br), 3.60-3.78 (32H, br), 4.06 (2H, t, J = 5.5 Hz), 4.44 (2H, t, J = 5.5 Hz), 7.14 (1H, dd, J = 7.6 Hz, 1.2 Hz), 7.41 (3H, m), 8.12 (1H, dd, J = 8.2 Hz, 1.7 Hz), 8.94 (1H, dd, J = 4.4 Hz, 1.7 Hz ).
Nonaethylene glycol mono(7-coumaryl) ether (9af) Nonaethylene glycol mono (7-coumaryl) ether (9af)
7af (202 mg, 1.25 mmol) 及び塩化ベンジルトリエチルアンモニウム (66 mg, 0.29 mmol) を THF (2.5 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 58 mg, 1.45 mmol) を加え室温にて1時間撹拌した。このものに 5 (190 mg, 0.33 mmol) の THF (5.0 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を水 (10 mL) で希釈し、クロロホルム (10 mL×4) で抽出した。クロロホルム層は、水 (10 mL)、飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 4 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 90 対 1 → 12 対 1 → 4 対 1 ) で分離し、1H-NMR 積分比より 9af と 5 の 7 対 1 混合物 (158 mg) を得た。(9af の換算収量 138 mg, 0.25 mmol, 換算収率 74%)1H-NMR(CDCl3)δ: 2.63 (1H, br), 3.58-3.74 (32H, br), 3.89 (2H, t, J=4.8 Hz), 4.19 (2H, t, J=4.8 Hz), 6.24 (1H, d, J=9.4 Hz), 6.86 (1H, dd, J=8.7 Hz, 2.3 Hz), 6.87 (1H,d, J=2.3 Hz), 7.36 (1H, d, J=8.7 Hz), 7.62 (1H, d, J=9.4 Hz)。 7af (202 mg, 1.25 mmol) and benzyltriethylammonium chloride (66 mg, 0.29 mmol) were dissolved in THF (2.5 mL). To this, sodium hydride (mineral oil suspension, purity 60%, 58 mg, 1.45 mmol) was added and stirred at room temperature for 1 hour. To this was added a solution of 5 (190 mg, 0.33 mmol) in THF (5.0 mL) and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with water (10 mL) and extracted with chloroform (10 mL × 4). The chloroform layer was washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The obtained residue was separated by silica gel column chromatography (silica gel: 4 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 90 to 1 → 12 to 1 → 4 to 1), and 1 H-NMR integration ratio A 9: 1 mixture of 9af and 5 (158 mg) was obtained. (Converted yield of 9af 138 mg, 0.25 mmol, converted yield 74%) 1 H-NMR (CDCl 3 ) δ: 2.63 (1H, br), 3.58-3.74 (32H, br), 3.89 (2H, t, J = 4.8 Hz), 4.19 (2H, t, J = 4.8 Hz), 6.24 (1H, d, J = 9.4 Hz), 6.86 (1H, dd, J = 8.7 Hz, 2.3 Hz), 6.87 (1H, d, J = 2.3 Hz), 7.36 (1H, d, J = 8.7 Hz), 7.62 (1H, d, J = 9.4 Hz).
Nonaethylene glycol mono(5-isoquinolyl) ether (9ag) Nonaethylene glycol mono (5-isoquinolyl) ether (9ag)
7ag (136 mg, 0.94 mmol) 及び塩化ベンジルトリエチルアンモニウム (25 mg, 0.11 mmol) を THF (1.5 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 46 mg, 1.15 mmol) を加え室温にて1時間撹拌した。このものに 5 (196 mg, 0.34 mmol) の THF (2.5 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を水 (10 mL) で希釈し、クロロホルム (10 mL×4) で抽出した。クロロホルム層は、水 (10 mL)、飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 4 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 60 対 1 → 12 対 1 → 4 対 1) で分離精製し、9ag (136 mg, 0.25 mmol, 収率 73%) を得た。1H-NMR(CDCl3)δ: 2.73 (1H, br), 3.59-3.73 (30H, br), 3.79 (2H, t, J=4.6 Hz), 4.00 (2H, t, J=4.8 Hz), 4.32 (2H, t, J=4.8 Hz), 7.02 (1H, dd, J=7.8 Hz, 0.9 Hz), 7.51 (2H, m), 8.03 (1H, d, J=6.0 Hz), 8.52 (1H, d, J=6.0 Hz), 9.20 (1H, s)。 7ag (136 mg, 0.94 mmol) and benzyltriethylammonium chloride (25 mg, 0.11 mmol) were dissolved in THF (1.5 mL). To this, sodium hydride (mineral oil suspension, purity 60%, 46 mg, 1.15 mmol) was added and stirred at room temperature for 1 hour. To this was added a solution of 5 (196 mg, 0.34 mmol) in THF (2.5 mL) and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with water (10 mL) and extracted with chloroform (10 mL × 4). The chloroform layer was washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The resulting residue was separated and purified by silica gel column chromatography (silica gel: 4 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 60 to 1 → 12 to 1 → 4 to 1), and 9ag (136 mg, 0.25 mmol, yield 73%). 1 H-NMR (CDCl 3 ) δ: 2.73 (1H, br), 3.59-3.73 (30H, br), 3.79 (2H, t, J = 4.6 Hz), 4.00 (2H, t, J = 4.8 Hz), 4.32 (2H, t, J = 4.8 Hz), 7.02 (1H, dd, J = 7.8 Hz, 0.9 Hz), 7.51 (2H, m), 8.03 (1H, d, J = 6.0 Hz), 8.52 (1H, d, J = 6.0 Hz), 9.20 (1H, s).
Nonaethylene glycol mono(4-iodophenyl) ether (9ah) Nonaethylene glycol mono (4-iodophenyl) ether (9ah)
7ah (230 mg, 1.05 mmol) を THF (2.0 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 49 mg, 1.23 mmol) を加え室温にて1時間撹拌した。このものに 5 (210 mg, 0.37 mmol) の THF (2.0 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を酢酸エチル (10 mL) で希釈し、水 (10 mL)、飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 4 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 90 対 1 → 12 対 1 → 4 対 1) で分離精製し、9ah (154 mg, 0.25 mmol, 収率 68%) を得た。1H-NMR(CDCl3)δ: 2.61 (1H, br), 3.57-3.73 (32H, br), 3.84 (2H, t, J=4.8 Hz), 4.09 (2H, t, J=4.8 Hz), 6.69 (2H, d, J=9.2 Hz), 7.54 (2H, d, J=9.2 Hz)。 7ah (230 mg, 1.05 mmol) was dissolved in THF (2.0 mL). To this, sodium hydride (mineral oil suspension, purity 60%, 49 mg, 1.23 mmol) was added and stirred at room temperature for 1 hour. To this was added a solution of 5 (210 mg, 0.37 mmol) in THF (2.0 mL) and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with ethyl acetate (10 mL), and washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The obtained residue was separated and purified by silica gel column chromatography (silica gel: 4 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 90 to 1 → 12 to 1 → 4 to 1), and 9ah (154 mg, 0.25 mmol, yield 68%). 1 H-NMR (CDCl 3 ) δ: 2.61 (1H, br), 3.57-3.73 (32H, br), 3.84 (2H, t, J = 4.8 Hz), 4.09 (2H, t, J = 4.8 Hz), 6.69 (2H, d, J = 9.2 Hz), 7.54 (2H, d, J = 9.2 Hz).
Nonaethylene glycol mono(4-chlorophenyl) ether (9ai) Nonaethylene glycol mono (4-chlorophenyl) ether (9ai)
7ai (120 mg, 0.93 mmol) を THF (1.0 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 44 mg, 1.10 mmol) を加え室温にて1時間撹拌した。このものに 5 (207 mg, 0.36 mmol) の THF (1.5 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を酢酸エチル (10 mL) で希釈し、水 (10 mL)、飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 4 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 90 対 1 → 10 対 1 → 4 対 1) で分離精製し、9ai (123 mg, 0.23 mmol, 収率 64%) を得た。1H-NMR(CDCl3)δ: 2.56 (1H, br), 3.59-3.74 (32H, br), 3.84 (2H, t, J=4.8 Hz), 4.10 (2H, t, J=4.8 Hz), 6.84 (2H, d, J=8.9 Hz), 7.22 (2H, d, J=8.9 Hz)。 7ai (120 mg, 0.93 mmol) was dissolved in THF (1.0 mL). To this, sodium hydride (mineral oil suspension, purity 60%, 44 mg, 1.10 mmol) was added and stirred at room temperature for 1 hour. To this was added a solution of 5 (207 mg, 0.36 mmol) in THF (1.5 mL) and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with ethyl acetate (10 mL), and washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The resulting residue was separated and purified by silica gel column chromatography (silica gel: 4 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 90 to 1 → 10 to 1 → 4 to 1), and 9ai (123 mg, 0.23 mmol, yield 64%). 1 H-NMR (CDCl 3 ) δ: 2.56 (1H, br), 3.59-3.74 (32H, br), 3.84 (2H, t, J = 4.8 Hz), 4.10 (2H, t, J = 4.8 Hz), 6.84 (2H, d, J = 8.9 Hz), 7.22 (2H, d, J = 8.9 Hz).
Nonaethylene glycol mono(p-biphenyl) ether (9aj) Nonaethylene glycol mono (p-biphenyl) ether (9aj)
7aj (170 mg, 1.00 mmol) を THF (1.5 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 44 mg, 1.10 mmol) を加え室温にて1時間撹拌した。このものに 5 (205 mg, 0.36 mmol) の THF (2.0 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を酢酸エチル (10 mL) で希釈し、水 (10 mL)、飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 4 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 90 対 1 → 12 対 1 → 4 対 1) で分離精製し、9aj (172 mg, 0.30 mmol, 収率 84%) を得た。1H-NMR(CDCl3)δ: 2.77 (1H, t, J=6.0 Hz), 3.59-3.75 (32H, br), 3.88 (2H, t, J=5.4 Hz), 4.18 (2H, t, J=5.4 Hz), 6.98 (2H, d, J=8.7 Hz), 7.30-7.56 (7H, m)。 7aj (170 mg, 1.00 mmol) was dissolved in THF (1.5 mL). To this, sodium hydride (mineral oil suspension, purity 60%, 44 mg, 1.10 mmol) was added and stirred at room temperature for 1 hour. To this was added a solution of 5 (205 mg, 0.36 mmol) in THF (2.0 mL) and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with ethyl acetate (10 mL), and washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The obtained residue was separated and purified by silica gel column chromatography (silica gel: 4 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 90 to 1 → 12 to 1 → 4 to 1), and 9aj (172 mg, 0.30 mmol, yield 84%). 1 H-NMR (CDCl 3 ) δ: 2.77 (1H, t, J = 6.0 Hz), 3.59-3.75 (32H, br), 3.88 (2H, t, J = 5.4 Hz), 4.18 (2H, t, J = 5.4 Hz), 6.98 (2H, d, J = 8.7 Hz), 7.30-7.56 (7H, m).
Nonaethylene glycol mono(5-quinolyl) ether (9ak) Nonaethylene glycol mono (5-quinolyl) ether (9ak)
7ak (140 mg, 0.96 mmol) 及び塩化ベンジルトリエチルアンモニウム (24 mg, 0.11 mmol) を THF (1.5 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 46 mg, 1.15 mmol) を加え室温にて1時間撹拌した。このものに 5 (210 mg, 0.37 mmol) の THF (2.0 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を水 (10 mL) で希釈し、クロロホルム (10 mL×4) で抽出した。クロロホルム層は、水 (10 mL)、飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 4 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 16 対 1 → 8 対 1 → 4 対 1) で分離精製し、9ak (126 mg, 0.23 mmol, 収率 63%) を得た。1H-NMR(CDCl3)δ: 2.98 (1H, br), 3.59-3.71 (30H, br), 3.79 (2H, t, J=4.8 Hz), 4.00 (2H, t, J=4.8 Hz), 4.32 (2H, t, J=4.8 Hz), 6.87 (1H, d, J=7.8 Hz), 7.38 (1H, dd, J=8.6 Hz, 4.4 Hz), 7.60 (1H, dd, J=8.5 Hz, 7.8 Hz), 7.70 (1H, d, J=8.5 Hz), 8.62 (1H, d, J=8.6 Hz), 8.91 (1H, dd, J=4.4 Hz, 1.2 Hz)。 7ak (140 mg, 0.96 mmol) and benzyltriethylammonium chloride (24 mg, 0.11 mmol) were dissolved in THF (1.5 mL). To this, sodium hydride (mineral oil suspension, purity 60%, 46 mg, 1.15 mmol) was added and stirred at room temperature for 1 hour. To this was added a solution of 5 (210 mg, 0.37 mmol) in THF (2.0 mL) and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with water (10 mL) and extracted with chloroform (10 mL × 4). The chloroform layer was washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The obtained residue was separated and purified by silica gel column chromatography (silica gel: 4 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 16 to 1 → 8 to 1 → 4 to 1), and 9ak (126 mg, 0.23 mmol, yield 63%). 1 H-NMR (CDCl 3 ) δ: 2.98 (1H, br), 3.59-3.71 (30H, br), 3.79 (2H, t, J = 4.8 Hz), 4.00 (2H, t, J = 4.8 Hz), 4.32 (2H, t, J = 4.8 Hz), 6.87 (1H, d, J = 7.8 Hz), 7.38 (1H, dd, J = 8.6 Hz, 4.4 Hz), 7.60 (1H, dd, J = 8.5 Hz, 7.8 Hz), 7.70 (1H, d, J = 8.5 Hz), 8.62 (1H, d, J = 8.6 Hz), 8.91 (1H, dd, J = 4.4 Hz, 1.2 Hz).
Nonaethylene glycol mono(4-indolyl) ether (9al) Nonaethylene glycol mono (4-indolyl) ether (9al)
7al (150 mg, 1.13 mmol) 及び塩化ベンジルトリエチルアンモニウム (24 mg, 0.11 mmol) を THF (1.5 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 50 mg, 1.25 mmol) を加え室温にて1時間撹拌した。このものに 5 (200 mg, 0.35 mmol) の THF (2.0 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を水 (10 mL) で希釈し、クロロホルム (10 mL×4) で抽出した。クロロホルム層は、水 (10 mL)、飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 4 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 45 対 1 → 8 対 1 → 4 対 1) で分離精製し、9al (73 mg, 0.14 mmol, 収率 39%) を得た。1H-NMR(CDCl3)δ: 2.68 (1H, br), 3.59-3.80 (32H, br), 3.95 (2H, t, J=5.1 Hz), 4.30 (2H, t, J=5.1 Hz), 6.52 (1H, d, J=7.3 Hz), 6.66 (1H, br), 7.02-7.13 (3H, m), 8.39 (1H, br)。 7al (150 mg, 1.13 mmol) and benzyltriethylammonium chloride (24 mg, 0.11 mmol) were dissolved in THF (1.5 mL). To this, sodium hydride (mineral oil suspension, purity 60%, 50 mg, 1.25 mmol) was added and stirred at room temperature for 1 hour. To this was added a solution of 5 (200 mg, 0.35 mmol) in THF (2.0 mL) and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with water (10 mL) and extracted with chloroform (10 mL × 4). The chloroform layer was washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The obtained residue was separated and purified by silica gel column chromatography (silica gel: 4 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 45 to 1 → 8 to 1 → 4 to 1), and 9al (73 mg, 0.14 mmol, yield 39%). 1 H-NMR (CDCl 3 ) δ: 2.68 (1H, br), 3.59-3.80 (32H, br), 3.95 (2H, t, J = 5.1 Hz), 4.30 (2H, t, J = 5.1 Hz), 6.52 (1H, d, J = 7.3 Hz), 6.66 (1H, br), 7.02-7.13 (3H, m), 8.39 (1H, br).
Nonaethylene glycol mono(5-indolyl) ether (9am) Nonaethylene glycol mono (5-indolyl) ether (9am)
7am (130 mg, 0.98 mmol) 及び塩化ベンジルトリエチルアンモニウム (22 mg, 0.10 mmol) を THF (1.5 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 38 mg, 0.95 mmol) を加え室温にて1時間撹拌した。このものに 5 (185 mg, 0.33 mmol) の THF (2.0 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を水 (10 mL) で希釈し、クロロホルム (10 mL×4) で抽出した。クロロホルム層は、水 (10 mL)、飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 4 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 45 対 1 → 8 対 1 → 4 対 1) で分離精製し、9am (142 mg, 0.27 mmol, 収率 83%) を得た。1H-NMR(CDCl3)δ: 2.82 (1H, br), 3.58-3.75 (32H, br), 3.87 (2H, t, J=4.8 Hz), 4.18 (2H, t, J=4.8 Hz), 6.45 (1H, br), 6.88 (1H, dd, J=8.7 Hz, 2.6 Hz), 7.11 (1H, d, J=2.3 Hz), 7.18 (1H, t, J=2.8 Hz), 7.28 (1H, d, J=8.7 Hz), 8.33 (1H, br)。 7am (130 mg, 0.98 mmol) and benzyltriethylammonium chloride (22 mg, 0.10 mmol) were dissolved in THF (1.5 mL). Sodium hydride (mineral oil suspension, purity 60%, 38 mg, 0.95 mmol) was added thereto, and the mixture was stirred at room temperature for 1 hour. To this was added a solution of 5 (185 mg, 0.33 mmol) in THF (2.0 mL) and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with water (10 mL) and extracted with chloroform (10 mL × 4). The chloroform layer was washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The resulting residue was separated and purified by silica gel column chromatography (silica gel: 4 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 45 to 1 → 8 to 1 → 4 to 1), and 9am (142 mg, 0.27 mmol, yield 83%). 1 H-NMR (CDCl 3 ) δ: 2.82 (1H, br), 3.58-3.75 (32H, br), 3.87 (2H, t, J = 4.8 Hz), 4.18 (2H, t, J = 4.8 Hz), 6.45 (1H, br), 6.88 (1H, dd, J = 8.7 Hz, 2.6 Hz), 7.11 (1H, d, J = 2.3 Hz), 7.18 (1H, t, J = 2.8 Hz), 7.28 (1H, d, J = 8.7 Hz), 8.33 (1H, br).
Nonaethylene glycol mono(3-estronyl) ether (9an) Nonaethylene glycol mono (3-estronyl) ether (9an)
7an (265 mg, 0.98 mmol) を THF (2.0 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 42 mg, 1.05 mmol) を加え室温にて1時間撹拌した。このものに 5 (200 mg, 0.35 mmol) の THF (2.0 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を酢酸エチル (10 mL) で希釈し、水 (10 mL)、飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 4 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 90 対 1 → 45 対 1 → 30 対 1 → 8 対 1 → 4 対 1) で分離精製し、9an (208 mg, 0.31 mmol, 収率 89%) を得た。1H-NMR(CDCl3)δ: 0.91 (3H, s), 1.38-1.73 (6H, m), 194-2.19 (4H, m), 2.24-2.54 (3H, m), 2.87 (3H, m), 3.59-3.73 (32H, br), 3.84 (2H, t, J=4.9 Hz), 4.10 (2H, t, J=4.9 Hz),6.66 (1H, d, J=2.6 Hz), 6.72 (1H, dd, J=8.6 Hz, 2.6 Hz), 7.18 (1H, t, J=8.6 Hz)。 7an (265 mg, 0.98 mmol) was dissolved in THF (2.0 mL). Sodium hydride (mineral oil suspension, purity 60%, 42 mg, 1.05 mmol) was added thereto, and the mixture was stirred at room temperature for 1 hour. To this was added a solution of 5 (200 mg, 0.35 mmol) in THF (2.0 mL) and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with ethyl acetate (10 mL), and washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The obtained residue was separated by silica gel column chromatography (silica gel: 4 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 90 to 1 → 45 to 1 → 30 to 1 → 8 to 1 → 4 to 1) Purification gave 9an (208 mg, 0.31 mmol, 89% yield). 1 H-NMR (CDCl 3 ) δ: 0.91 (3H, s), 1.38-1.73 (6H, m), 194-2.19 (4H, m), 2.24-2.54 (3H, m), 2.87 (3H, m) , 3.59-3.73 (32H, br), 3.84 (2H, t, J = 4.9 Hz), 4.10 (2H, t, J = 4.9 Hz), 6.66 (1H, d, J = 2.6 Hz), 6.72 (1H, dd, J = 8.6 Hz, 2.6 Hz), 7.18 (1H, t, J = 8.6 Hz).
Nonaethylene glycol mono(3,4-methylenedioxyphenyl) ether (9ao) Nonaethylene glycol mono (3,4-methylenedioxyphenyl) ether (9ao)
7ao (135 mg, 0.98 mmol) を THF (1.5 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 46 mg, 1.15 mmol) を加え室温にて1時間撹拌した。このものに 5 (186 mg, 0.35 mmol) の THF (2.0 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を酢酸エチル (10 mL) で希釈し、水 (10 mL)、飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 4 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 60 対 1 → 8 対 1 → 4 対 1) で分離精製し、9ao (109 mg, 0.20 mmol, 収率 62%) を得た。1H-NMR(CDCl3)δ: 2.86 (1H, br), 3.59-3.72 (32H, br), 3.82 (2H, t, J=4.8 Hz), 4.05 (2H, t, J=4.8 Hz), 5.91 (2H, s), 6.33 (1H, dd, J=8.5 Hz, 2.6 Hz), 6.51 (1H, d, J=2.6 Hz), 6.69 (1H, t, J=8.5 Hz)。 7ao (135 mg, 0.98 mmol) was dissolved in THF (1.5 mL). To this, sodium hydride (mineral oil suspension, purity 60%, 46 mg, 1.15 mmol) was added and stirred at room temperature for 1 hour. To this was added a solution of 5 (186 mg, 0.35 mmol) in THF (2.0 mL) and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with ethyl acetate (10 mL), and washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The resulting residue was separated and purified by silica gel column chromatography (silica gel: 4 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 60 to 1 → 8 to 1 → 4 to 1), and 9ao (109 mg, 0.20 mmol, 62% yield). 1 H-NMR (CDCl 3 ) δ: 2.86 (1H, br), 3.59-3.72 (32H, br), 3.82 (2H, t, J = 4.8 Hz), 4.05 (2H, t, J = 4.8 Hz), 5.91 (2H, s), 6.33 (1H, dd, J = 8.5 Hz, 2.6 Hz), 6.51 (1H, d, J = 2.6 Hz), 6.69 (1H, t, J = 8.5 Hz).
Nonaethylene glycol mono(5,6,7,8-tetrahydro-2-naphthyl) ether (9ap) Nonaethylene glycol mono (5,6,7,8-tetrahydro-2-naphthyl) ether (9ap)
7ap (160 mg, 1.08 mmol) を THF (1.5 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 49 mg, 1.23 mmol) を加え室温にて1時間撹拌した。このものに 5 (210 mg, 0.37 mmol) の THF (2.0 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を酢酸エチル (10 mL) で希釈し、水 (10 mL)、飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 5 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 90 対 1 → 8 対 1 → 4 対 1) で分離精製し、9ap (105 mg, 0.19 mmol, 収率 52%) を得た。1H-NMR(CDCl3)δ: 1.77 (4H, m), 2.70 (4H, m), 2.81 (1H, br), 3.59-3.73 (32H, br), 3.83 (2H, t, J=5.1 Hz), 4.09 (2H, t, J=5.1 Hz), 6.62 (1H, d, J=2.8 Hz), 6.67 (1H, dd, J=8.5 Hz, 2.8 Hz), 6.95 (1H, t, J=8.5 Hz)。 7ap (160 mg, 1.08 mmol) was dissolved in THF (1.5 mL). To this, sodium hydride (mineral oil suspension, purity 60%, 49 mg, 1.23 mmol) was added and stirred at room temperature for 1 hour. To this was added a solution of 5 (210 mg, 0.37 mmol) in THF (2.0 mL) and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with ethyl acetate (10 mL), and washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The resulting residue was separated and purified by silica gel column chromatography (silica gel: 5 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 90 to 1 → 8 to 1 → 4 to 1), and 9ap (105 mg, 0.19 mmol, yield 52%). 1 H-NMR (CDCl 3 ) δ: 1.77 (4H, m), 2.70 (4H, m), 2.81 (1H, br), 3.59-3.73 (32H, br), 3.83 (2H, t, J = 5.1 Hz ), 4.09 (2H, t, J = 5.1 Hz), 6.62 (1H, d, J = 2.8 Hz), 6.67 (1H, dd, J = 8.5 Hz, 2.8 Hz), 6.95 (1H, t, J = 8.5 Hz).
Nonaethylene glycol mono(4-acetamidophenyl) ether (9aq)
<7aq からの合成>
Nonaethylene glycol mono (4-acetamidophenyl) ether (9aq)
< Synthesis from 7aq >
7aq (145 mg, 0.96 mmol) を THF (1.5 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 49 mg, 1.23 mmol) を加え室温にて1時間撹拌した。このものに 5 (200 mg, 0.35 mmol) の THF (2.0 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を酢酸エチル (10 mL) で希釈し、水 (10 mL) および飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 4 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 45 対 1 → 45 対 2 → 16 対 1 → 8 対 1 → 4 対 1) で分離精製し、1H-NMR 積分比より 9aq と 5 の 2.3 対 1 混合物 (19 mg) を得た。(9aq の換算収量 13 mg, 0.02 mmol, 換算収率 7%)
<9m' からの合成>
7aq (145 mg, 0.96 mmol) was dissolved in THF (1.5 mL). To this, sodium hydride (mineral oil suspension, purity 60%, 49 mg, 1.23 mmol) was added and stirred at room temperature for 1 hour. To this was added a solution of 5 (200 mg, 0.35 mmol) in THF (2.0 mL) and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with ethyl acetate (10 mL), and washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. Separation of the resulting residue by silica gel column chromatography (silica gel: 4 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 45 to 1 → 45 to 2 → 16 to 1 → 8 to 1 → 4 to 1) The product was purified and a 2.3 to 1 mixture (19 mg) of 9aq and 5 was obtained from 1 H-NMR integration ratio. (Equivalent yield of 9aq 13 mg, 0.02 mmol, Equivalent yield 7%)
<Synthesis from 9m ' >
9m' (42 mg, 0.08 mmol) を ジクロロメタン (1.0 mL) に溶解させた。これにトリエチルアミン (0.10 mL, 0.72 mmol) および無水酢酸 (0.05 mL, 0.53 mmol) を添加し、室温で24時間撹拌を続けた。反応溶液を水 (5 mL) で希釈し、クロロホルム (5 mL×4) で抽出した。クロロホルム層は、水 (10 mL)、飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をメタノール (1.0 mL) に溶解し、炭酸カリウム (16 mg, 0.12 mmol) を加え室温にて3時間撹拌した。反応溶液を水 (5 mL) で希釈し、クロロホルム (5 mL×4) で抽出した。クロロホルム層は、水 (10 mL)、飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 4 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 4 対 1) で分離精製し、淡黄色液体 9aq (9 mg, 0.02 mmol, 収率 19%) を得た。1H-NMR(CDCl3)δ: 2.14 (3H, s), 3.20-3.50 (1H, br), 3.58-3.73 (33H, br), 3.83 (2H, t, J=4.9 Hz), 4.11 (2H, t, J=4.9 Hz), 6.86 (2H, d, J=9.0 Hz), 7.41 (2H, d, J=9.0 Hz), 7.58 (1H, br)。 9m '(42 mg, 0.08 mmol) was dissolved in dichloromethane (1.0 mL). Triethylamine (0.10 mL, 0.72 mmol) and acetic anhydride (0.05 mL, 0.53 mmol) were added thereto, and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with water (5 mL) and extracted with chloroform (5 mL × 4). The chloroform layer was washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The obtained residue was dissolved in methanol (1.0 mL), potassium carbonate (16 mg, 0.12 mmol) was added, and the mixture was stirred at room temperature for 3 hr. The reaction solution was diluted with water (5 mL) and extracted with chloroform (5 mL × 4). The chloroform layer was washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The obtained residue was separated and purified by silica gel column chromatography (silica gel: 4 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 4 to 1), and pale yellow liquid 9aq (9 mg, 0.02 mmol, yield) 19%). 1 H-NMR (CDCl 3 ) δ: 2.14 (3H, s), 3.20-3.50 (1H, br), 3.58-3.73 (33H, br), 3.83 (2H, t, J = 4.9 Hz), 4.11 (2H , t, J = 4.9 Hz), 6.86 (2H, d, J = 9.0 Hz), 7.41 (2H, d, J = 9.0 Hz), 7.58 (1H, br).
Nonaethylene glycol mono(4-benzoylphenyl) ether (9ar) Nonaethylene glycol mono (4-benzoylphenyl) ether (9ar)
7ar (192 mg, 0.97 mmol) を THF (2.0 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 44 mg, 1.10 mmol) を加え室温にて1時間撹拌した。このものに 5 (198 mg, 0.35 mmol) の THF (2.0 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を酢酸エチル (10 mL) で希釈し、水 (10 mL)、飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 4 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 60 対 1 → 8 対 1 → 4 対 1) で分離精製し、9ar (133 mg, 0. mmol, 収率 64%) を得た。1H-NMR(CDCl3)δ: 2.92 (1H, br), 3.59-3.75 (32H, br), 3.89 (2H, t, J=4.8 Hz), 4.22 (2H, t, J=4.8 Hz), 6.98 (2H, d, J=8.7 Hz), 7.47 (2H, m), 7.57 (1H, m), 7.75 (2H, dd, J=8.2 Hz, 1.4 Hz), 7.81 (2H, d, J=9.2 Hz)。 7ar (192 mg, 0.97 mmol) was dissolved in THF (2.0 mL). To this, sodium hydride (mineral oil suspension, purity 60%, 44 mg, 1.10 mmol) was added and stirred at room temperature for 1 hour. To this was added a solution of 5 (198 mg, 0.35 mmol) in THF (2.0 mL) and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with ethyl acetate (10 mL), and washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The resulting residue was separated and purified by silica gel column chromatography (silica gel: 4 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 60 to 1 → 8 to 1 → 4 to 1), and 9ar (133 mg, 0. mmol, yield 64%). 1 H-NMR (CDCl 3 ) δ: 2.92 (1H, br), 3.59-3.75 (32H, br), 3.89 (2H, t, J = 4.8 Hz), 4.22 (2H, t, J = 4.8 Hz), 6.98 (2H, d, J = 8.7 Hz), 7.47 (2H, m), 7.57 (1H, m), 7.75 (2H, dd, J = 8.2 Hz, 1.4 Hz), 7.81 (2H, d, J = 9.2 Hz).
Nonaethylene glycol mono(5-indanyl) ether (9as) Nonaethylene glycol mono (5-indanyl) ether (9as)
7as (132 mg, 0.98 mmol) を THF (1.5 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 44 mg, 1.10 mmol) を加え室温にて1時間撹拌した。このものに 5 (190 mg, 0.33 mmol) の THF (2.0 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を酢酸エチル (10 mL) で希釈し、水 (10 mL)、飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 4 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 90 対 1 → 8 対 1 → 4 対 1) で分離精製し、9as (125 mg, 0. mmol, 収率 71%) を得た。1H-NMR(CDCl3)δ: 2.06 (2H, m), 2.85 (5H, br), 3.59-3.74 (32H, br), 3.84 (2H, t, J=4.9 Hz), 4.10 (2H, t, J=4.9 Hz), 6.70 (1H, dd, J=8.0 Hz, 2.6 Hz), 6.80 (1H, d, J=2.6 Hz), 7.19 (1H, t, J=8.0 Hz)。 7as (132 mg, 0.98 mmol) was dissolved in THF (1.5 mL). To this, sodium hydride (mineral oil suspension, purity 60%, 44 mg, 1.10 mmol) was added and stirred at room temperature for 1 hour. To this was added 5 (190 mg, 0.33 mmol) in THF (2.0 mL) and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with ethyl acetate (10 mL), and washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The obtained residue was separated and purified by silica gel column chromatography (silica gel: 4 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 90 to 1 → 8 to 1 → 4 to 1), and 9as (125 mg, 0. mmol, 71% yield). 1 H-NMR (CDCl 3 ) δ: 2.06 (2H, m), 2.85 (5H, br), 3.59-3.74 (32H, br), 3.84 (2H, t, J = 4.9 Hz), 4.10 (2H, t , J = 4.9 Hz), 6.70 (1H, dd, J = 8.0 Hz, 2.6 Hz), 6.80 (1H, d, J = 2.6 Hz), 7.19 (1H, t, J = 8.0 Hz).
Nonaethylene glycol mono(3-methoxyphenyl) ether (9av) Nonaethylene glycol mono (3-methoxyphenyl) ether (9av)
7av (148 mg, 1.19 mmol) を THF (1.5 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 50 mg, 1.25 mmol) を加え室温にて1時間撹拌した。このものに 5 (147 mg, 0.26 mmol) の THF (1.5 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を酢酸エチル (10 mL) で希釈し、水 (10 mL)、飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 4 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 90 対 1 → 45 対 1 → 8 対 1 → 4 対 1) で分離精製し、9av (93 mg, 0.18 mmol, 収率 69%) を得た。1H-NMR(CDCl3)δ: 3.07 (1H, br), 3.59-3.74 (32H, br), 3.78 (3H, s), 3.85 (2H, t, J=5.0 Hz), 4.11 (2H, t, J=5.0 Hz), 6.50 (3H, m), 7.17 (1H, m)。 7av (148 mg, 1.19 mmol) was dissolved in THF (1.5 mL). To this, sodium hydride (mineral oil suspension, purity 60%, 50 mg, 1.25 mmol) was added and stirred at room temperature for 1 hour. To this was added a solution of 5 (147 mg, 0.26 mmol) in THF (1.5 mL) and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with ethyl acetate (10 mL), and washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The obtained residue was separated and purified by silica gel column chromatography (silica gel: 4 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 90 to 1 → 45 to 1 → 8 to 1 → 4 to 1). (93 mg, 0.18 mmol, 69% yield) was obtained. 1 H-NMR (CDCl 3 ) δ: 3.07 (1H, br), 3.59-3.74 (32H, br), 3.78 (3H, s), 3.85 (2H, t, J = 5.0 Hz), 4.11 (2H, t , J = 5.0 Hz), 6.50 (3H, m), 7.17 (1H, m).
Nonaethylene glycol mono(3,4-dihydro-2(1H)-quinolon-6-yl) ether (9aw) Nonaethylene glycol mono (3,4-dihydro-2 (1H) -quinolon-6-yl) ether (9aw)
7aw (156 mg, 0.96 mmol) を THF (1.5 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 43 mg, 1.08 mmol) を加え室温にて1時間撹拌した。このものに 5 (190 mg, 0.33 mmol) の THF (2.0 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を水 (10 mL) で希釈し、クロロホルム (10 mL×4) で抽出した。クロロホルム層は、水 (10 mL)、飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 4 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 45 対 1 → 16 対 1 → 8 対 1 → 4 対 1) で分離し、1H-NMR 積分比より 9aw と 5 の 9 対 1 混合物 (30 mg) を得た。(9aw の換算収量 27 mg, 0.05 mmol, 換算収率 14%)
1H-NMR(CDCl3)δ: 2.60 (2H, m), 2.92 (3H, m), 3.58-3.73 (33H, br), 3.83 (2H, t, J=4.9 Hz), 4.09 (2H, t, J=4.9 Hz), 6.65 (1H, d, J=8.5 Hz), 6.74 (2H, m)。
7aw (156 mg, 0.96 mmol) was dissolved in THF (1.5 mL). To this was added sodium hydride (mineral oil suspension, purity 60%, 43 mg, 1.08 mmol), and the mixture was stirred at room temperature for 1 hour. To this was added 5 (190 mg, 0.33 mmol) in THF (2.0 mL) and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with water (10 mL) and extracted with chloroform (10 mL × 4). The chloroform layer was washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The obtained residue was separated by silica gel column chromatography (silica gel: 4 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 45 to 1 → 16 to 1 → 8 to 1 → 4 to 1), and 1 H -9: 1 mixture (30 mg) of 9aw and 5 was obtained from the NMR integration ratio. (9aw conversion yield 27 mg, 0.05 mmol, conversion yield 14%)
1 H-NMR (CDCl 3 ) δ: 2.60 (2H, m), 2.92 (3H, m), 3.58-3.73 (33H, br), 3.83 (2H, t, J = 4.9 Hz), 4.09 (2H, t , J = 4.9 Hz), 6.65 (1H, d, J = 8.5 Hz), 6.74 (2H, m).
Nonaethylene glycol mono(4-carbomethoxymethylphenyl) ether (9ax) Nonaethylene glycol mono (4-carbomethoxymethylphenyl) ether (9ax)
7ax (156 mg, 0.94 mmol) を THF (1.5 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 40 mg, 1.00 mmol) を加え室温にて1時間撹拌した。このものに 5 (190 mg, 0.33 mmol) の THF (2.0 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を水 (10 mL) で希釈し、クロロホルム (10 mL×4) で抽出した。クロロホルム層は、水 (10 mL)、飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 4 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 45 対 1 → 20 対 1 → 4 対 1) で分離精製し、9ax (90 mg, 0.16 mmol, 収率 48%) を得た。1H-NMR(CDCl3)δ: 2.88 (1H, br), 3.56-3.73 (34H, br), 3.68 (3H, s), 3.84 (2H, t, J=5.0 Hz), 4.11 (2H, t, J=5.0 Hz), 6.87 (2H, d, J=8.7 Hz), 7.18 (2H, d, J=8.7 Hz)。 7ax (156 mg, 0.94 mmol) was dissolved in THF (1.5 mL). To this was added sodium hydride (mineral oil suspension, purity 60%, 40 mg, 1.00 mmol), and the mixture was stirred at room temperature for 1 hour. To this was added 5 (190 mg, 0.33 mmol) in THF (2.0 mL) and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with water (10 mL) and extracted with chloroform (10 mL × 4). The chloroform layer was washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The obtained residue was separated and purified by silica gel column chromatography (silica gel: 4 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 45 to 1 → 20 to 1 → 4 to 1), and 9ax (90 mg, 0.16 mmol, 48% yield). 1 H-NMR (CDCl 3 ) δ: 2.88 (1H, br), 3.56-3.73 (34H, br), 3.68 (3H, s), 3.84 (2H, t, J = 5.0 Hz), 4.11 (2H, t , J = 5.0 Hz), 6.87 (2H, d, J = 8.7 Hz), 7.18 (2H, d, J = 8.7 Hz).
Nonaethylene glycol mono(3-fluorophenyl) ether (9ay) Nonaethylene glycol mono (3-fluorophenyl) ether (9ay)
7ay (110 mg, 0.98 mmol) を THF (1.5 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 45 mg, 1.13 mmol) を加え室温にて1時間撹拌した。このものに 5 (208 mg, 0.37 mmol) の THF (2.0 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を酢酸エチル (10 mL) で希釈し、水 (10 mL)、飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 4 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 50 対 1 → 8 対 1 → 4 対 1) で分離精製し、9ay (110 mg, 0.22 mmol, 収率 59%) を得た。1H-NMR(CDCl3)δ: 2.76 (1H, br), 3.59-3.73 (32H, br), 3.85 (2H, t, J=4.8 Hz), 4.11 (2H, t, J=4.8 Hz), 6.61-6.71 (3H, m), 7.22 (1H, m)。 7ay (110 mg, 0.98 mmol) was dissolved in THF (1.5 mL). To this, sodium hydride (mineral oil suspension, purity 60%, 45 mg, 1.13 mmol) was added and stirred at room temperature for 1 hour. To this was added a solution of 5 (208 mg, 0.37 mmol) in THF (2.0 mL) and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with ethyl acetate (10 mL), and washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The obtained residue was separated and purified by silica gel column chromatography (silica gel: 4 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 50 to 1 → 8 to 1 → 4 to 1), and 9ay (110 mg, 0.22 mmol, yield 59%). 1 H-NMR (CDCl 3 ) δ: 2.76 (1H, br), 3.59-3.73 (32H, br), 3.85 (2H, t, J = 4.8 Hz), 4.11 (2H, t, J = 4.8 Hz), 6.61-6.71 (3H, m), 7.22 (1H, m).
Nonaethylene glycol mono(4-cyclohexylphenyl) ether (9az) Nonaethylene glycol mono (4-cyclohexylphenyl) ether (9az)
7az (173 mg, 0.98 mmol) を THF (1.5 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 43 mg, 1.08 mmol) を加え室温にて1時間撹拌した。このものに 5 (200 mg, 0.35 mmol) の THF (2.0 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を酢酸エチル (10 mL) で希釈し、水 (10 mL)、飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 4 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 90 対 1 → 45 対 1 → 8 対 1 → 4 対 1) で分離精製し、9az (114 mg, 0.20 mmol, 収率 57%) を得た。1H-NMR(CDCl3)δ: 1.37 (4H, br), 1.73 (2H, br), 1.83 (4H, br), 2.43 (1H, br), 2.77 (1H, br), 3.59-3.73 (32H, br), 3.84 (2H, t, J=4.9 Hz), 4.10 (2H, t, J=4.9 Hz), 6.84 (2H, d, J=8.7 Hz), 7.10 (2H, d, J=8.7 Hz)。 7az (173 mg, 0.98 mmol) was dissolved in THF (1.5 mL). To this was added sodium hydride (mineral oil suspension, purity 60%, 43 mg, 1.08 mmol), and the mixture was stirred at room temperature for 1 hour. To this was added a solution of 5 (200 mg, 0.35 mmol) in THF (2.0 mL) and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with ethyl acetate (10 mL), and washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The resulting residue was separated and purified by silica gel column chromatography (silica gel: 4 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 90 to 1 → 45 to 1 → 8 to 1 → 4 to 1). (114 mg, 0.20 mmol, 57% yield) was obtained. 1 H-NMR (CDCl 3 ) δ: 1.37 (4H, br), 1.73 (2H, br), 1.83 (4H, br), 2.43 (1H, br), 2.77 (1H, br), 3.59-3.73 (32H , br), 3.84 (2H, t, J = 4.9 Hz), 4.10 (2H, t, J = 4.9 Hz), 6.84 (2H, d, J = 8.7 Hz), 7.10 (2H, d, J = 8.7 Hz) ).
Nonaethylene glycol mono(4-isopropoxycarbonylphenyl) ether (9ba) Nonaethylene glycol mono (4-isopropoxycarbonylphenyl) ether (9ba)
7ba (174 mg, 0.95 mmol) を THF (2.0 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 44 mg, 1.10 mmol) を加え室温にて1時間撹拌した。このものに 5 (202 mg, 0.36 mmol) の THF (2.0 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を酢酸エチル (10 mL) で希釈し、水 (10 mL)、飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 4 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 90 対 1 → 45 対 1 → 8 対 1 → 4 対 1) で分離精製し、9ba (151 mg, 0.26 mmol, 収率 78%) を得た。1H-NMR(CDCl3)δ: 1.35 (6H, d, J=6.4 Hz) 2.76 (1H, br), 3.59-3.74 (32H, br), 3.87 (2H, t, J=4.8 Hz), 4.18 (2H, t, J=4.8 Hz), 5.22 (1H, septet, J=6.4 Hz), 6.92 (2H, d, J=8.7 Hz), 7.97 (2H, d, J=8.7 Hz)。 7ba (174 mg, 0.95 mmol) was dissolved in THF (2.0 mL). To this, sodium hydride (mineral oil suspension, purity 60%, 44 mg, 1.10 mmol) was added and stirred at room temperature for 1 hour. To this was added a solution of 5 (202 mg, 0.36 mmol) in THF (2.0 mL) and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with ethyl acetate (10 mL), and washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The resulting residue was separated and purified by silica gel column chromatography (silica gel: 4 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 90 to 1 → 45 to 1 → 8 to 1 → 4 to 1). (151 mg, 0.26 mmol, 78% yield) was obtained. 1 H-NMR (CDCl 3 ) δ: 1.35 (6H, d, J = 6.4 Hz) 2.76 (1H, br), 3.59-3.74 (32H, br), 3.87 (2H, t, J = 4.8 Hz), 4.18 (2H, t, J = 4.8 Hz), 5.22 (1H, septet, J = 6.4 Hz), 6.92 (2H, d, J = 8.7 Hz), 7.97 (2H, d, J = 8.7 Hz).
Nonaethylene glycol mono(2-methoxy-4-(2-propenyl)phenyl) ether (9bb) Nonaethylene glycol mono (2-methoxy-4- (2-propenyl) phenyl) ether (9bb)
7bb (180 mg, 1.10 mmol) を THF (1.5 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 50 mg, 1.25 mmol) を加え室温にて1時間撹拌した。このものに 5 (188 mg, 0.33 mmol) の THF (2.0 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を酢酸エチル (10 mL) で希釈し、水 (10 mL)、飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 4 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 90 対 1 → 45 対 1 → 8 対 1 → 4 対 1) で分離精製し、9bb (140 mg, 0.25 mmol, 収率 76%) を得た。1H-NMR(CDCl3)δ: 2.84 (1H, br), 3.33 (2H,d, J=6.9 Hz), 3.59-3.73 (32H, br), 3.84 (3H, s), 3.86 (2H, t, J=5.3 Hz), 4.16 (2H, t, J=5.3 Hz), 5.07 (2H, m), 5.94 (1H, m), 6.69 (2H, m), 6.85 (1H, d, J=8.7 Hz)。 7bb (180 mg, 1.10 mmol) was dissolved in THF (1.5 mL). To this, sodium hydride (mineral oil suspension, purity 60%, 50 mg, 1.25 mmol) was added and stirred at room temperature for 1 hour. To this was added 5 (188 mg, 0.33 mmol) in THF (2.0 mL) and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with ethyl acetate (10 mL), and washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The obtained residue was separated and purified by silica gel column chromatography (silica gel: 4 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 90 to 1 → 45 to 1 → 8 to 1 → 4 to 1), 9bb (140 mg, 0.25 mmol, yield 76%) was obtained. 1 H-NMR (CDCl 3 ) δ: 2.84 (1H, br), 3.33 (2H, d, J = 6.9 Hz), 3.59-3.73 (32H, br), 3.84 (3H, s), 3.86 (2H, t , J = 5.3 Hz), 4.16 (2H, t, J = 5.3 Hz), 5.07 (2H, m), 5.94 (1H, m), 6.69 (2H, m), 6.85 (1H, d, J = 8.7 Hz ).
Nonaethylene glycol mono(3,4-dihydro-2(1H)-quinolon-7-yl) ether (9bc) Nonaethylene glycol mono (3,4-dihydro-2 (1H) -quinolon-7-yl) ether (9bc)
7bc (163 mg, 1.00 mmol) を THF (2.0 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 43 mg, 1.08 mmol) を加え室温にて1時間撹拌した。このものに 5 (195 mg, 0.34 mmol) の THF (2.0 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を水 (10 mL) で希釈し、クロロホルム (10 mL×4) で抽出した。クロロホルム層は、水 (10 mL)、飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 4 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 16 対 1 → 8 対 1 → 4 対 1) で分離し、1H-NMR 積分比より 9bc と 5 の 8.3 対 1 混合物 (93 mg) を得た。(9bc の換算収量 83 mg, 0.15 mmol, 換算収率 43%)1H-NMR(CDCl3)δ: 2.60 (2H, t, J=7.3 Hz), 2.89 (2H, t, J=7.3 Hz), 2.94 (1H, m), 3.58-3.73 (32H, br), 3.84 (2H, t, J=4.8 Hz), 4.10 (2H, t, J=4.8 Hz), 6.38 (1H, d, J=2.3 Hz), 6.53 (1H, dd, J=8.3 Hz, 2.3 Hz), 7.03 (1H, d, J=8.3 Hz), 7.79 (1H, br)。 7bc (163 mg, 1.00 mmol) was dissolved in THF (2.0 mL). To this was added sodium hydride (mineral oil suspension, purity 60%, 43 mg, 1.08 mmol), and the mixture was stirred at room temperature for 1 hour. To this was added a solution of 5 (195 mg, 0.34 mmol) in THF (2.0 mL) and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with water (10 mL) and extracted with chloroform (10 mL × 4). The chloroform layer was washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The obtained residue was separated by silica gel column chromatography (silica gel: 4 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 16 to 1 → 8 to 1 → 4 to 1), and 1 H-NMR integration ratio From this, an 8.3 to 1 mixture of 9bc and 5 (93 mg) was obtained. (Converted yield of 9bc 83 mg, 0.15 mmol, converted yield 43%) 1 H-NMR (CDCl 3 ) δ: 2.60 (2H, t, J = 7.3 Hz), 2.89 (2H, t, J = 7.3 Hz) , 2.94 (1H, m), 3.58-3.73 (32H, br), 3.84 (2H, t, J = 4.8 Hz), 4.10 (2H, t, J = 4.8 Hz), 6.38 (1H, d, J = 2.3 Hz), 6.53 (1H, dd, J = 8.3 Hz, 2.3 Hz), 7.03 (1H, d, J = 8.3 Hz), 7.79 (1H, br).
Nonaethylene glycol mono(4-phenylmethylphenyl) ether (9bd) Nonaethylene glycol mono (4-phenylmethylphenyl) ether (9bd)
7bd (200 mg, 1.10 mmol) を THF (2.0 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 48 mg, 1.20 mmol) を加え室温にて1時間撹拌した。このものに 5 (196 mg, 0.34 mmol) の THF (2.0 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を酢酸エチル (10 mL) で希釈し、水 (10 mL)、飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 4 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 120 対 1 → 90 対 1 → 16 対 1) で分離精製し、9bd (123 mg, 0.21 mmol, 収率 62%) を得た。1H-NMR(CDCl3)δ: 2.71 (1H, br), 3.59-3.72 (32H, br), 3.83 (2H, t, J=5.0 Hz), 3.92 (2H, s), 4.10 (2H, t, J=5.0 Hz), 6.83 (2H, d, J=8.7 Hz), 7.08 (2H, d, J=8.7 Hz), 7.18 (3H, m), 7.27 (2H, m)。 7bd (200 mg, 1.10 mmol) was dissolved in THF (2.0 mL). To this, sodium hydride (mineral oil suspension, purity 60%, 48 mg, 1.20 mmol) was added and stirred at room temperature for 1 hour. To this was added a solution of 5 (196 mg, 0.34 mmol) in THF (2.0 mL) and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with ethyl acetate (10 mL), and washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The resulting residue was separated and purified by silica gel column chromatography (silica gel: 4 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 120 to 1 → 90 to 1 → 16 to 1), and 9bd (123 mg, 0.21 mmol, yield 62%). 1 H-NMR (CDCl 3 ) δ: 2.71 (1H, br), 3.59-3.72 (32H, br), 3.83 (2H, t, J = 5.0 Hz), 3.92 (2H, s), 4.10 (2H, t , J = 5.0 Hz), 6.83 (2H, d, J = 8.7 Hz), 7.08 (2H, d, J = 8.7 Hz), 7.18 (3H, m), 7.27 (2H, m).
Nonaethylene glycol mono(2-tert-butyl-4-ethylphenyl) ether (9bf) Nonaethylene glycol mono (2-tert-butyl-4-ethylphenyl) ether (9bf)
7bf (182 mg, 1.02 mmol) を THF (2.0 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 48 mg, 1.20 mmol) を加え室温にて1時間撹拌した。このものに 5 (197 mg, 0.35 mmol) の THF (2.0 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を酢酸エチル (10 mL) で希釈し、水 (10 mL)、飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 4 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 120 対 1 → 45 対 1 → 16 対 1 → 4 対 1) で分離精製し、9bf (119 mg, 0.21 mmol, 収率 60%) を得た。1H-NMR(CDCl3)δ: 1.21 (3H, t, J=7.6 Hz), 1.38 (9H, s), 2.58 (2H, q, J=7.6 Hz), 2.72 (1H, br), 3.59-3.72 (32H, br), 3.88 (2H, t, J=5.0 Hz), 4.12 (2H, t, J=5.0 Hz), 6.78 (1H, d, J=8.3 Hz), 6.98 (1H, dd, J=8.3 Hz, 2.3 Hz), 7.09 (1H, d, J=2.3 Hz)。 7bf (182 mg, 1.02 mmol) was dissolved in THF (2.0 mL). To this, sodium hydride (mineral oil suspension, purity 60%, 48 mg, 1.20 mmol) was added and stirred at room temperature for 1 hour. To this was added 5 (197 mg, 0.35 mmol) in THF (2.0 mL) and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with ethyl acetate (10 mL), and washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The resulting residue was separated and purified by silica gel column chromatography (silica gel: 4 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 120 to 1 → 45 to 1 → 16 to 1 → 4 to 1), and 9bf (119 mg, 0.21 mmol, 60% yield) was obtained. 1 H-NMR (CDCl 3 ) δ: 1.21 (3H, t, J = 7.6 Hz), 1.38 (9H, s), 2.58 (2H, q, J = 7.6 Hz), 2.72 (1H, br), 3.59- 3.72 (32H, br), 3.88 (2H, t, J = 5.0 Hz), 4.12 (2H, t, J = 5.0 Hz), 6.78 (1H, d, J = 8.3 Hz), 6.98 (1H, dd, J = 8.3 Hz, 2.3 Hz), 7.09 (1H, d, J = 2.3 Hz).
Nonaethylene glycol mono(2,3-dihydro-2,2-dimethylbenzofuran-7-yl) ether (9bg) Nonaethylene glycol mono (2,3-dihydro-2,2-dimethylbenzofuran-7-yl) ether (9bg)
7bg (162 mg, 0.99 mmol) を THF (1.5 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 48 mg, 1.20 mmol) を加え室温にて1時間撹拌した。このものに 5 (184 mg, 0.32 mmol) の THF (2.0 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を酢酸エチル (10 mL) で希釈し、水 (10 mL)、飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 4 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 120 対 1 → 90 対 1 → 45 対 1 → 8 対 1 → 4 対 1) で分離精製し、9bg (126 mg, 0.22 mmol, 収率 70%) を得た。1H-NMR(CDCl3)δ: 1.49 (9H, s), 2.91 (1H, br), 3.01 (2H, s), 3.59-3.73 (32H, br), 3.84 (2H, t, J=5.4 Hz), 4.22 (2H, t, J=5.4 Hz), 6.75 (3H, m)。 7bg (162 mg, 0.99 mmol) was dissolved in THF (1.5 mL). To this, sodium hydride (mineral oil suspension, purity 60%, 48 mg, 1.20 mmol) was added and stirred at room temperature for 1 hour. To this was added a solution of 5 (184 mg, 0.32 mmol) in THF (2.0 mL) and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with ethyl acetate (10 mL), and washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The obtained residue was separated by silica gel column chromatography (silica gel: 4 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 120 to 1 → 90 to 1 → 45 to 1 → 8 to 1 → 4 to 1) Purification gave 9bg (126 mg, 0.22 mmol, 70% yield). 1 H-NMR (CDCl 3 ) δ: 1.49 (9H, s), 2.91 (1H, br), 3.01 (2H, s), 3.59-3.73 (32H, br), 3.84 (2H, t, J = 5.4 Hz ), 4.22 (2H, t, J = 5.4 Hz), 6.75 (3H, m).
Nonaethylene glycol mono(4-(1-adamantyl)phenyl) ether (9bh) Nonaethylene glycol mono (4- (1-adamantyl) phenyl) ether (9bh)
7bh (226 mg, 0.99 mmol) を THF (2.0 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 44 mg, 1.10 mmol) を加え室温にて1時間撹拌した。このものに 5 (196 mg, 0.34 mmol) の THF (2.0 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を酢酸エチル (10 mL) で希釈し、水 (10 mL)、飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 4 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 150 対 1 → 90 対 1 → 45 対 1 → 16 対 1 → 4 対 1) で分離精製し、9bh (177 mg, 0.28 mmol, 収率 82%) を得た。1H-NMR(CDCl3)δ: 1.77 (6H, m), 1.88 (6H, br), 2.79 (1H, br), 3.59-3.73 (32H, br), 3.84 (2H, t, J=5.0 Hz), 4.11 (2H, t, J=5.0 Hz), 6.86 (2H, d, J=8.7 Hz), 7.26 (2H, d, J=8.7 Hz)。 7bh (226 mg, 0.99 mmol) was dissolved in THF (2.0 mL). To this, sodium hydride (mineral oil suspension, purity 60%, 44 mg, 1.10 mmol) was added and stirred at room temperature for 1 hour. To this was added a solution of 5 (196 mg, 0.34 mmol) in THF (2.0 mL) and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with ethyl acetate (10 mL), and washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The obtained residue was separated by silica gel column chromatography (silica gel: 4 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 150 to 1 → 90 to 1 → 45 to 1 → 16 to 1 → 4 to 1) Purification gave 9bh (177 mg, 0.28 mmol, 82% yield). 1 H-NMR (CDCl 3 ) δ: 1.77 (6H, m), 1.88 (6H, br), 2.79 (1H, br), 3.59-3.73 (32H, br), 3.84 (2H, t, J = 5.0 Hz ), 4.11 (2H, t, J = 5.0 Hz), 6.86 (2H, d, J = 8.7 Hz), 7.26 (2H, d, J = 8.7 Hz).
Nonaethylene glycol mono(4-ethylphenyl) ether (9bi) Nonaethylene glycol mono (4-ethylphenyl) ether (9bi)
7bi (122 mg, 1.00 mmol) を THF (1.5 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 45 mg, 1.13 mmol) を加え室温にて1時間撹拌した。このものに 5 (191 mg, 0.34 mmol) の THF (2.0 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を酢酸エチル (10 mL) で希釈し、水 (10 mL)、飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 4 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 90 対 1 → 8 対 1 → 4 対 1) で分離精製し、9bi (151 mg, 0.29 mmol, 収率 87%) を得た。1H-NMR(CDCl3)δ: 1.20 (3H, t, J=7.6 Hz), 2.58 (2H, q, J=7.6 Hz), 2.77 (1H, br), 3.59-3.73 (32H, br), 3.84 (2H, t, J=4.9 Hz), 4.11 (2H, t, J=4.9 Hz), 6.84 (2H, d, J=8.7 Hz), 7.10 (2H, d, J=8.7 Hz)。 7bi (122 mg, 1.00 mmol) was dissolved in THF (1.5 mL). To this, sodium hydride (mineral oil suspension, purity 60%, 45 mg, 1.13 mmol) was added and stirred at room temperature for 1 hour. To this was added a solution of 5 (191 mg, 0.34 mmol) in THF (2.0 mL) and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with ethyl acetate (10 mL), and washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The resulting residue was separated and purified by silica gel column chromatography (silica gel: 4 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 90 to 1 → 8 to 1 → 4 to 1), and 9bi (151 mg, 0.29 mmol, yield 87%). 1 H-NMR (CDCl 3 ) δ: 1.20 (3H, t, J = 7.6 Hz), 2.58 (2H, q, J = 7.6 Hz), 2.77 (1H, br), 3.59-3.73 (32H, br), 3.84 (2H, t, J = 4.9 Hz), 4.11 (2H, t, J = 4.9 Hz), 6.84 (2H, d, J = 8.7 Hz), 7.10 (2H, d, J = 8.7 Hz).
Nonaethylene glycol mono(4-(1-methyl-1-phenylethyl)phenyl) ether (9bj) Nonaethylene glycol mono (4- (1-methyl-1-phenylethyl) phenyl) ether (9bj)
7bj (222 mg, 1.05 mmol) を THF (2.0 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 51 mg, 1.28 mmol) を加え室温にて1時間撹拌した。このものに 5 (195 mg, 0.34 mmol) の THF (2.0 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を酢酸エチル (10 mL) で希釈し、水 (10 mL)、飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 4 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 150 対 1 → 8 対 1 → 4 対 1) で分離精製し、9bj (152 mg, 0.25 mmol, 収率 73%) を得た。1H-NMR(CDCl3)δ: 1.67 (6H, s), 2.89 (1H, br), 3.59-3.73 (32H, br), 3.83 (2H, t, J=4.8 Hz), 4.10 (2H, t, J=4.8 Hz), 6.81 (2H, d, J=8.7 Hz), 7.14 (3H, m), 7.24 (4H, m)。 7bj (222 mg, 1.05 mmol) was dissolved in THF (2.0 mL). Sodium hydride (mineral oil suspension, purity 60%, 51 mg, 1.28 mmol) was added thereto, and the mixture was stirred at room temperature for 1 hour. To this was added a solution of 5 (195 mg, 0.34 mmol) in THF (2.0 mL) and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with ethyl acetate (10 mL), and washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The resulting residue was separated and purified by silica gel column chromatography (silica gel: 4 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 150 to 1 → 8 to 1 → 4 to 1), and 9bj (152 mg, 0.25 mmol, yield 73%). 1 H-NMR (CDCl 3 ) δ: 1.67 (6H, s), 2.89 (1H, br), 3.59-3.73 (32H, br), 3.83 (2H, t, J = 4.8 Hz), 4.10 (2H, t , J = 4.8 Hz), 6.81 (2H, d, J = 8.7 Hz), 7.14 (3H, m), 7.24 (4H, m).
Nonaethylene glycol mono(4-ethoxycarbonylphenyl) ether (9bk) Nonaethylene glycol mono (4-ethoxycarbonylphenyl) ether (9bk)
7bk (176 mg, 1.06 mmol) を THF (2.0 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 50 mg, 1.25 mmol) を加え室温にて1時間撹拌した。このものに 5 (181 mg, 0.32 mmol) の THF (2.0 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を酢酸エチル (10 mL) で希釈し、水 (10 mL)、飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 4 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 90 対 1 → 8 対 1 → 4 対 1) で分離精製し、9bk (122 mg, 0.22 mmol, 収率 68%) を得た。1H-NMR(CDCl3)δ: 1.38 (3H, t, J=6.9 Hz), 2.80 (1H, br), 3.59-3.73 (32H, br), 3.87 (2H, t, J=4.8 Hz), 4.18 (2H, t, J=4.8 Hz), 4.33 (2H, q, J=6.9 Hz), 6.93 (2H, d, J=9.2 Hz), 7.98 (2H, d, J=9.2 Hz)。 7bk (176 mg, 1.06 mmol) was dissolved in THF (2.0 mL). To this, sodium hydride (mineral oil suspension, purity 60%, 50 mg, 1.25 mmol) was added and stirred at room temperature for 1 hour. To this was added a solution of 5 (181 mg, 0.32 mmol) in THF (2.0 mL) and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with ethyl acetate (10 mL), and washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The resulting residue was separated and purified by silica gel column chromatography (silica gel: 4 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 90 to 1 → 8 to 1 → 4 to 1), and 9bk (122 mg, 0.22 mmol, yield 68%). 1 H-NMR (CDCl 3 ) δ: 1.38 (3H, t, J = 6.9 Hz), 2.80 (1H, br), 3.59-3.73 (32H, br), 3.87 (2H, t, J = 4.8 Hz), 4.18 (2H, t, J = 4.8 Hz), 4.33 (2H, q, J = 6.9 Hz), 6.93 (2H, d, J = 9.2 Hz), 7.98 (2H, d, J = 9.2 Hz).
Nonaethylene glycol mono(4,6-di-tert-butyl-3-methylphenyl) ether (9bl) Nonaethylene glycol mono (4,6-di-tert-butyl-3-methylphenyl) ether (9bl)
7bl (226 mg, 1.03 mmol) を THF (2.0 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 50 mg, 1.25 mmol) を加え室温にて1時間撹拌した。このものに 5 (160 mg, 0.28 mmol) の THF (2.0 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を酢酸エチル (10 mL) で希釈し、水 (10 mL)、飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 4 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 150 対 1 → 90 対 1 → 8 対 1 → 4 対 1) で分離精製し、9bl (109 mg, 0.18 mmol, 収率 61%) を得た。1H-NMR(CDCl3)δ: 1.37 (9H, s), 1.38 (9H, s), 2.48 (3H, s), 2.97 (1H, br), 3.59-3.72 (32H, br), 3.88 (2H, t, J=5.3 Hz), 4.12 (2H, t, J=5.3 Hz), 6.60 (1H, s), 7.28 (1H, s)。 7bl (226 mg, 1.03 mmol) was dissolved in THF (2.0 mL). To this, sodium hydride (mineral oil suspension, purity 60%, 50 mg, 1.25 mmol) was added and stirred at room temperature for 1 hour. To this was added a solution of 5 (160 mg, 0.28 mmol) in THF (2.0 mL) and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with ethyl acetate (10 mL), and washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The obtained residue was separated and purified by silica gel column chromatography (silica gel: 4 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 150 to 1 → 90 to 1 → 8 to 1 → 4 to 1). (109 mg, 0.18 mmol, 61% yield) was obtained. 1 H-NMR (CDCl 3 ) δ: 1.37 (9H, s), 1.38 (9H, s), 2.48 (3H, s), 2.97 (1H, br), 3.59-3.72 (32H, br), 3.88 (2H , t, J = 5.3 Hz), 4.12 (2H, t, J = 5.3 Hz), 6.60 (1H, s), 7.28 (1H, s).
Nonaethylene glycol mono(2-(1-adamantyl)-4-methylphenyl) ether (9bm) Nonaethylene glycol mono (2- (1-adamantyl) -4-methylphenyl) ether (9bm)
7bm (234 mg, 0.97 mmol) を THF (2.0 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 50 mg, 1.25 mmol) を加え室温にて1時間撹拌した。このものに 5 (182 mg, 0.32 mmol) の THF (2.0 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を酢酸エチル (10 mL) で希釈し、水 (10 mL)、飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 4 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 150 対 1 → 90 対 1 → 8 対 1 → 4 対 1) で分離精製し、9bm (94 mg, 0.15 mmol, 収率 46%) を得た。1H-NMR(CDCl3)δ: 1.76 (6H, br), 2.05 (3H, br), 2.11 (6H, br), 2.27 (3H, s), 2.93 (1H, br), 3.59-3.73 (32H, br), 3.89 (2H, t, J=5.0 Hz), 4.10 (2H, t, J=5.0 Hz), 6.74 (1H, d, J=8.2 Hz), 6.94 (1H, dd, J=8.2 Hz, 2.3 Hz), 7.01 (1H, d, J=2.3 Hz)。 7bm (234 mg, 0.97 mmol) was dissolved in THF (2.0 mL). To this, sodium hydride (mineral oil suspension, purity 60%, 50 mg, 1.25 mmol) was added and stirred at room temperature for 1 hour. To this was added a solution of 5 (182 mg, 0.32 mmol) in THF (2.0 mL) and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with ethyl acetate (10 mL), and washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The obtained residue was separated and purified by silica gel column chromatography (silica gel: 4 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 150 to 1 → 90 to 1 → 8 to 1 → 4 to 1), 9bm (94 mg, 0.15 mmol, 46% yield) was obtained. 1 H-NMR (CDCl 3 ) δ: 1.76 (6H, br), 2.05 (3H, br), 2.11 (6H, br), 2.27 (3H, s), 2.93 (1H, br), 3.59-3.73 (32H , br), 3.89 (2H, t, J = 5.0 Hz), 4.10 (2H, t, J = 5.0 Hz), 6.74 (1H, d, J = 8.2 Hz), 6.94 (1H, dd, J = 8.2 Hz) , 2.3 Hz), 7.01 (1H, d, J = 2.3 Hz).
Nonaethylene glycol mono(2-n-dodecyl-4-methylphenyl) ether (9bn) Nonaethylene glycol mono (2-n-dodecyl-4-methylphenyl) ether (9bn)
7bn (274 mg, 0.99 mmol) を THF (2.0 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 46 mg, 1.15 mmol) を加え室温にて1時間撹拌した。このものに 5 (168 mg, 0.30 mmol) の THF (2.0 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を酢酸エチル (10 mL) で希釈し、水 (10 mL)、飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 4 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 300 対 1 → 90 対 1 → 8 対 1) で分離精製し、9bn (97 mg, 0.14 mmol, 収率 49%) を得た。1H-NMR(CDCl3)δ: 0.88 (3H, t, J=7.3 Hz), 1.26 (18H, br), 1.55 (2H, m), 2.26 (3H, s), 2.56 (2H, t, J=7.3 Hz), 2.91 (1H, br), 3.59-3.74 (32H, br), 3.84 (2H, t, J=5.0 Hz), 4.09 (2H, t, J=5.0 Hz), 6.72 (1H, d, J=8.7 Hz), 6.93 (2H, m)。 7bn (274 mg, 0.99 mmol) was dissolved in THF (2.0 mL). To this, sodium hydride (mineral oil suspension, purity 60%, 46 mg, 1.15 mmol) was added and stirred at room temperature for 1 hour. To this was added a solution of 5 (168 mg, 0.30 mmol) in THF (2.0 mL) and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with ethyl acetate (10 mL), and washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The obtained residue was separated and purified by silica gel column chromatography (silica gel: 4 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 300 to 1 → 90 to 1 → 8 to 1), and 9bn (97 mg, 0.14 mmol, yield 49%). 1 H-NMR (CDCl 3 ) δ: 0.88 (3H, t, J = 7.3 Hz), 1.26 (18H, br), 1.55 (2H, m), 2.26 (3H, s), 2.56 (2H, t, J = 7.3 Hz), 2.91 (1H, br), 3.59-3.74 (32H, br), 3.84 (2H, t, J = 5.0 Hz), 4.09 (2H, t, J = 5.0 Hz), 6.72 (1H, d , J = 8.7 Hz), 6.93 (2H, m).
Nonaethylene glycol mono(2-tert-butyl-4-methoxyphenyl) ether (9bo) Nonaethylene glycol mono (2-tert-butyl-4-methoxyphenyl) ether (9bo)
7bo (186 mg, 1.03 mmol) を THF (1.5 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 48 mg, 1.20 mmol) を加え室温にて1時間撹拌した。このものに 5 (164 mg, 0.29 mmol) の THF (2.0 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を酢酸エチル (10 mL) で希釈し、水 (10 mL)、飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 4 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 120 対 1 → 45 対 1 → 8 対 1) で分離精製し、9bo (150 mg, 0.26 mmol, 収率 90%) を得た。1H-NMR(CDCl3)δ: 1.37 (9H, s), 2.96 (1H, br), 3.59-3.73 (32H, br), 3.76 (3H, s), 3.88 (2H, t, J=5.0 Hz), 4.09 (2H, t, J=5.0 Hz), 6.67 (1H, dd, J=8.7 Hz, 3.1 Hz), 6.78 (1H, d, J=8.7 Hz), 6.88 (1H, d, J=3.1 Hz)。 7bo (186 mg, 1.03 mmol) was dissolved in THF (1.5 mL). To this, sodium hydride (mineral oil suspension, purity 60%, 48 mg, 1.20 mmol) was added and stirred at room temperature for 1 hour. To this was added a solution of 5 (164 mg, 0.29 mmol) in THF (2.0 mL) and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with ethyl acetate (10 mL), and washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The resulting residue was separated and purified by silica gel column chromatography (silica gel: 4 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 120 to 1 → 45 to 1 → 8 to 1), and 9bo (150 mg, 0.26 mmol, yield 90%). 1 H-NMR (CDCl 3 ) δ: 1.37 (9H, s), 2.96 (1H, br), 3.59-3.73 (32H, br), 3.76 (3H, s), 3.88 (2H, t, J = 5.0 Hz ), 4.09 (2H, t, J = 5.0 Hz), 6.67 (1H, dd, J = 8.7 Hz, 3.1 Hz), 6.78 (1H, d, J = 8.7 Hz), 6.88 (1H, d, J = 3.1 Hz).
Nonaethylene glycol mono(4-phenoxyphenyl) ether (9bp) Nonaethylene glycol mono (4-phenoxyphenyl) ether (9bp)
7bp (185 mg, 0.99 mmol) を THF (2.0 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 46 mg, 1.15 mmol) を加え室温にて1時間撹拌した。このものに 5 (164 mg, 0.29 mmol) の THF (2.0 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を酢酸エチル (10 mL) で希釈し、水 (10 mL)、飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 4 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 180 対 1 → 45 対 1 → 8 対 1) で分離精製し、9bp (151 mg, 0.26 mmol, 収率 90%) を得た。1H-NMR(CDCl3)δ: 2.88 (1H, br), 3.59-3.75 (32H, br), 3.86 (2H, t, J=4.8 Hz), 4.12 (2H, t, J=4.8 Hz), 6.95 (6H, m), 7.04 (1H, d, J=7.3 Hz), 7.30 (2H, m)。 7bp (185 mg, 0.99 mmol) was dissolved in THF (2.0 mL). To this, sodium hydride (mineral oil suspension, purity 60%, 46 mg, 1.15 mmol) was added and stirred at room temperature for 1 hour. To this was added a solution of 5 (164 mg, 0.29 mmol) in THF (2.0 mL) and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with ethyl acetate (10 mL), and washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The obtained residue was separated and purified by silica gel column chromatography (silica gel: 4 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 180 to 1 → 45 to 1 → 8 to 1), and 9 bp (151 mg, 0.26 mmol, yield 90%). 1 H-NMR (CDCl 3 ) δ: 2.88 (1H, br), 3.59-3.75 (32H, br), 3.86 (2H, t, J = 4.8 Hz), 4.12 (2H, t, J = 4.8 Hz), 6.95 (6H, m), 7.04 (1H, d, J = 7.3 Hz), 7.30 (2H, m).
Nonaethylene glycol mono(4-trifluoromethoxyphenyl) ether (9bq) Nonaethylene glycol mono (4-trifluoromethoxyphenyl) ether (9bq)
7bq (170 mg, 0.95 mmol) を THF (1.5 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 46 mg, 1.15 mmol) を加え室温にて1時間撹拌した。このものに 5 (184 mg, 0.32 mmol) の THF (2.0 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を酢酸エチル (10 mL) で希釈し、水 (10 mL)、飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 4 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 8 対 1 → 4 対 1) で分離精製し、9bq (179 mg, 0.31 mmol, 収率 96%) を得た。1H-NMR(CDCl3)δ: 2.89 (1H, br), 3.59-3.73 (32H, br), 3.85 (2H, t, J=4.8 Hz), 4.12 (2H, t, J=4.8 Hz), 6.90 (2H, d, J=9.2 Hz), 7.13 (2H, d, J=9.2 Hz)。 7bq (170 mg, 0.95 mmol) was dissolved in THF (1.5 mL). To this, sodium hydride (mineral oil suspension, purity 60%, 46 mg, 1.15 mmol) was added and stirred at room temperature for 1 hour. To this was added a solution of 5 (184 mg, 0.32 mmol) in THF (2.0 mL) and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with ethyl acetate (10 mL), and washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The obtained residue was separated and purified by silica gel column chromatography (silica gel: 4 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 8 to 1 → 4 to 1), and 9bq (179 mg, 0.31 mmol, yield) Rate 96%). 1 H-NMR (CDCl 3 ) δ: 2.89 (1H, br), 3.59-3.73 (32H, br), 3.85 (2H, t, J = 4.8 Hz), 4.12 (2H, t, J = 4.8 Hz), 6.90 (2H, d, J = 9.2 Hz), 7.13 (2H, d, J = 9.2 Hz).
Nonaethylene glycol mono(4-tritylphenyl) ether (9br) Nonaethylene glycol mono (4-tritylphenyl) ether (9br)
7br (322 mg, 0.96 mmol) を THF (2.0 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 46 mg, 1.15 mmol) を加え室温にて1時間撹拌した。このものに 5 (181 mg, 0.32 mmol) の THF (2.0 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を酢酸エチル (10 mL) で希釈し、水 (10 mL)、飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 4 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 200 対 1 → 30 対 1 → 8 対 1 → 4 対 1) で分離精製し、9br (186 mg, 0.25 mmol, 収率 80%) を得た。1H-NMR(CDCl3)δ: 2.84 (1H, br), 3.59 -3.72 (32H, br), 3.84 (2H, t, J=4.8 Hz), 4.10 (2H, t, J=4.8 Hz), 6.78 (2H, d, J=9.2 Hz), 7.08 (2H, d, J=9.2 Hz), 7.15-7.24 (15H, br)。 7br (322 mg, 0.96 mmol) was dissolved in THF (2.0 mL). To this, sodium hydride (mineral oil suspension, purity 60%, 46 mg, 1.15 mmol) was added and stirred at room temperature for 1 hour. To this was added a solution of 5 (181 mg, 0.32 mmol) in THF (2.0 mL) and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with ethyl acetate (10 mL), and washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The resulting residue was separated and purified by silica gel column chromatography (silica gel: 4 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 200 to 1 → 30 to 1 → 8 to 1 → 4 to 1). (186 mg, 0.25 mmol, 80% yield) was obtained. 1 H-NMR (CDCl 3 ) δ: 2.84 (1H, br), 3.59 -3.72 (32H, br), 3.84 (2H, t, J = 4.8 Hz), 4.10 (2H, t, J = 4.8 Hz), 6.78 (2H, d, J = 9.2 Hz), 7.08 (2H, d, J = 9.2 Hz), 7.15-7.24 (15H, br).
Nonaethylene glycol mono(2,4-diisopropylphenyl) ether (9bs) Nonaethylene glycol mono (2,4-diisopropylphenyl) ether (9bs)
7bs (162 mg, 0.91 mmol) を THF (1.5 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 46 mg, 1.15 mmol) を加え室温にて1時間撹拌した。このものに 5 (180 mg, 0.32 mmol) の THF (2.0 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を酢酸エチル (10 mL) で希釈し、水 (10 mL)、飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 4 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 180 対 1 → 90 対 1 → 8 対 1 → 4 対 1) で分離精製し、9bs (106 mg, 0.19 mmol, 収率 59%) を得た。1H-NMR(CDCl3)δ: 1.12 (6H, d, J=6.9 Hz), 1.22 (6H, d, J=6.9 Hz), 2.85 (1H, septet, J=6.9 Hz), 2.93 (1H, br), 3.30 (1H, septet, J=6.9 Hz), 3.59-3.74 (32H, br), 3.86 (2H, t, J=5.0 Hz), 4.10 (2H, t, J=5.0 Hz), 6.76 (1H, d, J=8.3 Hz), 6.98 (1H, dd, J=8.3 Hz, 2.3 Hz), 7.05 (1H, d, J=2.3 Hz)。 7bs (162 mg, 0.91 mmol) was dissolved in THF (1.5 mL). To this, sodium hydride (mineral oil suspension, purity 60%, 46 mg, 1.15 mmol) was added and stirred at room temperature for 1 hour. To this was added a solution of 5 (180 mg, 0.32 mmol) in THF (2.0 mL) and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with ethyl acetate (10 mL), and washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The obtained residue was separated and purified by silica gel column chromatography (silica gel: 4 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 180 to 1 → 90 to 1 → 8 to 1 → 4 to 1), 9bs (106 mg, 0.19 mmol, yield 59%) was obtained. 1 H-NMR (CDCl 3 ) δ: 1.12 (6H, d, J = 6.9 Hz), 1.22 (6H, d, J = 6.9 Hz), 2.85 (1H, septet, J = 6.9 Hz), 2.93 (1H, br), 3.30 (1H, septet, J = 6.9 Hz), 3.59-3.74 (32H, br), 3.86 (2H, t, J = 5.0 Hz), 4.10 (2H, t, J = 5.0 Hz), 6.76 ( 1H, d, J = 8.3 Hz), 6.98 (1H, dd, J = 8.3 Hz, 2.3 Hz), 7.05 (1H, d, J = 2.3 Hz).
Nonaethylene glycol mono(2-(benzotriazol-2-yl)-4-(2,2,4,4-tetramethylbutyl)phenyl) ether (9bu) Nonaethylene glycol mono (2- (benzotriazol-2-yl) -4- (2,2,4,4-tetramethylbutyl) phenyl) ether (9bu)
7bu (322 mg, 1.00 mmol) を THF (2.5 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 45 mg, 1.13 mmol) を加え室温にて1時間撹拌した。このものに 5 (177 mg, 0.31 mmol) の THF (2.0 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を酢酸エチル (10 mL) で希釈し、水 (10 mL)、飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 4 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 8 対 1 → 4 対 1) で分離し、1H-NMR 積分比より 9bu と 5 の 10.3 対 1 混合物 (210 mg) を得た。(9bu の換算収量 195 mg, 0.27 mmol, 換算収率 87%)1H-NMR(CDCl3)δ: 0.77 (9H, s), 1.39 (6H, s), 1.75 (2H, s), 2.85 (1H, br), 3.30 (1H, septet, J=6.9 Hz), 3.41-3.73 (34H, br), 4.18 (2H, t, J=5.0 Hz), 7.08 (1H, d, J=8.7 Hz), 7.44 (3H, m), 7.63 (1H, d, J=2.3 Hz), 7.96 (2H, m)。 7bu (322 mg, 1.00 mmol) was dissolved in THF (2.5 mL). To this, sodium hydride (mineral oil suspension, purity 60%, 45 mg, 1.13 mmol) was added and stirred at room temperature for 1 hour. To this was added a solution of 5 (177 mg, 0.31 mmol) in THF (2.0 mL) and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with ethyl acetate (10 mL), and washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The obtained residue was separated by silica gel column chromatography (silica gel: 4 g, eluent: ethyl acetate-methanol mixed solvent 1 to 0 → 8 to 1 → 4 to 1). From the 1 H-NMR integration ratio, 9bu and 5 Of 10.3 to 1 mixture (210 mg). (Equivalent yield of 9bu 195 mg, 0.27 mmol, 87% equivalent yield) 1 H-NMR (CDCl 3 ) δ: 0.77 (9H, s), 1.39 (6H, s), 1.75 (2H, s), 2.85 ( 1H, br), 3.30 (1H, septet, J = 6.9 Hz), 3.41-3.73 (34H, br), 4.18 (2H, t, J = 5.0 Hz), 7.08 (1H, d, J = 8.7 Hz), 7.44 (3H, m), 7.63 (1H, d, J = 2.3 Hz), 7.96 (2H, m).
Nonaethylene glycol mono(2,4-bis(a,a-dimethylbenzyl)phenyl) ether (9bv) Nonaethylene glycol mono (2,4-bis (a, a-dimethylbenzyl) phenyl) ether (9bv)
7bv (330 mg, 1.00 mmol) を THF (2.5 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 50 mg, 1.25 mmol) を加え室温にて1時間撹拌した。このものに 5 (190 mg, 0.33 mmol) の THF (2.0 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を酢酸エチル (10 mL) で希釈し、水 (10 mL)、飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 4 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 180 対 1 → 45 対 1 → 8 対 1 → 3 対 1) で分離精製し、9bv (140 mg, 0.19 mmol, 収率 58%) を得た。1H-NMR(CDCl3)δ: 1.59 (6H, s), 1.71 (6H, s), 2.86 (1H, br), 3.18 (2H, t, J=5.2 Hz), 3.45 (2H, t, J=5.2 Hz), 3.55-3.72 (32H, br), 6.66 (1H, d, J=8.2 Hz), 7.03-7.29 (11H, m), 7.32 (1H, d, J=2.3 Hz)。 7bv (330 mg, 1.00 mmol) was dissolved in THF (2.5 mL). To this, sodium hydride (mineral oil suspension, purity 60%, 50 mg, 1.25 mmol) was added and stirred at room temperature for 1 hour. To this was added 5 (190 mg, 0.33 mmol) in THF (2.0 mL) and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with ethyl acetate (10 mL), and washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The obtained residue was separated and purified by silica gel column chromatography (silica gel: 4 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 180 to 1 → 45 to 1 → 8 to 1 → 3 to 1), and 9bv (140 mg, 0.19 mmol, 58% yield) was obtained. 1 H-NMR (CDCl 3 ) δ: 1.59 (6H, s), 1.71 (6H, s), 2.86 (1H, br), 3.18 (2H, t, J = 5.2 Hz), 3.45 (2H, t, J = 5.2 Hz), 3.55-3.72 (32H, br), 6.66 (1H, d, J = 8.2 Hz), 7.03-7.29 (11H, m), 7.32 (1H, d, J = 2.3 Hz).
Nonaethylene glycol mono(4'-iodo-4-biphenyl) ether (9bw) Nonaethylene glycol mono (4'-iodo-4-biphenyl) ether (9bw)
7bw (296 mg, 1.00 mmol) を THF (5.0 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 46 mg, 1.15 mmol) を加え室温にて1時間撹拌した。このものに 5 (176 mg, 0.31 mmol) の THF (3.0 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を酢酸エチル (10 mL) で希釈し、水 (10 mL)、飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 4 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 8 対 1 → 7 対 2) で分離精製し、9bw (119 mg, 0.17 mmol, 収率 55%) を得た。1H-NMR(CDCl3)δ: 2.64 (1H, br), 3.56-3.64 (32H, br), 3.88 (2H, t, J=4.9 Hz), 4.17 (2H, t, J=4.9 Hz), 6.98 (2H, d, J=8.6 Hz), 7.29 (2H, d, J=8.6 Hz), 7.47 (2H, d, J=8.6 Hz), 7.73 (2H, d, J=8.6 Hz)。 7bw (296 mg, 1.00 mmol) was dissolved in THF (5.0 mL). To this, sodium hydride (mineral oil suspension, purity 60%, 46 mg, 1.15 mmol) was added and stirred at room temperature for 1 hour. To this was added 5 (176 mg, 0.31 mmol) in THF (3.0 mL) and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with ethyl acetate (10 mL), and washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The obtained residue was separated and purified by silica gel column chromatography (silica gel: 4 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 8 to 1 → 7 to 2), and 9 bw (119 mg, 0.17 mmol, yield) Rate 55%). 1 H-NMR (CDCl 3 ) δ: 2.64 (1H, br), 3.56-3.64 (32H, br), 3.88 (2H, t, J = 4.9 Hz), 4.17 (2H, t, J = 4.9 Hz), 6.98 (2H, d, J = 8.6 Hz), 7.29 (2H, d, J = 8.6 Hz), 7.47 (2H, d, J = 8.6 Hz), 7.73 (2H, d, J = 8.6 Hz).
Nonaethylene glycol mono(2-biphenyl) ether (9by) Nonaethylene glycol mono (2-biphenyl) ether (9by)
7by (167 mg, 0.98 mmol) を THF (1.5 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 45 mg, 1.13 mmol) を加え室温にて1時間撹拌した。このものに 5 (202 mg, 0.36 mmol) の THF (2.5 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を酢酸エチル (10 mL) で希釈し、水 (10 mL)、飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 4 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 45 対 1 → 30 対 1 → 45 対 2 → 8 対 1 → 7 対 2 → 2 対 1) で分離精製し、9by (135 mg, 0.24 mmol, 収率 67%) を得た。1H-NMR(CDCl3)δ: 2.93 (1H, br), 3.59-3.73 (32H, br), 3.77 (2H, t, J=5.0 Hz), 4.12 (2H, t, J=5.0 Hz), 6.98 (2H, m), 7.27-7.40 (5H, m), 7.56 (2H, d, J=8.2 Hz)。 7by (167 mg, 0.98 mmol) was dissolved in THF (1.5 mL). To this, sodium hydride (mineral oil suspension, purity 60%, 45 mg, 1.13 mmol) was added and stirred at room temperature for 1 hour. To this was added 5 (202 mg, 0.36 mmol) in THF (2.5 mL) and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with ethyl acetate (10 mL), and washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. Silica gel column chromatography (silica gel: 4 g, eluent: ethyl acetate-methanol mixed solvent 1 to 0 → 45 to 1 → 30 to 1 → 45 to 2 → 8 to 1 → 7 to 2 → 2 pairs Separation and purification in 1) gave 9by (135 mg, 0.24 mmol, yield 67%). 1 H-NMR (CDCl 3 ) δ: 2.93 (1H, br), 3.59-3.73 (32H, br), 3.77 (2H, t, J = 5.0 Hz), 4.12 (2H, t, J = 5.0 Hz), 6.98 (2H, m), 7.27-7.40 (5H, m), 7.56 (2H, d, J = 8.2 Hz).
Nonaethylene glycol mono(4-(1,1,3,3-tetramethylbutyl)phenyl) ether (9cb) Nonaethylene glycol mono (4- (1,1,3,3-tetramethylbutyl) phenyl) ether (9cb)
7cb (200 mg, 0.97 mmol) を THF (2.0 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 46 mg, 1.15 mmol) を加え室温にて1時間撹拌した。このものに 5 (175 mg, 0.31 mmol) の THF (2.0 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を酢酸エチル (10 mL) で希釈し、水 (10 mL)、飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 4 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 45 対 1 → 30 対 1 → 45 対 2 → 8 対 1 → 7 対 2) で分離精製し、9cb (105 mg, 0.17 mmol, 収率 57%) を得た。1H-NMR(CDCl3)δ: 0.70 (9H, s), 1.33 (6H, s), 1.69 (2H, s), 2.76 (1H, br), 3.59-3.74 (32H, br), 3.84 (2H, t, J=4.8 Hz), 4.11 (2H, t, J=4.8 Hz), 6.82 (2H, d, J=8.5 Hz), 7.25 (1H, d, J=8.5 Hz)。 7cb (200 mg, 0.97 mmol) was dissolved in THF (2.0 mL). To this, sodium hydride (mineral oil suspension, purity 60%, 46 mg, 1.15 mmol) was added and stirred at room temperature for 1 hour. To this was added a solution of 5 (175 mg, 0.31 mmol) in THF (2.0 mL) and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with ethyl acetate (10 mL), and washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The obtained residue was separated by silica gel column chromatography (silica gel: 4 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 45 to 1 → 30 to 1 → 45 to 2 → 8 to 1 → 7 to 2) Purification gave 9cb (105 mg, 0.17 mmol, 57% yield). 1 H-NMR (CDCl 3 ) δ: 0.70 (9H, s), 1.33 (6H, s), 1.69 (2H, s), 2.76 (1H, br), 3.59-3.74 (32H, br), 3.84 (2H , t, J = 4.8 Hz), 4.11 (2H, t, J = 4.8 Hz), 6.82 (2H, d, J = 8.5 Hz), 7.25 (1H, d, J = 8.5 Hz).
Nonaethylene glycol mono(2-iodo-4-biphenyl) ether (9cc) Nonaethylene glycol mono (2-iodo-4-biphenyl) ether (9cc)
7cc (299 mg, 1.01 mmol) を THF (3.0 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 44 mg, 1.10 mmol) を加え室温にて1時間撹拌した。このものに 5 (195 mg, 0.34 mmol) の THF (2.0 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を酢酸エチル (10 mL) で希釈し、水 (10 mL)、飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 5 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 45 対 2 → 8 対 1 → 7 対 2) で分離精製し、9cc (142 mg, 0.21 mmol, 収率 60%) を得た。1H-NMR(CDCl3)δ: 2.86 (1H, br), 3.58-3.73 (30H, br), 3.82 (2H, t, J=4.8 Hz), 3.95 (2H, t, J=5.2 Hz), 4.21 (2H, t, J=5.2 Hz), 6.90 (1H, d, J=8.7 Hz), 7.30-7.53 (6H, m), 8.01 (1H, d, J=2.3 Hz)。 7cc (299 mg, 1.01 mmol) was dissolved in THF (3.0 mL). To this, sodium hydride (mineral oil suspension, purity 60%, 44 mg, 1.10 mmol) was added and stirred at room temperature for 1 hour. To this was added a solution of 5 (195 mg, 0.34 mmol) in THF (2.0 mL) and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with ethyl acetate (10 mL), and washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The obtained residue was separated and purified by silica gel column chromatography (silica gel: 5 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 45 to 2 → 8 to 1 → 7 to 2), and 9 cc (142 mg, 142 mg, 0.21 mmol, yield 60%). 1 H-NMR (CDCl 3 ) δ: 2.86 (1H, br), 3.58-3.73 (30H, br), 3.82 (2H, t, J = 4.8 Hz), 3.95 (2H, t, J = 5.2 Hz), 4.21 (2H, t, J = 5.2 Hz), 6.90 (1H, d, J = 8.7 Hz), 7.30-7.53 (6H, m), 8.01 (1H, d, J = 2.3 Hz).
Nonaethylene glycol mono(4-n-dodecylphenyl) ether (9cf) Nonaethylene glycol mono (4-n-dodecylphenyl) ether (9cf)
7cf (300 mg, 1.14 mmol) を THF (2.5 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 52 mg, 1.30 mmol) を加え室温にて1時間撹拌した。このものに 5 (215 mg, 0.38 mmol) の THF (2.5 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を酢酸エチル (10 mL) で希釈し、水 (10 mL)、飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 5 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 45 対 1 → 45 対 2 → 8 対 1 → 2 対 1) で分離精製し、9cf (168 mg, 0.25 mmol, 収率 67%) を得た。1H-NMR(CDCl3)δ: 0.64-0.90 (13H, m), 1.09-1.34 (12H, m), 2.75 (1H, br), 3.59-3.73 (32H, r), 3.84 (2H, t, J=4.9 Hz), 4.11 (2H, t, J=4.9 Hz), 6.82-6.84 (2H, br), 7.12-7.24 (2H, m)。 7cf (300 mg, 1.14 mmol) was dissolved in THF (2.5 mL). To this, sodium hydride (mineral oil suspension, purity 60%, 52 mg, 1.30 mmol) was added and stirred at room temperature for 1 hour. To this was added 5 (215 mg, 0.38 mmol) in THF (2.5 mL) and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with ethyl acetate (10 mL), and washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The obtained residue was separated and purified by silica gel column chromatography (silica gel: 5 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 45 to 1 → 45 to 2 → 8 to 1 → 2 to 1), 9cf (168 mg, 0.25 mmol, 67% yield) was obtained. 1 H-NMR (CDCl 3 ) δ: 0.64-0.90 (13H, m), 1.09-1.34 (12H, m), 2.75 (1H, br), 3.59-3.73 (32H, r), 3.84 (2H, t, J = 4.9 Hz), 4.11 (2H, t, J = 4.9 Hz), 6.82-6.84 (2H, br), 7.12-7.24 (2H, m).
Nonaethylene glycol mono(4-n-dodecyl-2-methylphenyl) ether (9cg) Nonaethylene glycol mono (4-n-dodecyl-2-methylphenyl) ether (9cg)
7cg (296 mg, 1.07 mmol) を THF (2.5 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 55 mg, 1.38 mmol) を加え室温にて1時間撹拌した。このものに 5 (203 mg, 0.36 mmol) の THF (2.5 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を酢酸エチル (10 mL) で希釈し、水 (10 mL)、飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 5 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 120 対 1 → 45 対 2 → 8 対 1 → 7 対 2) で分離精製し、9cg (129 mg, 0.19 mmol, 収率 53%) を得た。1H-NMR(CDCl3)δ: 0.88 (3H, t, J=6.8 Hz), 1.25-1.30 (18H, br), 1.55 (2H, m), 2.49 (2H, m), 2.73 (1H, br), 3.59-3.75 (32H, br), 3.85 (2H, t, J=5.0 Hz), 4.10 (2H, t, J=5.0 Hz), 6.72 (1H, d, J=8.2 Hz), 6.92 (2H, m)。 7cg (296 mg, 1.07 mmol) was dissolved in THF (2.5 mL). To this, sodium hydride (mineral oil suspension, purity 60%, 55 mg, 1.38 mmol) was added and stirred at room temperature for 1 hour. To this was added a solution of 5 (203 mg, 0.36 mmol) in THF (2.5 mL) and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with ethyl acetate (10 mL), and washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The obtained residue was separated and purified by silica gel column chromatography (silica gel: 5 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 120 to 1 → 45 to 2 → 8 to 1 → 7 to 2), and 9 cg (129 mg, 0.19 mmol, 53% yield) was obtained. 1 H-NMR (CDCl 3 ) δ: 0.88 (3H, t, J = 6.8 Hz), 1.25-1.30 (18H, br), 1.55 (2H, m), 2.49 (2H, m), 2.73 (1H, br ), 3.59-3.75 (32H, br), 3.85 (2H, t, J = 5.0 Hz), 4.10 (2H, t, J = 5.0 Hz), 6.72 (1H, d, J = 8.2 Hz), 6.92 (2H , m).
Nonaethylene glycol mono(4'-fluoro-4-biphenyl) ether (9ch) Nonaethylene glycol mono (4'-fluoro-4-biphenyl) ether (9ch)
7ch (190 mg, 1.01 mmol) を THF (2.0 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 46 mg, 1.15 mmol) を加え室温にて1時間撹拌した。このものに 5 (195 mg, 0.31 mmol) の THF (2.0 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を酢酸エチル (10 mL) で希釈し、水 (10 mL)、飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 6 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 90 対 1 → 8 対 1 → 2 対 1) で分離精製し、9ch (133 mg, 0.23 mmol, 収率 66%) を得た。1H-NMR(CDCl3)δ: 2.69 (1H, br), 3.59-3.74 (32H, br), 3.88 (2H, t, J=4.9 Hz), 4.17 (2H, t, J=4.9 Hz), 6.98 (2H, d, J=8.7 Hz), 7.09 (2H, d, J=8.7 Hz), 7.44-7.51 (4H, m)。 7ch (190 mg, 1.01 mmol) was dissolved in THF (2.0 mL). To this, sodium hydride (mineral oil suspension, purity 60%, 46 mg, 1.15 mmol) was added and stirred at room temperature for 1 hour. To this was added a solution of 5 (195 mg, 0.31 mmol) in THF (2.0 mL) and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with ethyl acetate (10 mL), and washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The obtained residue was separated and purified by silica gel column chromatography (silica gel: 6 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 90 to 1 → 8 to 1 → 2 to 1), and 9ch (133 mg, 0.23 mmol, yield 66%). 1 H-NMR (CDCl 3 ) δ: 2.69 (1H, br), 3.59-3.74 (32H, br), 3.88 (2H, t, J = 4.9 Hz), 4.17 (2H, t, J = 4.9 Hz), 6.98 (2H, d, J = 8.7 Hz), 7.09 (2H, d, J = 8.7 Hz), 7.44-7.51 (4H, m).
Nonaethylene glycol mono(4'-cyano-4-biphenyl) ether (9ci) Nonaethylene glycol mono (4'-cyano-4-biphenyl) ether (9ci)
7ci (199 mg, 1.02 mmol) を THF (2.0 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 49 mg, 1.23 mmol) を加え室温にて1時間撹拌した。このものに 5 (203 mg, 0.36 mmol) の THF (2.0 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を酢酸エチル (10 mL) で希釈し、水 (10 mL)、飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 6 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 45 対 2 → 8 対 1 → 2 対 1) で分離精製し、9ci (165 mg, 0.28 mmol, 収率 78%) を得た。1H-NMR(CDCl3)δ: 2.81 (1H, br), 3.59-3.75 (32H, br), 3.89 (2H, t, J=4.8 Hz), 4.19 (2H, t, J=4.8 Hz), 7.02 (2H, d, J=9.2 Hz), 7.53 (2H, d, J=9.2 Hz), 7.64 (2H, d, J=8.7 Hz), 7.70 (2H, d, J=8.7 Hz)。 7ci (199 mg, 1.02 mmol) was dissolved in THF (2.0 mL). To this, sodium hydride (mineral oil suspension, purity 60%, 49 mg, 1.23 mmol) was added and stirred at room temperature for 1 hour. To this was added a solution of 5 (203 mg, 0.36 mmol) in THF (2.0 mL) and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with ethyl acetate (10 mL), and washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The obtained residue was separated and purified by silica gel column chromatography (silica gel: 6 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 45 to 2 → 8 to 1 → 2 to 1), and 9ci (165 mg, 0.28 mmol, yield 78%). 1 H-NMR (CDCl 3 ) δ: 2.81 (1H, br), 3.59-3.75 (32H, br), 3.89 (2H, t, J = 4.8 Hz), 4.19 (2H, t, J = 4.8 Hz), 7.02 (2H, d, J = 9.2 Hz), 7.53 (2H, d, J = 9.2 Hz), 7.64 (2H, d, J = 8.7 Hz), 7.70 (2H, d, J = 8.7 Hz).
Nonaethylene glycol mono(4-cyclopentyl) ether (9cj) Nonaethylene glycol mono (4-cyclopentyl) ether (9cj)
7cj (170 mg, 1.05 mmol) を THF (2.0 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 52 mg, 1.30 mmol) を加え室温にて1時間撹拌した。このものに 5 (207 mg, 0.34 mmol) の THF (2.0 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を酢酸エチル (10 mL) で希釈し、水 (10 mL)、飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 5 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 30 対 1 → 45 対 2 → 8 対 1 → 7 対 2) で分離精製し、9cj (136 mg, 0.24 mmol, 収率 60%) を得た。1H-NMR(CDCl3)δ: 1.54 (2H, m), 1.67 (2H, m), 1.78 (2H, m), 2.02 (2H, br), 2.74 (1H, br), 2.93 (1H, m), 3.59-3.73 (32H, br), 3.84 (2H, t, J=4.9 Hz), 4.11 (2H, t, J=4.9 Hz), 6.84 (2H, d, J=8.7 Hz), 7.14 (2H, d, J=8.7 Hz)。 7cj (170 mg, 1.05 mmol) was dissolved in THF (2.0 mL). To this, sodium hydride (mineral oil suspension, purity 60%, 52 mg, 1.30 mmol) was added and stirred at room temperature for 1 hour. To this was added a solution of 5 (207 mg, 0.34 mmol) in THF (2.0 mL) and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with ethyl acetate (10 mL), and washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The resulting residue was separated and purified by silica gel column chromatography (silica gel: 5 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 30 to 1 → 45 to 2 → 8 to 1 → 7 to 2), and 9cj (136 mg, 0.24 mmol, 60% yield) was obtained. 1 H-NMR (CDCl 3 ) δ: 1.54 (2H, m), 1.67 (2H, m), 1.78 (2H, m), 2.02 (2H, br), 2.74 (1H, br), 2.93 (1H, m ), 3.59-3.73 (32H, br), 3.84 (2H, t, J = 4.9 Hz), 4.11 (2H, t, J = 4.9 Hz), 6.84 (2H, d, J = 8.7 Hz), 7.14 (2H , d, J = 8.7 Hz).
Nonaethylene glycol mono(4-(4'-tert-butoxycarbonypiperazin-1'-yl)-phenyl) ether (9ck) Nonaethylene glycol mono (4- (4'-tert-butoxycarbonypiperazin-1'-yl) -phenyl) ether (9ck)
7ck (342 mg, 1.23 mmol) を THF (3.0 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 62 mg, 1.55 mmol) を加え室温にて1時間撹拌した。このものに 5 (290 mg, 0.51 mmol) の THF (3.0 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を酢酸エチル (10 mL) で希釈し、水 (10 mL) および飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 5 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 40 対 1 → 30 対 1 → 7 対 2) で分離精製し、9ck (242 mg, 0.36 mmol, 収率 70%) を得た。1H-NMR(CDCl3)δ: 1.48 (9H, s), 2.75 (1H, br), 3.00 (2H, t, J=5.1 Hz), 3.57 (2H, t, J=5.1 Hz), 3.59-3.73 (32H, br), 3.83 (2H, t, J=5.1 Hz), 4.08 (2H, t, J=5.1 Hz), 6.85 (2H, d, J=9.5 Hz), 6.88 (2H, d, J=9.5 Hz)。 7ck (342 mg, 1.23 mmol) was dissolved in THF (3.0 mL). To this was added sodium hydride (mineral oil suspension, purity 60%, 62 mg, 1.55 mmol), and the mixture was stirred at room temperature for 1 hour. To this was added a solution of 5 (290 mg, 0.51 mmol) in THF (3.0 mL) and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with ethyl acetate (10 mL), and washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The resulting residue was separated and purified by silica gel column chromatography (silica gel: 5 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 40 to 1 → 30 to 1 → 7 to 2), and 9ck (242 mg, 0.36 mmol, yield 70%) was obtained. 1 H-NMR (CDCl 3 ) δ: 1.48 (9H, s), 2.75 (1H, br), 3.00 (2H, t, J = 5.1 Hz), 3.57 (2H, t, J = 5.1 Hz), 3.59- 3.73 (32H, br), 3.83 (2H, t, J = 5.1 Hz), 4.08 (2H, t, J = 5.1 Hz), 6.85 (2H, d, J = 9.5 Hz), 6.88 (2H, d, J = 9.5 Hz).
Nonaethylene glycol mono(4-(piperazin-1'-yl)-phenyl) ether (9ck') Nonaethylene glycol mono (4- (piperazin-1'-yl) -phenyl) ether (9ck ')
9ck (47 mg, 0.07 mmol) を メタノール (0.5 mL) に溶解させた。これに10% 塩酸 (1.0 mL) を添加し、室温で24時間撹拌した。反応溶液を水 (10 mL) で希釈し、トルエン (5 mL×4) で抽出した。水層に 20% 水酸化ナトリウム水溶液 (5.0 mL) を加えジクロロメタン (5 mL×4) で抽出した。ジクロロメタン層は、水 (10 mL)、飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮 することで 9ck' (37 mg, 0.06 mmol, 収率 93%) を得た。1H-NMR(CDCl3)δ: 1.81 (2H, br), 3.58-3.73 (36H, br), 3.83 (2H, t, J=4.8 Hz), 4.08 (2H, t, J=4.8 Hz), 6.85 (2H, d, J=9.2 Hz), 6.88 (2H, d, J=9.2 Hz)。 9ck (47 mg, 0.07 mmol) was dissolved in methanol (0.5 mL). To this was added 10% hydrochloric acid (1.0 mL), and the mixture was stirred at room temperature for 24 hours. The reaction solution was diluted with water (10 mL) and extracted with toluene (5 mL × 4). To the aqueous layer was added 20% aqueous sodium hydroxide solution (5.0 mL), and the mixture was extracted with dichloromethane (5 mL × 4). The dichloromethane layer was washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator to obtain 9ck ′ (37 mg, 0.06 mmol, yield 93%). 1 H-NMR (CDCl 3 ) δ: 1.81 (2H, br), 3.58-3.73 (36H, br), 3.83 (2H, t, J = 4.8 Hz), 4.08 (2H, t, J = 4.8 Hz), 6.85 (2H, d, J = 9.2 Hz), 6.88 (2H, d, J = 9.2 Hz).
Nonaethylene glycol mono(2,2,5,7,8-pentamethylchroman-6-yl) ether (9cl) Nonaethylene glycol mono (2,2,5,7,8-pentamethylchroman-6-yl) ether (9cl)
7cl (222 mg, 1.01 mmol) を THF (2.0 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 48 mg, 1.20 mmol) を加え室温にて1時間撹拌した。このものに 5 (200 mg, 0.35 mmol) の THF (2.0 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を酢酸エチル (10 mL) で希釈し、水 (10 mL) および飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 5 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 30 対 1 → 10 対 1 → 7 対 2) で分離精製し、9cl (162 mg, 0.26 mmol, 収率 75%) を得た。1H-NMR(CDCl3)δ: 1.29 (6H, s), 1.78 (2H, t, J=6.9 Hz), 2.07 (3H, s), 2.13 (3H, s), 2.17 (3H, s), 2.58 (2H, t, J=6.9 Hz), 2.73 (1H, br), 3.58-3.81 (36H, br)。 7cl (222 mg, 1.01 mmol) was dissolved in THF (2.0 mL). To this, sodium hydride (mineral oil suspension, purity 60%, 48 mg, 1.20 mmol) was added and stirred at room temperature for 1 hour. To this was added a solution of 5 (200 mg, 0.35 mmol) in THF (2.0 mL) and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with ethyl acetate (10 mL), and washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The resulting residue was separated and purified by silica gel column chromatography (silica gel: 5 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 30 to 1 → 10 to 1 → 7 to 2), and 9cl (162 mg, 0.26 mmol, 75% yield). 1 H-NMR (CDCl 3 ) δ: 1.29 (6H, s), 1.78 (2H, t, J = 6.9 Hz), 2.07 (3H, s), 2.13 (3H, s), 2.17 (3H, s), 2.58 (2H, t, J = 6.9 Hz), 2.73 (1H, br), 3.58-3.81 (36H, br).
Nonaethylene glycol mono(4'-methoxy-4-biphenyl) ether (9cm) Nonaethylene glycol mono (4'-methoxy-4-biphenyl) ether (9cm)
7cm (201 mg, 1.00 mmol) を THF (2.0 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 46 mg, 1.15 mmol) を加え室温にて1時間撹拌した。このものに 5 (206 mg, 0.36 mmol) の THF (2.0 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を酢酸エチル (10 mL) で希釈し、水 (10 mL)、飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 5 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 45 対 1 → 4 対 1 → 2 対 1) で分離精製し、9cm (161 mg, 0.27 mmol, 収率 74%) を得た。1H-NMR(CDCl3)δ: 2.73 (1H, br), 3.59-3.75 (32H, br), 3.84 (3H, s), 3.88 (2H, t, J=4.9 Hz), 4.17 (2H, t, J=4.9 Hz), 6.95 (2H, d, J=8.7 Hz), 6.96 (2H, d, J=8.7 Hz), 7.46 (2H, d, J=9.1 Hz), 7.47 (2H, d, J=9.1 Hz)。 7 cm (201 mg, 1.00 mmol) was dissolved in THF (2.0 mL). To this, sodium hydride (mineral oil suspension, purity 60%, 46 mg, 1.15 mmol) was added and stirred at room temperature for 1 hour. To this was added a solution of 5 (206 mg, 0.36 mmol) in THF (2.0 mL) and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with ethyl acetate (10 mL), and washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The obtained residue was separated and purified by silica gel column chromatography (silica gel: 5 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 45 to 1 → 4 to 1 → 2 to 1), and 9 cm (161 mg, 0.27 mmol, yield 74%). 1 H-NMR (CDCl 3 ) δ: 2.73 (1H, br), 3.59-3.75 (32H, br), 3.84 (3H, s), 3.88 (2H, t, J = 4.9 Hz), 4.17 (2H, t , J = 4.9 Hz), 6.95 (2H, d, J = 8.7 Hz), 6.96 (2H, d, J = 8.7 Hz), 7.46 (2H, d, J = 9.1 Hz), 7.47 (2H, d, J = 9.1 Hz).
Nonaethylene glycol mono(2-bromo-4,6-difluorophenyl) ether (9cp) Nonaethylene glycol mono (2-bromo-4,6-difluorophenyl) ether (9cp)
7cp (212 mg, 1.01 mmol) を THF (2.0 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 48 mg, 1.20 mmol) を加え室温にて1時間撹拌した。このものに 5 (202 mg, 0.36 mmol) の THF (2.0 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を酢酸エチル (10 mL) で希釈し、水 (10 mL) および飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 6 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 45 対 1 → 20 対 1 → 8 対 1 → 1 対 1) で分離精製し、9cp (85 mg, 0.14 mmol, 収率 40%) を得た。1H-NMR(CDCl3)δ: 2.75 (1H, br), 3.59-3.73 (32H, br), 3.85 (2H, t, J=4.5 Hz), 4.20 (2H, t, J=4.5 Hz), 6.84 (1H, m), 7.09 (1H, m)。 7cp (212 mg, 1.01 mmol) was dissolved in THF (2.0 mL). To this, sodium hydride (mineral oil suspension, purity 60%, 48 mg, 1.20 mmol) was added and stirred at room temperature for 1 hour. To this was added a solution of 5 (202 mg, 0.36 mmol) in THF (2.0 mL) and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with ethyl acetate (10 mL), and washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The resulting residue was separated and purified by silica gel column chromatography (silica gel: 6 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 45 to 1 → 20 to 1 → 8 to 1 → 1 to 1), 9 cp (85 mg, 0.14 mmol, 40% yield) was obtained. 1 H-NMR (CDCl 3 ) δ: 2.75 (1H, br), 3.59-3.73 (32H, br), 3.85 (2H, t, J = 4.5 Hz), 4.20 (2H, t, J = 4.5 Hz), 6.84 (1H, m), 7.09 (1H, m).
Nonaethylene glycol mono(dl-a-tocopherolyl) ether (9cq) Nonaethylene glycol mono (dl-a-tocopherolyl) ether (9cq)
7cq (450 mg, 1.04 mmol) を THF (4.0 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 54 mg, 1.35 mmol) を加え室温にて1時間撹拌した。このものに 5 (204 mg, 0.36 mmol) の THF (3.0 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を酢酸エチル (10 mL) で希釈し、水 (10 mL) および飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 5 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 45 対 1 → 8 対 1 → 7 対 2) で分離精製し、9cq (272 mg, 0.32 mmol, 収率 91%) を得た。1H-NMR(CDCl3)δ: 1.29 (12H, m), 1.07-1.81 (23H, br), 1.22 (3H, s), 2.07 (3H, s), 2.13 (3H, s), 2.17 (3H, s), 2.56 (2H, t, J=6.8 Hz), 3.60-3.81 (36H, br)。 7cq (450 mg, 1.04 mmol) was dissolved in THF (4.0 mL). To this, sodium hydride (mineral oil suspension, purity 60%, 54 mg, 1.35 mmol) was added and stirred at room temperature for 1 hour. To this was added a solution of 5 (204 mg, 0.36 mmol) in THF (3.0 mL) and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with ethyl acetate (10 mL), and washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The obtained residue was separated and purified by silica gel column chromatography (silica gel: 5 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 45 to 1 → 8 to 1 → 7 to 2), and 9cq (272 mg, 0.32 mmol, yield 91%) was obtained. 1 H-NMR (CDCl 3 ) δ: 1.29 (12H, m), 1.07-1.81 (23H, br), 1.22 (3H, s), 2.07 (3H, s), 2.13 (3H, s), 2.17 (3H , s), 2.56 (2H, t, J = 6.8 Hz), 3.60-3.81 (36H, br).
Dodecaethylene glycol mono(p-toluenesulfonyl) ester (3) Dodecaethylene glycol mono (p-toluenesulfonyl) ester (3)
ドデカエチレングリコール 1 (1.00 g, 1.83 mmol) をトルエン (10 mL) に溶解させた。これに塩化ベンジルトリエチルアンモニウム (0.04 g, 0.19 mmol) および20% 水酸化ナトリウム水溶液 (10 mL) を加え撹拌した。このものに塩化p-トルエンスルホニル (0.36 g, 1.90 mmol) のトルエン (5.0 mL) 溶液を添加し、室温で18時間撹拌を続けた。その後10% 塩酸 (25 mL) を加えトルエン層と水層を分離した。水層は酢酸エチル (25 mL×3) で抽出した。トルエン層と酢酸エチル層を合し、水 (20 mL)、飽和重曹水 (20 mL)、飽和食塩水 (20 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 16 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 60 対 1 → 8 対 1) で分離精製し、無色液体3 (0.76 g, 1.08 mmol, 収率 60%) を得た。IR(ATR) v max cm-1: 3462。1H-NMR(CDCl3)δ: 2.03 (1H, br), 2.27 (3H, s), 3.56-3.64 (46H, br), 4.14 (2H, t, J=5.0 Hz), 7.34 (2H, d, J=8.4 Hz), 7.79 (2H, d, J=8.4 Hz)。 Dodecaethylene glycol 1 (1.00 g, 1.83 mmol) was dissolved in toluene (10 mL). To this, benzyltriethylammonium chloride (0.04 g, 0.19 mmol) and 20% aqueous sodium hydroxide solution (10 mL) were added and stirred. To this was added a solution of p-toluenesulfonyl chloride (0.36 g, 1.90 mmol) in toluene (5.0 mL), and stirring was continued at room temperature for 18 hours. Thereafter, 10% hydrochloric acid (25 mL) was added, and the toluene layer and the aqueous layer were separated. The aqueous layer was extracted with ethyl acetate (25 mL × 3). The toluene layer and the ethyl acetate layer were combined, and washed successively with water (20 mL), saturated aqueous sodium bicarbonate (20 mL), and saturated brine (20 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The resulting residue was separated and purified by silica gel column chromatography (silica gel: 16 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 60 to 1 → 8 to 1), and colorless liquid 3 (0.76 g, 1.08 mmol) , Yield 60%). IR (ATR) v max cm -1 : 3462. 1 H-NMR (CDCl 3 ) δ: 2.03 (1H, br), 2.27 (3H, s), 3.56-3.64 (46H, br), 4.14 (2H, t, J = 5.0 Hz), 7.34 (2H, d , J = 8.4 Hz), 7.79 (2H, d, J = 8.4 Hz).
Dodecaethylene glycol monophenyl ether (8b) Dodecaethylene glycol monophenyl ether (8b)
7b (60 mg, 0.64 mmol) を THF (1.0 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 31 mg, 0.78 mmol) を加え室温にて1時間撹拌した。このものに 3 (160 mg, 0.23 mmol) の THF (1.5 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を酢酸エチル (10 mL) で希釈し、水 (10 mL)、飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 4 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 8 対 1) で分離精製し、8b (30 mg, 0.05 mmol, 収率 21%) を得た。1H-NMR(CDCl3)δ: 2.77 (1H, br), 3.58-3.63 (44H, br), 3.85 (2H, t, J=4.8 Hz), 4.12 (2H, t, J=4.8 Hz), 6.88-6.95 (2H, m), 7.24-7.29 (3H, m)。 7b (60 mg, 0.64 mmol) was dissolved in THF (1.0 mL). To this, sodium hydride (mineral oil suspension, purity 60%, 31 mg, 0.78 mmol) was added and stirred at room temperature for 1 hour. To this was added a solution of 3 (160 mg, 0.23 mmol) in THF (1.5 mL) and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with ethyl acetate (10 mL), and washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The resulting residue was separated and purified by silica gel column chromatography (silica gel: 4 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 8 to 1), and 8b (30 mg, 0.05 mmol, yield 21%) Got. 1 H-NMR (CDCl 3 ) δ: 2.77 (1H, br), 3.58-3.63 (44H, br), 3.85 (2H, t, J = 4.8 Hz), 4.12 (2H, t, J = 4.8 Hz), 6.88-6.95 (2H, m), 7.24-7.29 (3H, m).
Dodecaethylene glycol mono(2,6-dimethylphenyl) ether (8c) Dodecaethylene glycol mono (2,6-dimethylphenyl) ether (8c)
7c (83 mg, 0.68 mmol) を THF (1.0 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 35 mg, 0.87 mmol) を加え室温にて1時間撹拌した。このものに 3 (140 mg, 0.20 mmol) の THF (1.5 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を酢酸エチル (10 mL) で希釈し、水 (10 mL)、飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 4 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 12 対 1) で分離精製し、8c (91 mg, 0.14 mmol, 収率 70%) を得た。1H-NMR(CDCl3)δ: 2.28 (6H, s), 2.77 (1H, br), 3.58-3.66 (44H, br), 3.82 (2H, t, J=4.9 Hz), 3.93 (2H, t, J=4.9 Hz), 6.88-7.00 (3H, m)。 7c (83 mg, 0.68 mmol) was dissolved in THF (1.0 mL). To this was added sodium hydride (mineral oil suspension, purity 60%, 35 mg, 0.87 mmol), and the mixture was stirred at room temperature for 1 hour. To this was added a solution of 3 (140 mg, 0.20 mmol) in THF (1.5 mL) and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with ethyl acetate (10 mL), and washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The obtained residue was separated and purified by silica gel column chromatography (silica gel: 4 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 12 to 1), and 8c (91 mg, 0.14 mmol, yield 70%) Got. 1 H-NMR (CDCl 3 ) δ: 2.28 (6H, s), 2.77 (1H, br), 3.58-3.66 (44H, br), 3.82 (2H, t, J = 4.9 Hz), 3.93 (2H, t , J = 4.9 Hz), 6.88-7.00 (3H, m).
Dodecaethylene glycol mono(3-bromophenyl) ether (8f) Dodecaethylene glycol mono (3-bromophenyl) ether (8f)
7f (89 mg, 0.51 mmol) を THF (1.0 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 25 mg, 0.63 mmol) を加え室温にて1時間撹拌した。このものに 3 (150 mg, 0.21 mmol) の THF (1.5 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を酢酸エチル (10 mL) で希釈し、水 (10 mL)、飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 4 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 8 対 1) で分離精製し、8f (126 mg, 0.18 mmol, 収率 84%) を得た。1H-NMR(CDCl3)δ: 2.75 (1H, br), 3.57-3.64 (44H, br), 3.83 (2H, t, J=4.8 Hz), 4.10 (2H, t, J=4.8 Hz), 6.84 (1H, m), 7.05-7.14 (3H, m)。 7f (89 mg, 0.51 mmol) was dissolved in THF (1.0 mL). To this was added sodium hydride (mineral oil suspension, purity 60%, 25 mg, 0.63 mmol), and the mixture was stirred at room temperature for 1 hour. To this was added a solution of 3 (150 mg, 0.21 mmol) in THF (1.5 mL) and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with ethyl acetate (10 mL), and washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The obtained residue was separated and purified by silica gel column chromatography (silica gel: 4 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 8 to 1), and 8f (126 mg, 0.18 mmol, 84% yield) Got. 1 H-NMR (CDCl 3 ) δ: 2.75 (1H, br), 3.57-3.64 (44H, br), 3.83 (2H, t, J = 4.8 Hz), 4.10 (2H, t, J = 4.8 Hz), 6.84 (1H, m), 7.05-7.14 (3H, m).
Dodecaethylene glycol mono(2,4-bis(1,1-dimethylethyl)phenyl) ether (8g) Dodecaethylene glycol mono (2,4-bis (1,1-dimethylethyl) phenyl) ether (8g)
7g (174 mg, 0.84 mmol) を THF (1.5 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 40 mg, 1.00 mmol) を加え室温にて1時間撹拌した。このものに 3 (200 mg, 0.29 mmol) の THF (1.5 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を酢酸エチル (10 mL) で希釈し、水 (10 mL)、飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 4 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 12 対 1) で分離精製し、8g (174 mg, 0.24 mmol, 収率 83%) を得た。1H-NMR(CDCl3)δ: 1.29 (9H, s), 1.38 (9H, s), 1.88 (1H, br), 3.58-3.64 (44H, br), 3.88 (2H, t, J=5.1 Hz), 4.11 (2H, t, J=5.1 Hz), 6.76 (1H, d, J=8.6 Hz), 7.14 (1H, dd, J=8.6 Hz, 2.5 Hz), 7.30 (1H, d, J=2.5 Hz)。 7 g (174 mg, 0.84 mmol) was dissolved in THF (1.5 mL). To this was added sodium hydride (mineral oil suspension, purity 60%, 40 mg, 1.00 mmol), and the mixture was stirred at room temperature for 1 hour. To this was added a solution of 3 (200 mg, 0.29 mmol) in THF (1.5 mL) and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with ethyl acetate (10 mL), and washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The obtained residue was separated and purified by silica gel column chromatography (silica gel: 4 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 12 to 1), and 8 g (174 mg, 0.24 mmol, yield 83%) Got. 1 H-NMR (CDCl 3 ) δ: 1.29 (9H, s), 1.38 (9H, s), 1.88 (1H, br), 3.58-3.64 (44H, br), 3.88 (2H, t, J = 5.1 Hz ), 4.11 (2H, t, J = 5.1 Hz), 6.76 (1H, d, J = 8.6 Hz), 7.14 (1H, dd, J = 8.6 Hz, 2.5 Hz), 7.30 (1H, d, J = 2.5 Hz).
Dodecaethylene glycol mono(4-bromophenyl) ether (8j) Dodecaethylene glycol mono (4-bromophenyl) ether (8j)
7j (169 mg, 0.98 mmol) を THF (1.5 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 47 mg, 1.18 mmol) を加え室温にて1時間撹拌した。このものに 3 (215 mg, 0.31 mmol) の THF (2.0 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を酢酸エチル (10 mL) で希釈し、水 (10 mL)、飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 4 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 30 対 1 → 8 対 1 → 7 対 2) で分離精製し、8j (44 mg, 0.06 mmol, 収率 20%) を得た。1H-NMR(CDCl3)δ: 2.78 (1H, br), 3.58-3.65 (44H, br), 3.83 (2H, t, J=4.6 Hz), 4.08 (2H, t, J=4.6 Hz), 6.79 (2H, d, J=9.2 Hz), 7.35 (2H, d, J=9.2 Hz)。 7j (169 mg, 0.98 mmol) was dissolved in THF (1.5 mL). Sodium hydride (mineral oil suspension, purity 60%, 47 mg, 1.18 mmol) was added thereto, and the mixture was stirred at room temperature for 1 hour. A solution of 3 (215 mg, 0.31 mmol) in THF (2.0 mL) was added to this, and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with ethyl acetate (10 mL), and washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The obtained residue was separated and purified by silica gel column chromatography (silica gel: 4 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 30 to 1 → 8 to 1 → 7 to 2), and 8j (44 mg, 0.06 mmol, yield 20%). 1 H-NMR (CDCl 3 ) δ: 2.78 (1H, br), 3.58-3.65 (44H, br), 3.83 (2H, t, J = 4.6 Hz), 4.08 (2H, t, J = 4.6 Hz), 6.79 (2H, d, J = 9.2 Hz), 7.35 (2H, d, J = 9.2 Hz).
Dodecaethylene glycol mono(4-methoxycarbonylphenyl) ether (8k) Dodecaethylene glycol mono (4-methoxycarbonylphenyl) ether (8k)
7k (152 mg, 1.00 mmol) を THF (1.5 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 47 mg, 1.18 mmol) を加え室温にて1時間撹拌した。このものに 3 (181 mg, 0.26 mmol) の THF (2.0 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を水 (10 mL) で希釈し、クロロホルム (10 mL×4) で抽出した。クロロホルム層は、水 (10 mL)、飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 4 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 30 対 1 → 8 対 1 → 7 対 2) で分離精製し、8k (115 mg, 0.17 mmol, 収率 65%) を得た。1H-NMR(CDCl3)δ: 2.77 (1H, br), 3.59-3.75 (44H, br), 3.86 (2H, t, J=4.5 Hz), 3.88 (3H, s), 4.18 (2H, t, J=4.5 Hz), 6.93 (2H, d, J=9.0 Hz), 7.98 (2H, d, J=9.0 Hz)。 7k (152 mg, 1.00 mmol) was dissolved in THF (1.5 mL). Sodium hydride (mineral oil suspension, purity 60%, 47 mg, 1.18 mmol) was added thereto, and the mixture was stirred at room temperature for 1 hour. To this was added a solution of 3 (181 mg, 0.26 mmol) in THF (2.0 mL) and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with water (10 mL) and extracted with chloroform (10 mL × 4). The chloroform layer was washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The obtained residue was separated and purified by silica gel column chromatography (silica gel: 4 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 30 to 1 → 8 to 1 → 7 to 2), and 8k (115 mg, 0.17 mmol, yield 65%). 1 H-NMR (CDCl 3 ) δ: 2.77 (1H, br), 3.59-3.75 (44H, br), 3.86 (2H, t, J = 4.5 Hz), 3.88 (3H, s), 4.18 (2H, t , J = 4.5 Hz), 6.93 (2H, d, J = 9.0 Hz), 7.98 (2H, d, J = 9.0 Hz).
Dodecaethylene glycol mono(4-tert-butoxycarboxamidophenyl) ether (8m) Dodecaethylene glycol mono (4-tert-butoxycarboxamidophenyl) ether (8m)
7m (210 mg, 1.00 mmol) を THF (2.0 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 43 mg, 1.08 mmol) を加え室温にて1時間撹拌した。このものに 3 (204 mg, 0.29 mmol) の THF (2.0 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を酢酸エチル (10 mL) で希釈し、水 (10 mL) および飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 4 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 45 対 1 → 30 対 1 → 8 対 1 → 4 対 1) で分離精製し、8m (131 mg, 0.18 mmol, 収率 61%) を得た。1H-NMR(CDCl3)δ: 1.51 (9H, s), 2.81 (1H, br), 3.60-3.74 (44H, br), 3.83 (2H, t, J=4.9 Hz), 4.09 (2H, t, J=4.9 Hz), 6.44 (1H, br), 6.85 (2H, d, J=9.2 Hz), 7.25 (2H, d, J=9.2 Hz)。 7m (210 mg, 1.00 mmol) was dissolved in THF (2.0 mL). To this was added sodium hydride (mineral oil suspension, purity 60%, 43 mg, 1.08 mmol), and the mixture was stirred at room temperature for 1 hour. To this was added a solution of 3 (204 mg, 0.29 mmol) in THF (2.0 mL) and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with ethyl acetate (10 mL), and washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The obtained residue was separated and purified by silica gel column chromatography (silica gel: 4 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 45 to 1 → 30 to 1 → 8 to 1 → 4 to 1), 8 m (131 mg, 0.18 mmol, 61% yield) was obtained. 1 H-NMR (CDCl 3 ) δ: 1.51 (9H, s), 2.81 (1H, br), 3.60-3.74 (44H, br), 3.83 (2H, t, J = 4.9 Hz), 4.09 (2H, t , J = 4.9 Hz), 6.44 (1H, br), 6.85 (2H, d, J = 9.2 Hz), 7.25 (2H, d, J = 9.2 Hz).
Dodecaethylene glycol mono(4-trifluoromethylphenyl) ether (8o) Dodecaethylene glycol mono (4-trifluoromethylphenyl) ether (8o)
7o (162 mg, 1.00 mmol) を THF (2.0 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 65 mg, 1.63 mmol) を加え室温にて1時間撹拌した。このものに 3 (250 mg, 0.36 mmol) の THF (1.5 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を酢酸エチル (10 mL) で希釈し、水 (10 mL)、飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 5 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 45 対 1 → 8 対 1) で分離精製し、8o (54 mg, 0.08 mmol, 収率 22%) を得た。1H-NMR(CDCl3)δ: 2.75 (1H, br), 3.57-3.73 (44H, br), 3.87 (2H, t, J=4.8 Hz), 4.17 (2H, t, J=4.8 Hz), 6.98 (2H, d, J=8.5 Hz), 7.53 (2H, d, J=8.5 Hz)。 7o (162 mg, 1.00 mmol) was dissolved in THF (2.0 mL). To this, sodium hydride (mineral oil suspension, purity 60%, 65 mg, 1.63 mmol) was added and stirred at room temperature for 1 hour. To this was added a solution of 3 (250 mg, 0.36 mmol) in THF (1.5 mL) and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with ethyl acetate (10 mL), and washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The obtained residue was separated and purified by silica gel column chromatography (silica gel: 5 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 45 to 1 → 8 to 1), and 8o (54 mg, 0.08 mmol, collected) Rate 22%). 1 H-NMR (CDCl 3 ) δ: 2.75 (1H, br), 3.57-3.73 (44H, br), 3.87 (2H, t, J = 4.8 Hz), 4.17 (2H, t, J = 4.8 Hz), 6.98 (2H, d, J = 8.5 Hz), 7.53 (2H, d, J = 8.5 Hz).
Dodecaethylene glycol mono(4-cyanophenyl) ether (8r) Dodecaethylene glycol mono (4-cyanophenyl) ether (8r)
7r (118 mg, 1.00 mmol) 及び塩化ベンジルトリエチルアンモニウム (26 mg, 0.11 mmol) を THF (1.5 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 52 mg, 1.30 mmol) を加え室温にて1時間撹拌した。このものに 3 (200 mg, 0.29 mmol) の THF (2.0 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を酢酸エチル (10 mL) で希釈し、水 (10 mL)、飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 4 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 60 対 1 → 11 対 2 → 7 対 2) で分離精製し、8r (38 mg, 0.06 mmol, 収率 20%) を得た。1H-NMR(CDCl3)δ: 2.93 (1H, br), 3.59-3.74 (44H, br), 3.86 (2H, t, J=4.8 Hz), 4.18 (2H, t, J=4.8 Hz), 6.97 (2H, d, J=9.2 Hz), 7.58 (2H, d, J=9.2 Hz)。 7r (118 mg, 1.00 mmol) and benzyltriethylammonium chloride (26 mg, 0.11 mmol) were dissolved in THF (1.5 mL). To this, sodium hydride (mineral oil suspension, purity 60%, 52 mg, 1.30 mmol) was added and stirred at room temperature for 1 hour. To this was added a solution of 3 (200 mg, 0.29 mmol) in THF (2.0 mL) and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with ethyl acetate (10 mL), and washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The resulting residue was separated and purified by silica gel column chromatography (silica gel: 4 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 60 to 1 → 11 to 2 → 7 to 2), and 8r (38 mg, 0.06 mmol, yield 20%). 1 H-NMR (CDCl 3 ) δ: 2.93 (1H, br), 3.59-3.74 (44H, br), 3.86 (2H, t, J = 4.8 Hz), 4.18 (2H, t, J = 4.8 Hz), 6.97 (2H, d, J = 9.2 Hz), 7.58 (2H, d, J = 9.2 Hz).
Dodecaethylene glycol mono(6-quinolyl) ether (8s) Dodecaethylene glycol mono (6-quinolyl) ether (8s)
7s (140 mg, 0.96 mmol) 及び塩化ベンジルトリエチルアンモニウム (22 mg, 0.10 mmol) を THF (1.5 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 44 mg, 1.10 mmol) を加え室温にて1時間撹拌した。このものに 3 (175 mg, 0.25 mmol) の THF (2.0 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を水 (10 mL) で希釈し、クロロホルム (10 mL×4) で抽出した。クロロホルム層は、水 (10 mL)、飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 4 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 16 対 1 → 4 対 1) で分離精製し、8s (132 mg, 0.20 mmol, 収率 79%) を得た。1H-NMR(CDCl3)δ: 2.80 (1H, br), 3.58-3.79 (44H, br), 3.94 (2H, t, J=4.8 Hz), 4.26 (2H, t, J=4.8 Hz), 7.08 (1H, d, J=2.7 Hz), 7.35 (1H, dd, J=8.3 Hz, 3.3 Hz), 7.40 (1H, dd, J=9.2 Hz, 2.7 Hz), 7.99 (1H, d, J=9.2 Hz), 8.04 (1H, d, J=8.3 Hz), 8.77 (1H, d, J=3.3 Hz)。 7s (140 mg, 0.96 mmol) and benzyltriethylammonium chloride (22 mg, 0.10 mmol) were dissolved in THF (1.5 mL). To this, sodium hydride (mineral oil suspension, purity 60%, 44 mg, 1.10 mmol) was added and stirred at room temperature for 1 hour. A solution of 3 (175 mg, 0.25 mmol) in THF (2.0 mL) was added to this, and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with water (10 mL) and extracted with chloroform (10 mL × 4). The chloroform layer was washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The obtained residue was separated and purified by silica gel column chromatography (silica gel: 4 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 16 to 1 → 4 to 1), and 8s (132 mg, 0.20 mmol, collected) Rate 79%). 1 H-NMR (CDCl 3 ) δ: 2.80 (1H, br), 3.58-3.79 (44H, br), 3.94 (2H, t, J = 4.8 Hz), 4.26 (2H, t, J = 4.8 Hz), 7.08 (1H, d, J = 2.7 Hz), 7.35 (1H, dd, J = 8.3 Hz, 3.3 Hz), 7.40 (1H, dd, J = 9.2 Hz, 2.7 Hz), 7.99 (1H, d, J = 9.2 Hz), 8.04 (1H, d, J = 8.3 Hz), 8.77 (1H, d, J = 3.3 Hz).
Dodecaethylene glycol mono(1-naphthyl) ether (8t) Dodecaethylene glycol mono (1-naphthyl) ether (8t)
7t (141 mg, 0.98 mmol) を THF (1.5 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 53 mg, 1.33 mmol) を加え室温にて1時間撹拌した。このものに 3 (206 mg, 0.29 mmol) の THF (2.0 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を酢酸エチル (10 mL) で希釈し、水 (10 mL)、飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 4 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 45 対 1 → 30 対 1 → 8 対 1 → 4 対 1) で分離精製し、8t (68 mg, 0.10 mmol, 収率 34%) を得た。1H-NMR(CDCl3)δ: 2.93 (1H, br), 3.59-3.66 (44H, br), 3.93 (2H, t, J=4.8 Hz), 4.26 (2H, t, J=4.8 Hz), 7.13-7.18 (2H, m), 7.30-7.46 (2H, m), 7.71-7.78 (3H, m)。 7t (141 mg, 0.98 mmol) was dissolved in THF (1.5 mL). To this, sodium hydride (mineral oil suspension, purity 60%, 53 mg, 1.33 mmol) was added and stirred at room temperature for 1 hour. To this was added a solution of 3 (206 mg, 0.29 mmol) in THF (2.0 mL) and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with ethyl acetate (10 mL), and washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The resulting residue was separated and purified by silica gel column chromatography (silica gel: 4 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 45 to 1 → 30 to 1 → 8 to 1 → 4 to 1) (68 mg, 0.10 mmol, 34% yield) was obtained. 1 H-NMR (CDCl 3 ) δ: 2.93 (1H, br), 3.59-3.66 (44H, br), 3.93 (2H, t, J = 4.8 Hz), 4.26 (2H, t, J = 4.8 Hz), 7.13-7.18 (2H, m), 7.30-7.46 (2H, m), 7.71-7.78 (3H, m).
Dodecaethylene glycol mono(1-naphthyl) ether (8u) Dodecaethylene glycol mono (1-naphthyl) ether (8u)
7u (180 mg, 1.25 mmol) を THF (1.5 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 56 mg, 1.40 mmol) を加え室温にて1時間撹拌した。このものに 3 (240 mg, 0.34 mmol) の THF (2.0 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を酢酸エチル (10 mL) で希釈し、水 (10 mL)、飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 5 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 50 対 1 → 8 対 1 → 4 対 1) で分離精製し、8u (131 mg, 0.19 mmol, 収率 57%) を得た。1H-NMR(CDCl3)δ: 2.72 (1H, br), 3.58-3.65 (44H, br), 3.81 (2H, t, J=4.9 Hz), 4.01 (2H, t, J=4.9 Hz), 6.82 (1H, d, J=8.1 Hz), 7.33-7.49 (4H, m), 7.79 (1H, dd, J=6.7 Hz, 2.5 Hz), 8.28 (1H, d, J=8.1 Hz)。 7u (180 mg, 1.25 mmol) was dissolved in THF (1.5 mL). Sodium hydride (mineral oil suspension, purity 60%, 56 mg, 1.40 mmol) was added thereto, and the mixture was stirred at room temperature for 1 hour. To this was added a solution of 3 (240 mg, 0.34 mmol) in THF (2.0 mL) and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with ethyl acetate (10 mL), and washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The obtained residue was separated and purified by silica gel column chromatography (silica gel: 5 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 50 to 1 → 8 to 1 → 4 to 1), and 8u (131 mg, 0.19 mmol, 57% yield). 1 H-NMR (CDCl 3 ) δ: 2.72 (1H, br), 3.58-3.65 (44H, br), 3.81 (2H, t, J = 4.9 Hz), 4.01 (2H, t, J = 4.9 Hz), 6.82 (1H, d, J = 8.1 Hz), 7.33-7.49 (4H, m), 7.79 (1H, dd, J = 6.7 Hz, 2.5 Hz), 8.28 (1H, d, J = 8.1 Hz).
Dodecaethylene glycol mono(4-formylphenyl) ether (8v) Dodecaethylene glycol mono (4-formylphenyl) ether (8v)
7v (120 mg, 0.98 mmol) を THF (1.5 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 40 mg, 1.00 mmol) を加え室温にて1時間撹拌した。このものに 3 (180 mg, 0.26 mmol) の THF (2.0 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を酢酸エチル (10 mL) で希釈し、水 (10 mL)、飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 4 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 30 対 1 → 8 対 1 → 4 対 1) で分離し、1H-NMR 積分比より 8v と 3 の 1 対 1.3 混合物 (50 mg) を得た。(8v の換算収量 21 mg, 0.03 mmol, 換算収率 12%)1H-NMR(CDCl3)δ: 2.90 (1H, br), 3.58-3.65 (44H, br), 3.89 (2H, t, J=5.0 Hz), 4.22 (2H, t, J=5.0 Hz), 7.02 (1H, d, J=8.7 Hz), 7.83 (1H, d, J=8.7 Hz), 9.89 (1H, s)。 7v (120 mg, 0.98 mmol) was dissolved in THF (1.5 mL). To this was added sodium hydride (mineral oil suspension, purity 60%, 40 mg, 1.00 mmol), and the mixture was stirred at room temperature for 1 hour. To this was added a solution of 3 (180 mg, 0.26 mmol) in THF (2.0 mL) and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with ethyl acetate (10 mL), and washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The obtained residue was separated by silica gel column chromatography (silica gel: 4 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 30 to 1 → 8 to 1 → 4 to 1), and 1 H-NMR integration ratio Thus, a 1 to 1.3 mixture (50 mg) of 8v and 3 was obtained. (8v conversion yield 21 mg, 0.03 mmol, conversion yield 12%) 1 H-NMR (CDCl 3 ) δ: 2.90 (1H, br), 3.58-3.65 (44H, br), 3.89 (2H, t, J = 5.0 Hz), 4.22 (2H, t, J = 5.0 Hz), 7.02 (1H, d, J = 8.7 Hz), 7.83 (1H, d, J = 8.7 Hz), 9.89 (1H, s).
Dodecaethylene glycol mono(2-isopropyl-5-methylphenyl) ether (8y) Dodecaethylene glycol mono (2-isopropyl-5-methylphenyl) ether (8y)
7y (160 mg, 1.07 mmol) を THF (1.5 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 45 mg, 1.13 mmol) を加え室温にて1時間撹拌した。このものに 3 (220 mg, 0.31 mmol) の THF (2.0 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を酢酸エチル (10 mL) で希釈し、水 (10 mL)、飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 4 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 90 対 1 → 45 対 1 → 45 対 2 → 8 対 1 → 4 対 1) で分離精製し、8y (101 mg, 0.15 mmol, 収率 47%) を得た。1H-NMR(CDCl3)δ: 1.19 (6H, d, J=7.0 Hz), 2.31 (1H, s), 2.88 (1H, br), 3.28 (1H, septet, J=7.0 Hz), 3.58-3.65 (44H, br), 3.86 (2H, t, J=5.1 Hz), 4.12 (2H, t, J=5.1 Hz), 6.66 (1H, s), 6.74 (1H, d, J=7.8 Hz), 7.08 (1H, d, J=7.8 Hz)。 7y (160 mg, 1.07 mmol) was dissolved in THF (1.5 mL). To this, sodium hydride (mineral oil suspension, purity 60%, 45 mg, 1.13 mmol) was added and stirred at room temperature for 1 hour. A solution of 3 (220 mg, 0.31 mmol) in THF (2.0 mL) was added to this, and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with ethyl acetate (10 mL), and washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. Separation of the obtained residue by silica gel column chromatography (silica gel: 4 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 90 to 1 → 45 to 1 → 45 to 2 → 8 to 1 → 4 to 1) Purification gave 8y (101 mg, 0.15 mmol, 47% yield). 1 H-NMR (CDCl 3 ) δ: 1.19 (6H, d, J = 7.0 Hz), 2.31 (1H, s), 2.88 (1H, br), 3.28 (1H, septet, J = 7.0 Hz), 3.58- 3.65 (44H, br), 3.86 (2H, t, J = 5.1 Hz), 4.12 (2H, t, J = 5.1 Hz), 6.66 (1H, s), 6.74 (1H, d, J = 7.8 Hz), 7.08 (1H, d, J = 7.8 Hz).
Dodecaethylene glycol mono(2,4-bis(1,1-dimethylpropyl)phenyl) ether (8z) Dodecaethylene glycol mono (2,4-bis (1,1-dimethylpropyl) phenyl) ether (8z)
7z (240 mg, 1.02 mmol) を THF (2.0 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 53 mg, 1.33 mmol) を加え室温にて1時間撹拌した。このものに 3 (225 mg, 0.32 mmol) の THF (2.0 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を酢酸エチル (10 mL) で希釈し、水 (10 mL)、飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 4 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 60 対 1 → 30 対 1 → 4 対 1) で分離精製し、8z (192 mg, 0.25 mmol, 収率 79%) を得た。1H-NMR(CDCl3)δ: 0.61 (3H, t, J=7.5 Hz), 0.66 (3H, t, J=7.5 Hz), 1.25 (6H, s), 1.34 (6H, s), 1.59 (2H, q, J=7.5 Hz), 1.83 (2H, q, J=7.5 Hz), 2.73 (1H, br), 3.59-3.74 (44H, br), 3.86 (2H, t, J=5.2 Hz), 4.10 (2H, t, J=4.8 Hz), 6.75 (1H, d, J=8.4 Hz), 7.07 (1H, dd, J=8.4 Hz, 2.4 Hz), 7.16 (1H, d, J=2.4 Hz)。 7z (240 mg, 1.02 mmol) was dissolved in THF (2.0 mL). To this, sodium hydride (mineral oil suspension, purity 60%, 53 mg, 1.33 mmol) was added and stirred at room temperature for 1 hour. To this was added a solution of 3 (225 mg, 0.32 mmol) in THF (2.0 mL) and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with ethyl acetate (10 mL), and washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The obtained residue was separated and purified by silica gel column chromatography (silica gel: 4 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 60 to 1 → 30 to 1 → 4 to 1), and 8z (192 mg, 0.25 mmol, yield 79%). 1 H-NMR (CDCl 3 ) δ: 0.61 (3H, t, J = 7.5 Hz), 0.66 (3H, t, J = 7.5 Hz), 1.25 (6H, s), 1.34 (6H, s), 1.59 ( 2H, q, J = 7.5 Hz), 1.83 (2H, q, J = 7.5 Hz), 2.73 (1H, br), 3.59-3.74 (44H, br), 3.86 (2H, t, J = 5.2 Hz), 4.10 (2H, t, J = 4.8 Hz), 6.75 (1H, d, J = 8.4 Hz), 7.07 (1H, dd, J = 8.4 Hz, 2.4 Hz), 7.16 (1H, d, J = 2.4 Hz) .
Dodecaethylene glycol mono(4-methylphenyl) ether (8aa) Dodecaethylene glycol mono (4-methylphenyl) ether (8aa)
7aa (110 mg, 1.02 mmol) を THF (1.5 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 50 mg, 1.25 mmol) を加え室温にて1時間撹拌した。このものに 3 (250 mg, 0.36 mmol) の THF (2.0 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を酢酸エチル (10 mL) で希釈し、水 (10 mL)、飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 4 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 45 対 1 → 8 対 1 → 4 対 1) で分離精製し、8aa (85 mg, 0.13 mmol, 収率 37%) を得た。1H-NMR(CDCl3)δ: 2.28 (3H, s), 2.80 (1H, br), 3.59-3.66 (44H, br), 3.84 (2H, t, J=4.8 Hz), 4.10 (2H, t, J=4.8 Hz), 6.81 (2H, d, J=8.3 Hz), 7.06 (2H, d, J=8.3 Hz)。 7aa (110 mg, 1.02 mmol) was dissolved in THF (1.5 mL). To this, sodium hydride (mineral oil suspension, purity 60%, 50 mg, 1.25 mmol) was added and stirred at room temperature for 1 hour. To this was added a solution of 3 (250 mg, 0.36 mmol) in THF (2.0 mL) and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with ethyl acetate (10 mL), and washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The obtained residue was separated and purified by silica gel column chromatography (silica gel: 4 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 45 to 1 → 8 to 1 → 4 to 1) to obtain 8aa (85 mg, 0.13 mmol, yield 37%). 1 H-NMR (CDCl 3 ) δ: 2.28 (3H, s), 2.80 (1H, br), 3.59-3.66 (44H, br), 3.84 (2H, t, J = 4.8 Hz), 4.10 (2H, t , J = 4.8 Hz), 6.81 (2H, d, J = 8.3 Hz), 7.06 (2H, d, J = 8.3 Hz).
Dodecaethylene glycol mono(3-trifluoromethylphenyl) ether (8ab) Dodecaethylene glycol mono (3-trifluoromethylphenyl) ether (8ab)
7ab (180 mg, 1.12 mmol) を THF (1.5 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 58 mg, 1.45 mmol) を加え室温にて1時間撹拌した。このものに 3 (250 mg, 0.36 mmol) の THF (1.5 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を酢酸エチル (10 mL) で希釈し、水 (10 mL)、飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 5 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 45 対 1 → 8 対 1 → 4 対 1) で分離精製し、8ab (187 mg, 0.27 mmol, 収率 76%) を得た。1H-NMR(CDCl3)δ: 2.76 (1H, br), 3.59-3.64 (44H, br), 3.87 (2H, t, J=4.8 Hz), 4.17 (2H, t, J=4.8 Hz), 7.09 (1H, dd, J=8.3 Hz, 2.3 Hz), 7.15 (1H, br), 7.20 (2H, d, J=7.8 Hz), 7.38 (1H, dd, J=8.3 Hz, 7.8 Hz)。 7ab (180 mg, 1.12 mmol) was dissolved in THF (1.5 mL). To this, sodium hydride (mineral oil suspension, purity 60%, 58 mg, 1.45 mmol) was added and stirred at room temperature for 1 hour. To this was added a solution of 3 (250 mg, 0.36 mmol) in THF (1.5 mL) and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with ethyl acetate (10 mL), and washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The resulting residue was separated and purified by silica gel column chromatography (silica gel: 5 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 45 to 1 → 8 to 1 → 4 to 1), and 8ab (187 mg, 0.27 mmol, yield 76%). 1 H-NMR (CDCl 3 ) δ: 2.76 (1H, br), 3.59-3.64 (44H, br), 3.87 (2H, t, J = 4.8 Hz), 4.17 (2H, t, J = 4.8 Hz), 7.09 (1H, dd, J = 8.3 Hz, 2.3 Hz), 7.15 (1H, br), 7.20 (2H, d, J = 7.8 Hz), 7.38 (1H, dd, J = 8.3 Hz, 7.8 Hz).
Dodecaethylene glycol mono(2-trifluoromethylphenyl) ether (8ac) Dodecaethylene glycol mono (2-trifluoromethylphenyl) ether (8ac)
7ac (170 mg, 0.98 mmol) を THF (1.5 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 51 mg, 1.28 mmol) を加え室温にて1時間撹拌した。このものに 3 (204 mg, 0.29 mmol) の THF (2.0 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を酢酸エチル (10 mL) で希釈し、水 (10 mL) および飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 4 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 45 対 1 → 8 対 1 → 4 対 1 ) で分離し、1H-NMR 積分比より 8ac と 3 の 11 対 1 混合物 (90 mg) を得た。(8ac の換算収量 82 mg, 0.12 mmol, 換算収率 41%)1H-NMR(CDCl3)δ: 2.82 (1H, br), 3.59-3.64 (44H, br), 3.89 (2H, t, J=5.1 Hz), 4.21 (2H, t, J=5.1 Hz), 7.01 (2H, d, J=7.8 Hz), 7.47 (1H, m), 7.56 (1H, d, J=7.8 Hz)。 7ac (170 mg, 0.98 mmol) was dissolved in THF (1.5 mL). Sodium hydride (mineral oil suspension, purity 60%, 51 mg, 1.28 mmol) was added thereto, and the mixture was stirred at room temperature for 1 hour. To this was added a solution of 3 (204 mg, 0.29 mmol) in THF (2.0 mL) and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with ethyl acetate (10 mL), and washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The obtained residue was separated by silica gel column chromatography (silica gel: 4 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 45 to 1 → 8 to 1 → 4 to 1), and 1 H-NMR integration ratio As a result, an 11 to 1 mixture (90 mg) of 8ac and 3 was obtained. (Equivalent yield of 8ac 82 mg, 0.12 mmol, Equivalent yield 41%) 1 H-NMR (CDCl 3 ) δ: 2.82 (1H, br), 3.59-3.64 (44H, br), 3.89 (2H, t, J = 5.1 Hz), 4.21 (2H, t, J = 5.1 Hz), 7.01 (2H, d, J = 7.8 Hz), 7.47 (1H, m), 7.56 (1H, d, J = 7.8 Hz).
Dodecaethylene glycol mono(3,5-bis(trifluoromethyl)phenyl) ether (8ad) Dodecaethylene glycol mono (3,5-bis (trifluoromethyl) phenyl) ether (8ad)
7ad (225 mg, 0.98 mmol) を THF (1.5 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 45 mg, 1.13 mmol) を加え室温にて1時間撹拌した。このものに 3 (200 mg, 0.29 mmol) の THF (2.0 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を酢酸エチル (10 mL) で希釈し、水 (10 mL)、飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 4 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 45 対 1 → 30 対 1 → 8 対 1 → 7 対 2) で分離精製し、8ad (126 mg, 0.17 mmol, 収率 58%) を得た。1H-NMR(CDCl3)δ: 2.94 (1H, br), 3.57-3.63 (44H, br), 3.89 (2H, t, J=4.6 Hz), 4.22 (2H, t, J=4.6 Hz), 7.35 (2H, s), 7.45 (1H, s)。 7ad (225 mg, 0.98 mmol) was dissolved in THF (1.5 mL). To this, sodium hydride (mineral oil suspension, purity 60%, 45 mg, 1.13 mmol) was added and stirred at room temperature for 1 hour. To this was added a solution of 3 (200 mg, 0.29 mmol) in THF (2.0 mL) and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with ethyl acetate (10 mL), and washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The obtained residue was separated and purified by silica gel column chromatography (silica gel: 4 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 45 to 1 → 30 to 1 → 8 to 1 → 7 to 2), and 8ad (126 mg, 0.17 mmol, 58% yield) was obtained. 1 H-NMR (CDCl 3 ) δ: 2.94 (1H, br), 3.57-3.63 (44H, br), 3.89 (2H, t, J = 4.6 Hz), 4.22 (2H, t, J = 4.6 Hz), 7.35 (2H, s), 7.45 (1H, s).
Dodecaethylene glycol mono(4-iodophenyl) ether (8ah) Dodecaethylene glycol mono (4-iodophenyl) ether (8ah)
7ah (216 mg, 0.98 mmol) を THF (2.0 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 51 mg, 1.28 mmol) を加え室温にて1時間撹拌した。このものに 3 (172 mg, 0.25 mmol) の THF (2.0 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を酢酸エチル (10 mL) で希釈し、水 (10 mL)、飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 4 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 45 対 1 → 45 対 2 → 8 対 1) で分離精製し、8ah (74 mg, 0.10 mmol, 収率 40%) を得た。1H-NMR(CDCl3)δ: 2.70 (1H, br), 3.59-3.73 (44H, br), 3.84 (2H, t, J=4.8 Hz), 4.09 (2H, t, J=4.8 Hz), 6.70 (2H, d, J=8.9 Hz), 7.54 (2H, d, J=8.9 Hz)。 7ah (216 mg, 0.98 mmol) was dissolved in THF (2.0 mL). Sodium hydride (mineral oil suspension, purity 60%, 51 mg, 1.28 mmol) was added thereto, and the mixture was stirred at room temperature for 1 hour. To this was added a solution of 3 (172 mg, 0.25 mmol) in THF (2.0 mL) and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with ethyl acetate (10 mL), and washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The resulting residue was separated and purified by silica gel column chromatography (silica gel: 4 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 45 to 1 → 45 to 2 → 8 to 1), and 8ah (74 mg, 0.10 mmol, 40% yield). 1 H-NMR (CDCl 3 ) δ: 2.70 (1H, br), 3.59-3.73 (44H, br), 3.84 (2H, t, J = 4.8 Hz), 4.09 (2H, t, J = 4.8 Hz), 6.70 (2H, d, J = 8.9 Hz), 7.54 (2H, d, J = 8.9 Hz).
Dodecaethylene glycol mono(p-biphenyl) ether (8aj) Dodecaethylene glycol mono (p-biphenyl) ether (8aj)
7aj (173 mg, 1.02 mmol) を THF (1.5 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 45 mg, 1.13 mmol) を加え室温にて1時間撹拌した。このものに 3 (216 mg, 0.31 mmol) の THF (2.0 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を酢酸エチル (10 mL) で希釈し、水 (10 mL)、飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 4 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 45 対 1 → 30 対 1 → 45 対 2 → 8 対 1 → 7 対 2) で分離精製し、8aj (105 mg, 0.15 mmol, 収率 49%) を得た。1H-NMR(CDCl3)δ: 3.57 (1H, t, J=6.0 Hz), 3.59-3.75 (44H, br), 3.88 (2H, t, J=4.9 Hz), 4.18 (2H, t, J=4.9 Hz), 6.99 (2H, d, J=8.7 Hz), 7.30-7.57 (7H, m)。 7aj (173 mg, 1.02 mmol) was dissolved in THF (1.5 mL). To this, sodium hydride (mineral oil suspension, purity 60%, 45 mg, 1.13 mmol) was added and stirred at room temperature for 1 hour. To this was added a solution of 3 (216 mg, 0.31 mmol) in THF (2.0 mL) and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with ethyl acetate (10 mL), and washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The obtained residue was separated by silica gel column chromatography (silica gel: 4 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 45 to 1 → 30 to 1 → 45 to 2 → 8 to 1 → 7 to 2) Purification was performed to obtain 8aj (105 mg, 0.15 mmol, yield 49%). 1 H-NMR (CDCl 3 ) δ: 3.57 (1H, t, J = 6.0 Hz), 3.59-3.75 (44H, br), 3.88 (2H, t, J = 4.9 Hz), 4.18 (2H, t, J = 4.9 Hz), 6.99 (2H, d, J = 8.7 Hz), 7.30-7.57 (7H, m).
Dodecaethylene glycol mono(5,6,7,8-tetrahydro-2-naphthyl) ether (8ap) Dodecaethylene glycol mono (5,6,7,8-tetrahydro-2-naphthyl) ether (8ap)
7ap (144 mg, 0.97 mmol) を THF (1.5 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 52 mg, 1.30 mmol) を加え室温にて1時間撹拌した。このものに 3 (175 mg, 0.25 mmol) の THF (2.0 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を酢酸エチル (10 mL) で希釈し、水 (10 mL)、飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 4 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 30 対 1 → 4 対 1) で分離精製し、8ap (83 mg, 0.12 mmol, 収率 49%) を得た。1H-NMR(CDCl3)δ: 1.76 (4H, m), 2.70 (4H, m), 3.46 (1H, br), 3.59-3.74 (42H, br), 3.83 (2H, t, J=5.6 Hz), 4.09 (2H, t, J=4.9 Hz), 4.22 (2H, t, J=4.9 Hz), 6.62 (1H, d, J=2.6 Hz), 6.67 (1H, dd, J=8.5 Hz, 2.6 Hz), 6.95 (1H, d, J=8.5 Hz)。 7ap (144 mg, 0.97 mmol) was dissolved in THF (1.5 mL). To this, sodium hydride (mineral oil suspension, purity 60%, 52 mg, 1.30 mmol) was added and stirred at room temperature for 1 hour. A solution of 3 (175 mg, 0.25 mmol) in THF (2.0 mL) was added to this, and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with ethyl acetate (10 mL), and washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The obtained residue was separated and purified by silica gel column chromatography (silica gel: 4 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 30 to 1 → 4 to 1), and 8 ap (83 mg, 0.12 mmol, collected) Rate 49%). 1 H-NMR (CDCl 3 ) δ: 1.76 (4H, m), 2.70 (4H, m), 3.46 (1H, br), 3.59-3.74 (42H, br), 3.83 (2H, t, J = 5.6 Hz ), 4.09 (2H, t, J = 4.9 Hz), 4.22 (2H, t, J = 4.9 Hz), 6.62 (1H, d, J = 2.6 Hz), 6.67 (1H, dd, J = 8.5 Hz, 2.6 Hz), 6.95 (1H, d, J = 8.5 Hz).
Dodecaethylene glycol mono(4'-iodo-4-biphenyl) ether (8bw) Dodecaethylene glycol mono (4'-iodo-4-biphenyl) ether (8bw)
7bw (310 mg, 1.05 mmol) を THF (5.0 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 51 mg, 1.28 mmol) を加え室温にて1時間撹拌した。このものに 3 (200 mg, 0.29 mmol) の THF (2.0 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を酢酸エチル (10 mL) で希釈し、水 (10 mL)、飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 5 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 45 対 1 → 45 対 2 → 8 対 1 → 7 対 2) で分離し、8 bw (52 mg, 0.06 mmol, 収率 22%) を得た。1H-NMR(CDCl3)δ: 2.75 (1H, br), 3.56-3.64 (44H, br), 3.88 (2H, t, J=4.9 Hz), 4.17 (2H, t, J=4.9 Hz), 6.98 (2H, d, J=8.6 Hz), 7.29 (2H, d, J=8.6 Hz), 7.47 (2H, d, J=8.6 Hz), 7.73 (2H, d, J=8.6 Hz)。 7bw (310 mg, 1.05 mmol) was dissolved in THF (5.0 mL). Sodium hydride (mineral oil suspension, purity 60%, 51 mg, 1.28 mmol) was added thereto, and the mixture was stirred at room temperature for 1 hour. To this was added a solution of 3 (200 mg, 0.29 mmol) in THF (2.0 mL) and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with ethyl acetate (10 mL), and washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The obtained residue was separated by silica gel column chromatography (silica gel: 5 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 45 to 1 → 45 to 2 → 8 to 1 → 7 to 2), 8 bw (52 mg, 0.06 mmol, 22% yield) was obtained. 1 H-NMR (CDCl 3 ) δ: 2.75 (1H, br), 3.56-3.64 (44H, br), 3.88 (2H, t, J = 4.9 Hz), 4.17 (2H, t, J = 4.9 Hz), 6.98 (2H, d, J = 8.6 Hz), 7.29 (2H, d, J = 8.6 Hz), 7.47 (2H, d, J = 8.6 Hz), 7.73 (2H, d, J = 8.6 Hz).
Dodecaethylene glycol mono(4-(1,1,3,3-tetramethylbutyl)phenyl) ether (8cb) Dodecaethylene glycol mono (4- (1,1,3,3-tetramethylbutyl) phenyl) ether (8cb)
8cb (202 mg, 0.98 mmol) を THF (2.0 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 46 mg, 1.15 mmol) を加え室温にて1時間撹拌した。このものに 3 (203 mg, 0.29 mmol) の THF (2.5 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を酢酸エチル (10 mL) で希釈し、水 (10 mL)、飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 4 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 30 対 1 → 8 対 1 → 4 対 1) で分離精製し、8cb (81 mg, 0.11 mmol, 収率 38%) を得た。1H-NMR(CDCl3)δ: 0.70 (9H, s), 1.33 (6H, s), 1.69 (2H, s), 2.81 (1H, br), 3.59-3.72 (44H, br), 3.84 (2H, t, J=5.0 Hz), 4.11 (2H, t, J=5.0 Hz), 6.82 (2H, d, J=8.7 Hz), 7.25 (1H, d, J=8.7 Hz)。 8cb (202 mg, 0.98 mmol) was dissolved in THF (2.0 mL). To this, sodium hydride (mineral oil suspension, purity 60%, 46 mg, 1.15 mmol) was added and stirred at room temperature for 1 hour. To this was added a solution of 3 (203 mg, 0.29 mmol) in THF (2.5 mL) and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with ethyl acetate (10 mL), and washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The resulting residue was separated and purified by silica gel column chromatography (silica gel: 4 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 30 to 1 → 8 to 1 → 4 to 1), and 8cb (81 mg, 0.11 mmol, yield 38%). 1 H-NMR (CDCl 3 ) δ: 0.70 (9H, s), 1.33 (6H, s), 1.69 (2H, s), 2.81 (1H, br), 3.59-3.72 (44H, br), 3.84 (2H , t, J = 5.0 Hz), 4.11 (2H, t, J = 5.0 Hz), 6.82 (2H, d, J = 8.7 Hz), 7.25 (1H, d, J = 8.7 Hz).
Dodecaethylene glycol mono(2-iodo-4-biphenyl) ether (8cc) Dodecaethylene glycol mono (2-iodo-4-biphenyl) ether (8cc)
7cc (297 mg, 1.00 mmol) を THF (2.5 mL) に溶解させた。これに水素化ナトリウム (ミネラルオイル懸濁, 純度 60%, 46 mg, 1.15 mmol) を加え室温にて1時間撹拌した。このものに 3 (212 mg, 0.30 mmol) の THF (2.5 mL) 溶液を添加し、室温で24時間撹拌を続けた。反応溶液を酢酸エチル (10 mL) で希釈し、水 (10 mL)、飽和食塩水 (10 mL) で順次洗浄した。無水硫酸ナトリウムで乾燥後これを濾過し、エバポレーターで濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィー (シリカゲル : 5 g, 展開溶媒 : 酢酸エチル-メタノール混合溶媒 1 対 0 → 15 対 2 → 8 対 1 → 7 対 2) で分離精製し、8cc (46 mg, 0.06 mmol, 収率 19%) を得た。1H-NMR(CDCl3)δ: 2.75 (1H, br), 3.60-3.74 (42H, br), 3.83 (2H, t, J=4.8 Hz), 3.95 (2H, t, J=4.8 Hz), 4.22 (2H, t, J=4.8 Hz), 6.90 (1H, d, J=8.3 Hz), 7.30-7.53 (6H, m), 8.01 (1H, d, J=2.3 Hz)。 7cc (297 mg, 1.00 mmol) was dissolved in THF (2.5 mL). To this, sodium hydride (mineral oil suspension, purity 60%, 46 mg, 1.15 mmol) was added and stirred at room temperature for 1 hour. To this was added a solution of 3 (212 mg, 0.30 mmol) in THF (2.5 mL) and stirring was continued at room temperature for 24 hours. The reaction solution was diluted with ethyl acetate (10 mL), and washed successively with water (10 mL) and saturated brine (10 mL). After drying over anhydrous sodium sulfate, this was filtered and concentrated with an evaporator. The obtained residue was separated and purified by silica gel column chromatography (silica gel: 5 g, developing solvent: ethyl acetate-methanol mixed solvent 1 to 0 → 15 to 2 → 8 to 1 → 7 to 2), and 8 cc (46 mg, 0.06 mmol, 19% yield). 1 H-NMR (CDCl 3 ) δ: 2.75 (1H, br), 3.60-3.74 (42H, br), 3.83 (2H, t, J = 4.8 Hz), 3.95 (2H, t, J = 4.8 Hz), 4.22 (2H, t, J = 4.8 Hz), 6.90 (1H, d, J = 8.3 Hz), 7.30-7.53 (6H, m), 8.01 (1H, d, J = 2.3 Hz).
(試験例1)
細胞レべルでのバイオアッセイ
MTT法を用いて腫瘍細胞に対する細胞毒性の計測を行った。MTT法は比触法の一種である。MTT試薬[3-(4,5-Dimethylthioazol-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide]は生細胞中のミトコンドリア内脱水素酵素により、不溶性のMTT formazan (暗青色)に変換される。このMTT formaznの生成量を測定し、相対的な細胞の生存率として表す。
(Test Example 1)
Bioassay at the cellular level
The cytotoxicity against tumor cells was measured using the MTT method. The MTT method is a kind of specific touch method. MTT reagent [3- (4,5-Dimethylthioazol-2-thiazolyl) -2,5-diphenyl-2H-tetrazolium bromide] is converted into insoluble MTT formazan (dark blue) by mitochondrial dehydrogenase in living cells Is done. The amount of MTT formazn produced is measured and expressed as relative cell viability.
手順
1.細胞の前培養:初発細胞密度が2×104 cells/cm2となるように調整したHela細胞(子宮ガン由来)懸濁液を、50μ1ずつ96 well培養ブレートの各wellに分注した。CO2インキュベーター(37℃で、CO2濃度5 %)を用いて24時問培養した。
2.検定化合物の溶解:超純水に333μg/mlとなるよう溶解した。難溶で白濁するものに関しては、マグネチックスターラーによる撹拌を2時間以上継続することをもって溶解作業が終了したものとみなした。等量の2倍濃度細胞培養液と混合した後、クリーンべンチ内で濾過滅菌と同時に48 well培養ブレートに分注した。
3.検定化合物の希釈系列の作製:クリーンべンチ内で、48well培養プレートを用いて無菌的に、5倍希釈による濃度系列を作製した。細胞毒性活性の強さに応じて以下の2種類の濃度範囲のものを準備した。
1) 100、20、4、0.8およびO(ppm)(本培養時の最終濃度)
2) 4、0.8、0.16、0.032およびO(ppm)(本培養時の最終濃度)
4.本培養:所定濃度の検定化合物を含む培養液75μlを各wellに添加して本培養を開始した(培養液の全俄は125μlとなるため、検定化合物の濃度は60%に希釈される。すなわち、333μg/ml(検定化合物溶解時)→166.5 μg/ml(2倍濃度培養液との混合時)→ 99.9μg/ml(本培養開始時))。培養期間は3日間とした。
5.MTT反応:本培養終了後の培養プレートの各wellに0.5%MTT試薬を12.5μl添加し、C02インキュべーター内に4時間放置した。イソプロパノールに溶解した0.04N HClを各wellに137.5μ1加えて反応を停止させた後、青い粒子が溶けるまで十分にピペッティングを行った。
6.吸光度の測定:プレートリーダーにより570nm(peak)と630nm(bottom)における吸収光度差を測定した。
7.細胞生存率の算出:0ppm 作用区(生存率100%)における値に対する相対値を算出し、当該濃度作用区における細胞生存率(%)とした。なお、この値がマイナスになる場合は一律細胞生存率0%とみなした。
Procedure 1. Pre-culture of cells: Hela cell (uterine cancer-derived) suspension adjusted to have an initial cell density of 2 × 10 4 cells / cm 2 was dispensed into each well of a 96-well culture plate at 50 μl. The cells were cultured for 24 hours using a CO 2 incubator (37 ° C., CO 2 concentration 5%).
2. Dissolution of assay compound: Dissolved in ultrapure water to 333 μg / ml For those which were hardly soluble and clouded, it was considered that the melting operation was completed by continuing stirring with a magnetic stirrer for 2 hours or more. After mixing with an equal volume of double concentration cell culture, it was dispensed into a 48-well culture plate simultaneously with filter sterilization in a clean bench.
3. Preparation of dilution series of test compound: A series of concentrations was prepared by diluting 5 times aseptically using a 48-well culture plate in a clean bench. The following two concentration ranges were prepared according to the strength of cytotoxic activity.
1) 100, 20, 4, 0.8 and O (ppm) (final concentration during main culture)
2) 4, 0.8, 0.16, 0.032 and O (ppm) (final concentration during main culture)
4). Main culture: 75 μl of a culture solution containing a predetermined concentration of test compound was added to each well to initiate main culture (the total volume of the culture solution is 125 μl, so the concentration of the test compound is diluted to 60%. 333 μg / ml (when assay compound is dissolved) → 166.5 μg / ml (when mixed with double concentration culture medium) → 99.9 μg / ml (when main culture is started)). The culture period was 3 days.
5. MTT reaction: a 0.5% MTT reagent into each well of the culture plate after completion of the culture was added 12.5 [mu] l, and allowed to stand for 4 hours in a C0 2 incubator base Ta. After stopping the reaction by adding 137.5 μl of 0.04N HCl dissolved in isopropanol to each well, pipetting was sufficiently performed until the blue particles were dissolved.
6). Absorbance measurement: The difference in absorbance at 570 nm (peak) and 630 nm (bottom) was measured with a plate reader.
7). Calculation of cell viability: A relative value with respect to the value in the 0 ppm action group (survival rate 100%) was calculated and used as the cell viability (%) in the concentration action group. In addition, when this value became negative, it was considered that the uniform cell viability was 0%.
アッセイは3連で行い、数値計算は得られた3つの値の単純平均を用いて行う。 Assays are performed in triplicate and numerical calculations are performed using a simple average of the three values obtained.
(試験結果)
細胞レベルでのバイオアッセイにより得られた結果を以下に示す。表上に試験された化合物番号を記載している。また、PEG9は化合物2である。
(Test results)
The results obtained by the bioassay at the cellular level are shown below. The compound numbers tested are listed on the table. PEG9 is compound 2.
Claims (1)
One polyethylene glycol monoether compound or a salt thereof selected from the group consisting of the following compounds.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2008104089A JP5651291B2 (en) | 2008-04-11 | 2008-04-11 | Polyethylene glycol derivative and process for producing the intermediate |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2008104089A JP5651291B2 (en) | 2008-04-11 | 2008-04-11 | Polyethylene glycol derivative and process for producing the intermediate |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009256214A JP2009256214A (en) | 2009-11-05 |
| JP5651291B2 true JP5651291B2 (en) | 2015-01-07 |
Family
ID=41384122
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008104089A Expired - Fee Related JP5651291B2 (en) | 2008-04-11 | 2008-04-11 | Polyethylene glycol derivative and process for producing the intermediate |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP5651291B2 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0650263B2 (en) | 1983-04-18 | 1994-06-29 | 松下電器産業株式会社 | Infrared spectrophotometer |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5364532B2 (en) * | 2009-10-14 | 2013-12-11 | 株式会社センカファーマシー | Polyethylene glycol derivatives and antitumor agents containing them as active ingredients |
| TWI571458B (en) * | 2012-05-04 | 2017-02-21 | 陶氏全球科技責任有限公司 | Method for marking a petroleum hydrocarbon or a liquid biologically derived fuel |
| JP6539274B2 (en) | 2013-08-12 | 2019-07-03 | ファーマシューティカル マニュファクチュアリング リサーチ サービシズ,インコーポレーテッド | Extruded immediate release abuse deterrent pills |
| US10172797B2 (en) | 2013-12-17 | 2019-01-08 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded extended release abuse deterrent pill |
| US9492444B2 (en) | 2013-12-17 | 2016-11-15 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded extended release abuse deterrent pill |
| WO2016010771A1 (en) | 2014-07-17 | 2016-01-21 | Pharmaceutical Manufacturing Research Services, Inc. | Immediate release abuse deterrent liquid fill dosage form |
| JP6474565B2 (en) * | 2014-08-26 | 2019-02-27 | 東邦化学工業株式会社 | Urethane (meth) acrylate and active energy ray-curable composition containing the same |
| JP2017531026A (en) | 2014-10-20 | 2017-10-19 | ファーマシューティカル マニュファクチュアリング リサーチ サービシズ,インコーポレーテッド | Sustained release abuse deterrent liquid filler form |
| JP6638970B2 (en) * | 2015-06-30 | 2020-02-05 | 株式会社 東北テクノアーチ | Method for producing hetero-type monodisperse polyethylene glycol and intermediate for producing hetero-type monodisperse polyethylene glycol |
| CN106986789B (en) * | 2016-01-20 | 2019-07-16 | 中国人民解放军军事医学科学院生物医学分析中心 | Hydroquinone compound and preparation method thereof and the application in antitumor or immunological regulation |
| EP3208260A1 (en) | 2016-02-17 | 2017-08-23 | Clariant International Ltd | Alkoxylated hydroxybenzoic acid esters or amides |
| CN115353468B (en) * | 2022-08-19 | 2023-06-30 | 安阳工学院 | A kind of preparation method of p-toluenesulfonyloxy substituted tert-butyl oligoethylene glycol propionate |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3301807A (en) * | 1963-04-11 | 1967-01-31 | Thiokol Chemical Corp | Stabilized, concentrated polytetrafluoroethylene dispersions containing non-ionic surfactants |
| CA1083170A (en) * | 1975-09-05 | 1980-08-05 | Eugene P. Gosselink | Ethoxylated sulfonium switterionic compounds and detergent compositions containing them |
| JPS5521415A (en) * | 1978-07-28 | 1980-02-15 | Matsushita Electric Works Ltd | Thermosetting resin molding compound |
| DE3026448A1 (en) * | 1980-07-12 | 1982-02-04 | Bayer Ag, 5090 Leverkusen | ANTITUMORAL AGENTS |
| JPH0720860B2 (en) * | 1984-02-24 | 1995-03-08 | 理化学研究所 | Anti-cancer drug |
| JPS63104919A (en) * | 1986-10-21 | 1988-05-10 | Eisai Co Ltd | Anti-cancer drug consisting of adduct of menthanylphenol with ethylene oxide |
| JPH0742431B2 (en) * | 1987-05-12 | 1995-05-10 | 三菱化学株式会社 | Recording liquid |
| JPH02293844A (en) * | 1989-05-09 | 1990-12-05 | Fuji Photo Film Co Ltd | Silver halide photographic sensitive material |
| JP2001507706A (en) * | 1996-12-31 | 2001-06-12 | ザ ソールク インスチチュート フォア バイオロジカル スタディズ | Treatment of disease states resulting from neoplastic cell proliferation using PPAR-gamma activators and compositions useful for the treatment |
| KR100285275B1 (en) * | 1998-06-23 | 2001-05-02 | 김충섭 | Modified enzymes and their modifications |
| US6261434B1 (en) * | 1999-10-19 | 2001-07-17 | Kemet Electronics Corporation | Differential anodization process for electrolytic capacitor anode bodies |
| WO2004011993A1 (en) * | 2002-07-29 | 2004-02-05 | Menicon Co., Ltd. | Liquid enzyme preparation for contact lenses |
| WO2006043338A1 (en) * | 2004-10-18 | 2006-04-27 | Actice Co., Ltd. | Novel polyethylene glycol derivative or pharmaceutically acceptable salt thereof |
| WO2006134648A1 (en) * | 2005-06-15 | 2006-12-21 | Actice Co., Ltd. | Process for producing polyoxyethylene 2,4-diisooctylphenyl ether |
-
2008
- 2008-04-11 JP JP2008104089A patent/JP5651291B2/en not_active Expired - Fee Related
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0650263B2 (en) | 1983-04-18 | 1994-06-29 | 松下電器産業株式会社 | Infrared spectrophotometer |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2009256214A (en) | 2009-11-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5651291B2 (en) | Polyethylene glycol derivative and process for producing the intermediate | |
| JP5202635B2 (en) | Processes and intermediates for the preparation of integrase inhibitors | |
| JP2007505864A (en) | Manufacture of quetiapine | |
| HUE024989T2 (en) | Derivatives of azaindoles as inhibitors of protein kinases abl and src | |
| JPH1180142A (en) | Production of diphenylalkyl compound | |
| CN110330474A (en) | Apiolin-dithiocarbamate derivative preparation and antitumor application thereof | |
| US3055930A (en) | New benzophenone sulphonic acid amides | |
| CN103923080A (en) | Method for preparing antithrombotic drug apixaban | |
| JPH07110829B2 (en) | 5,8-dichloro-1,4,9,10-anthracene tron | |
| JP2009132722A (en) | 4-Chloro-3-methyl-2-butenylphenyl sulfide, di (4-chloro-3-methyl-2-butenyl) sulfide and di (4-chloro-3-methyl-) for the synthesis of natural carotenoid products Preparation of 2-butenyl) sulfone | |
| CN117164572B (en) | Coumarin-3-carboxamide derivative, preparation method thereof and application thereof in preparation of antitumor drugs | |
| KR19990082986A (en) | Process for alkylating hindered sulfonamides | |
| JP6795974B2 (en) | Method for producing optically active azetidineone compound | |
| CN113354498A (en) | Method for reducing aromatic C-N/O/Cl/Br/I bond into aromatic C-H/D | |
| JPS5929595B2 (en) | Production method of pyrimidine derivatives | |
| AP1155A (en) | Process for preparing phenoxphenysulfonyl halides. | |
| CN100408577C (en) | Process for the preparation of imidazo (1, 2-A) pyridine-3-acetamides | |
| CN113712961B (en) | Application of beta-selenoether imidazole compound in preparation of antitumor drugs | |
| CN105218581A (en) | A kind of synthetic method of 3-difluoro methylphosphonic acid diethyl-ester group oxoindole derivative | |
| CN118955233B (en) | A method for synthesizing monosubstituted bicyclo[1.1.1]pentane (BCP) | |
| JP4418430B2 (en) | Method for producing sulfonamide-containing indole compound | |
| JP2010202544A (en) | Method for producing thalidomide derivative | |
| JP6771775B2 (en) | Method for producing 2-aminonicotinic acid benzyl ester derivative | |
| CN117362209A (en) | Method for preparing N-dimercaptobenzamide and derivatives thereof by photocatalysis | |
| CN120774958A (en) | Preparation method of Bragg nylon |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20110405 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20130702 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130902 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20140318 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20140519 |
|
| RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20140530 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20141104 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20141117 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 5651291 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |